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One of the greatest challenges in synthetic chemistry is the development of 
reactions that can efficiently afford target compounds without creating byproducts.  One 
such class of reactions are [2+2+2] cycloadditions.  Here, three unsaturated coupling 
partners are combined to create six-membered rings, often with high regioselectivity, 
high yield, and no byproducts (i.e., secondary products).  To further increase the 
attractiveness of these reactions, iron, a cheap and abundant catalyst, can be used.  
However, for the [2+2+2] synthesis of pyridines, a very important class of compounds, 
iron has traditionally been a very poor catalyst.  By tethering unreactive nitriles to the 
more reactive alkynes, the first general iron-catalyzed [2+2+2] method to synthesize 
pyridines has been developed.  This reactivity was further explored with the 
cycloaddition of diynes and cyanamides.  Cyanamides demonstrated remarkable chemo- 
and regioselectivity.  The three-component cycloaddition of terminal alkynes and a 
cyanamide could be performed with high yield and complete chemoselectivity.  By 
combining aforementioned strategies of nitrile incorporation, the entirely novel 
cycloaddition of alkynenitriles and cyanamides has been developed.  In this case, iron 
demonstrated reactivity that few [2+2+2] cycloaddition catalyst exhibited by 
incorporating multiple nitrogen atoms into the resulting 6-membered ring.  Finally, 
isolation of presumed inorganic and organometallic intermediates provides a preliminary 
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A BRIEF INTRODUCTION TO [2+2+2] CYCLOADDITION, IRON 






 This chapter will introduce the relevant background in the three general fields in 
which this research has focused.  It will explain the basic mechanistic premise of [2+2+2] 
cycloadditions to make arenes and pyridines.  This section will conclude with 
regioselectivity challenges that have been largely unaddressed in three-component 
cyclizations.  The next discussion will weigh the benefits of using iron catalysts in place 
of precious metal catalysts.  This will highlight the challenges associated with iron-
catalysis and some examples where these challenges have been overcome.  Finally the 
importance of six-membered nitrogen heterocycles and the motivation to create synthetic 
methods by which they can be synthesized will be addressed.  These three general 
categories will be tied into the one main idea that encompasses this thesis. 
 
[2+2+2] Cycloaddition 
The cyclization of three acetylenes into benzene is a highly exothermic, 




high temperatures must be employed.1  The first such thermal cyclization was reported in 
1866 by Bertholet, however, this reaction was not further studied for the better part of a 
century.2  In 1948 Walter Reppe described the cyclotrimerization of acetylene by a nickel 
catalyst to produce benzene (equation 1).3  Since this initial report, countless studies have 
been undertaken in the field that is generally known as [2+2+2] cycloaddition.  A 
[2+2+2] cycloaddition is the combination of three unsaturated units, each containing two 
atoms, into a 6-membered ring.  This atom-economical transformation holds tremendous 
synthetic potential which, even after 55 years, continues to attract fervent interest.  
Reactions in this field have grown to encompass the synthesis of numerous carbocycles 
from various combinations of unsaturated hydrocarbons.4  Additionally, heteroatoms can 
be incorporated into cycloaddition products through the use of nitriles, carbonyls, and 
heteroallenes.5  This discussion will focus on the evolution of metal-catalyzed [2+2+2] 
arene and pyridine synthesis. 
 
Reppe demonstrated that the kinetic and entropic barriers to [2+2+2] 
cycloaddition can be overcome through the use of a transition metal.3  Subsequent 
mechanistic studies have uncovered the integral role played by metals in the 
cycloaddition mechanism (Figure 1).  When two alkynes coordinate to a low-oxidation-
state metal center, oxidative cyclization occurs.  This creates one of two possible 
metallacycles, which is dependent on the identity of the metal.  The formation of 
metallacyclopentadienes (1 for nickel and cobalt) or metalacyclopentatrienes (2 for 
ruthenium) has been substantiated through computational6 studies in addition to the 









of several possible reactions.6  The first possibility is a [4+2] cycloaddition, creating a 
cyclohexadiene bridged by the metal (3).  Alternatively, the alkyne can insert into the 
metal-carbon bond, creating a metallacycloheptatriene (4).  The third possibility involves 
a [2+2] cycloaddition between the metallacyclopenatriene and the alkyne, creating a 
metallabicycloheptatriene (5).  The bicyclic intermediate (5) then rearranges to the 
metallacycloheptatriene (4).  In any case, reductive elimination occurs creating the 
benzene product, thus completing the catalytic cycle. 
In 1973 Yamazaki reported the first use of a [2+2+2] cycloaddition to synthesize 
a heterocyclic compound.8  Here, pyridines were produced from the combination of two 
acetylenes and one nitrile in the presence of a cobalt catalyst (equation 2).  Like Reppe’s 
first reports of [2+2+2] cycloaddition, this report has led to countless subsequent studies 





The synthesis of pyridines from alkynes and nitriles by various metals is a well-
studied class of reactions.5  Two alkynes and one nitrile are cyclized in a [2+2+2] fashion 
which can follow one of two general catalytic cycles closely resembling that of alkyne 
cyclotrimerization (Figure 2).  The first catalytic cycle begins with oxidative cyclization 
of two alkynes (homocoupling) forming either a metallacyclopentadiene (6) or a 
metallacyclopentatriene (7).9  From here, three insertion intermediates (8-10), which are 
analogous to those of the alkyne trimerization, are possible.  The second pathway 
involves oxidative cyclization of an alkyne and a nitrile (heterocoupling) forming an 
azametallacyclopentadiene (11).  Insertion of alkynes into azametallacyclopentadienes 
has not been extensively studied and therefore only intermediate 9 is drawn. 
Today, the [2+2+2] construction of pyridines can be catalyzed by several metals, 
with cobalt traditionally being the most effective.  More recently systems involving 
ruthenium,10 rhodium,11 and iridium12 have been the subject of several studies.  Nickel 
was initially only useful for the stoichiometric conversion of azazirconacyclopentadienes 
to pyridines.13  Over the past decade the Louie group has established nickel/NHC (NHC 
= N-heterocyclic carbene) and nickel/Xantphos systems that are among the most effective 
methods of pyridine synthesis.14 
While conceptually straightforward, the [2+2+2] cyclization of two alkynes and 
one nitrile are quite challenging.  Reactions with unsymmetrical alkynes generally 





Figure 2.  Homocoupling and heterocoupling pathways for the [2+2+2] 
cycloaddition of alkynes and nitriles. 
 
alkyne cyclotrimerization further complicate the product mixture.  These complications 
are avoided by utilizing symmetrical diyne substrates, which can only afford one pyridine 
regioisomer (equation 4).16  Cycloadditions of diynes and nitriles produce bicyclic 
pyridines with the ring fusion at the 3- and 4-position.  To obtain two, 3-ring-fused 
pyridines, alkynenitrile substrates are used (equation 5).17  To build tricyclic pyridines in 








For the synthetic chemist, [2+2+2] cycloadditions provide a highly attractive tool 
for the atom-economic construction of 6-membered rings.  The cyclotrimerization of 
alkynes has been used as a key step in numerous total syntheses.19  The key step in the 
total syntheses of Alcyopterosins I, L, and M by Witulski and co-workers demonstrates 
the effectiveness of this strategy (Figure 3).20   
Although less frequently used, the [2+2+2] cycloaddition of two alkynes and a 
nitrile has also been applied to total syntheses.  The natural product (+)‒Complanadine A 
exhibits an interesting bipyridyl structure.  In an ambitious approach, the Siegel group 
created the bipyridyl bridge with two [2+2+2] intermolecular cobalt-mediated 
cycloadditions (Figure 4).21 
Ironically, the simplest substrates for [2+2+2] synthesis of pyridines, untethered 
alkynes and nitriles, provide the greatest challenge for metal-catalyzed [2+2+2] 
cycloaddition.  As mentioned earlier, cycloadditions with unsymmetrical alkynes can lead 
to the formation of numerous regioisomers (equation 3).15  Furthermore, terminal alkynes 





Figure 3.  Rhodium-catalyzed [2+2+2] cycloaddition of triynes in the total 





Figure 4.  Cobalt-catalyzed [2+2+2] cycloadditions of alkynes and 





[2+2+2] cycloadditions remain underdeveloped.  If regioselectivity challenges can be 
overcome, monocyclic six-membered rings of varying complexity can be synthesized 
from exceedingly simple starting materials. 
The synthetic power of a reaction that creates three new bonds in a single step 
with high atom efficiency is rare.  Currently, [2+2+2] cycloadditions to create substituted 
benzenes and pyridines are increasingly reliable and synthetically useful reactions.  
Future work in the field of [2+2+2] cycloaddition will involve improving the regio- and 




Nearly every iron-catalysis report starts with the same three points: iron is 
abundant, cheap, and nontoxic.  Iron’s abundance is the result of a process called stellar 
nucleosynthesis.23  Iron, because of its unique nuclear stability, is the final product of 
several stages of fusion in supergiant stars.  When these massive stars build up enough 
iron, their core becomes unstable, leading to a supernova.  The energy created by this 
enormous explosion causes various fusion and fission reactions, creating the elements 
that we know to populate the periodic table.  These newly formed elements, along with 
copious amounts of iron, are spread throughout space.  Over time, new stars and planets 
form from the debris.  This is the mechanism by which iron is spread throughout the 
universe and is the reason for its abundance on earth. 
The abundance of iron leads to its low cost and low toxicity.  Readily obtained on 
the earth’s crust, billions of tons of iron ore are extracted annually.24  Such largescale 
production ensures a low cost relative to precious metals such as Pt, Pd, Au, and so forth.  
Biological systems are very tolerant of iron because not only has life evolved in its 




presence, but most organisms have come to depend on it for basic functions.  This point 
is demonstrated by the prevalence of metalloproteins such as hemoglobin and 
nitrogenase.25 
Despite the economic and environmental advantages of iron, precious metals have 
come to dominate the field of transition metal catalysis.  This is because precious metals 
reliably undergo two-electron processes, while iron tends to undergo difficult-to-control 
single-electron processes.  Furthermore, iron exhibits a remarkably broad range of 
possible oxidation states as compared to other transition metals.  While the 2+ and 3+ 
oxidation states are most common, reports range from 6+ to 2-.26  This oxidative 
indecisiveness leads to the many side reactions, poor selectivity, and generally poor 
catalytic activity of iron. 
The combination of increasing refinement costs, environmental concerns, and 
ever-decreasing availability has led to the search for alternatives to precious metal 
catalysis.  In the past 20 years interest in iron-catalysis has grown immensely because 
iron is largely free from the economic, social, and environmental detriments associated 
with precious metals.  With so much attention over the past two decades, systems which 
overcome the challenges associated with iron-catalysis are now being realized. 
A very promising method of controlling iron reactivity is through the use of redox 
active ligands.27  Redox active (A.K.A. non-innocent) ligands exhibit HOMOs or 
LUMOs which are close in energy to their respective bound metal.28  The result of this 
energetic compatibility is that the metal center can share, or delocalize electron density 
onto the ligand.  This delocalization creates an exceedingly complicated electronic 
environment.  Despite this complexity, these ligands can impart extraordinary reactivity 




complexes grows, so does the scope and efficiency of the reactions which they catalyze. 
In 1998 Brookhart and Gibson independently discovered a class of iron catalysts 
that could polymerize ethylene with remarkably high turn-over-frequencies (equation 
7).29  The success of this reactivity can be attributed to the tridentate bis(imino)pyridine 
ligand bound to the iron center.  Subsequent studies into the mechanism of this reaction 
brought to light the unique electronic structure of these complexes.  For this reaction, the 
catalyst is activated by MAO (methylaluminoxane), creating a methylated, cationic 
complex.  The catalytic cycle involves continuous ethylene coordination and insertion, 
which repeats until a chain-termination event occurs (Figure 5).  Traditional chemical 
intuition and several density functional theory (DFT) studies classify the oxidation state 
of iron as Fe(II).30  However, conflicting DFT31 and spectroscopic32 studies suggest that 
the active catalyst may be Fe(III). 
 
The unique (iPrPDI)Fe(N)2 complex has been synthesized by Chirik and co-
workers (PDI = pyridyl diimine).33  In-depth spectroscopic and computational studies 
have been performed on this compound, clearly demonstrating the redox activity of  
bis(imino)pyridine ligands (Figure 6).34  What at first glance appears to be an Fe(0)  
complex is actually an Fe(II) coupled to a diradical dianionic ligand.  The first signs of an 















Elongation of the imine bonds and contraction of the Cimine-Cipso bonds suggest 
the presence of a radical centered on the imine carbons.  The NMR spectrum of 
(iPrPDI)Fe(N)2 shows an unusual shift of 13.61 ppm for the imine methyl protons and 
2.58 ppm for the p-pyridine proton.  This is especially unique when comparing to the 
similar bis(carbene)pyridine iron dinitrogen complex (27) prepared by Danopoulos and 
co-workers.35  In the dicarbene complex, the p-pyridine proton is found in the usual 
aromatic range of 7.20-7.35 ppm.  Mössbauer spectroscopy and SQUID magnetometry in 
combination with DFT studies further substantiate the diradical dianionic nature of 
(iPrPDI)Fe(N)2.  This study also compared the nonreduced dihalide (iPrPDI)FeCl2 and the 
single-electron reduced complex (iPrPDI)FeCl with (iPrPDI)Fe(N)2.  In each case iron 
retains its +2 oxidation state.  The bis(imino)pyridine ligands maintain an oxidatively 
stable iron center while still providing a place to store added electrons.  In the case of 
(iPrPDI)Fe(N)2, the ligand appears to promote the two-electron processes necessary to  
catalyze reactions such as ethylene polymerization.  Meanwhile it prevents the one-
electron processes that lead to undesirable side products. 
The dinitrogen complex and its analogues have demonstrated remarkable catalytic 
activity in a number of reactions.  Olefin hydrogenation by (iPrPDAI)Fe(N)2 exhibited a 
turnover frequency (TOF) of 1814 mol/h.33  This result is astounding when compared to 
the TOF for precious metal hydrogenation catalysts (Table 1). In a second example by 
Chirik, the antimarkovnikov hydrosilylation of terminal alkenes was carried out with  
only 0.02 mol% of the dimeric complex [(MePDI)Fe(N2)]2(μ-N2) (equation 8).36  In an 
excellent demonstration of the advantages offered by iron over precious metals, 
(iPrPDAI)Fe(N)2 was capable of cross-linking hydrido- and vinyl-functionalized silicone 




Table 1.  Comparison of Hydrogenation Catalysts 
 
present a significant challenge for catalyst recovery.  While catalyst recovery is necessary 








workers for the polymerization of 1,3-dienes (Figure 7).37  In this system, two different 
bidentate imiopyridine ligands can be used with catalyst loadings of only 0.02 mol%.  
The first ligand exhibits a tertiary alkyl imine substituent that selectively produces trans-
polydienes.  Remarkably, replacing the alkyl imine with an aromatic imine substituent 
reverses the selectivity to produce cis-polydienes in >99:1 (cis:trans). 
The aforementioned examples of iron-catalysts rivalling or outperforming their 
respective precious metal counterparts are likely only the beginning of a much larger 
trend.  As our understanding of redox-active iron complexes continues to advance, so will 
the scope of reactions that are efficiently catalyzed by iron. 
 
Six-Membered Nitrogen Heterocyles 
Six-membered nitrogen heterocycles represent a class of compounds with several 
important applications.  The FDA provides information on drug approvals on a monthly 
basis.38  For the past 10 years, 181 small-molecule drugs have been introduced in the US. 
Out of these 181 compounds, 50% contain at least one six-membered nitrogen- 
containing heterocycle (Figure 8).  This demonstrates the tremendous importance that this 
class of compounds holds in the pharmaceutical industry.  Furthermore, numerous natural 
products contain six-membered nitrogen heterocycles such as pyridines, pyrimidines,  
piperidines, and so forth.39  Six-membered nitrogen heterocycles also constitute 
numerous inorganic ligands and can be found in organic materials.40 
Billions of dollars are made annually by the top agrochemical companies.41  
Research and development in this industry can never cease because pest species are 
continuously evolving resistance to these chemicals.  A recent example is the appearance  










Figure 8.  Breakdown of six-membered N-heterocycles found in drugs 







complications is the quickly growing world population, which is expected to reach 8 
billion by 2024.42   To avoid a world food crisis it is imperative that high crop yields can  
be maintained without excessive costs.  The chemical industry must be able to supply 
safe and effective agrochemicals that can be produced at low cost.  Several known 
agrochemicals use 6-membered N-heterocycles (Figure 9).  
Organic light emitting diode (OLED) devices are an emerging technology that 
offer a combination of flexibility, durability and minimal energy consumption.  This new 
technology has very recently achieved commercialization in the form of electronic 
displays used in devices such as smart phones and televisions.  In 2013 this fledgling 
industry was projected to create $53 million in revenue.  That number is projected to 
increase to $3.4 billion by 2017.43  Currently, the excessive costs of these products limit 
their availability to only wealthy customers.  For this exponentially growing industry to 
expand into broader markets, costs must be reduced through improved fabrication 
methods and more effective production of raw materials. 
The raw materials that make OLED technologies special are known as electroluminescent 
materials.  These revolutionary materials often include 6-membered N-heterocycles.  
Improved methods to produce electroluminescent N-heterocycles will decrease costs and  
potentially open up previously unavailable materials for study.  Figure 10 highlights a 




A major area of study in the Louie group is the development of metal-catalyzed 
[2+2+2] cycloadditions which produce six-membered nitrogen heterocycles.  Atom- 





Figure 9.  Chemicals commonly used in the agrochemical industry. 
 
 





simple, inexpensive starting materials.  Our aim is to create efficient catalysts to give 
access to these important molecular scaffolds.  The purpose of this work has been to 
expand this focus to include iron catalysts.  The economic and environmental benefits of 
iron would further enhance the synthetic desirability and efficiency of [2+2+2] 
cycloaddition reactions.  Furthermore, introducing a new metal catalyst to the field opens 
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THE IRON-CATALYZED CYCLOADDITION OF ALKYNENITRILES AND 
ALKYNES; THE FIRST GENERAL IRON-CATALYZED 
METHOD TO PRODUCE PYRIDINES 
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Iron has long been known as an effective catalyst for the [2+2+2] 
cyclotrimerization of alkynes, with reports dating back to 1960.1  This reaction has since 
been expanded to regioselective 3-component cyclizations2 and the intramolecular 
cyclization of triynes.3  These methods are an excellent example of how complex 
products can be made in an atom-economical fashion using an inexpensive nontoxic 
catalyst. 
The iron-catalyzed synthesis of pyridines does not share the same efficiency.  
Despite early reports that iron is capable of producing pyridines in a [2+2+2] fashion, few 
efforts have been made to develop this into useful methodology.  The first report of iron-
catalyzed pyridine synthesis from acetylene and acetonitrile was in 1992 by Zenneck.4  
Although pyridine production was catalytic, it was significantly overshadowed by 
cyclotrimerization of the more reactive acetylene.  In an effort to favor the production of 




(equation 1).5  Although turnover numbers (TON) for pyridine production were as high as 
160 (mole pyridine/mole catalyst), arenes still dominated the product mixture.  Guerchais 
then demonstrated that pyridines could be produced exclusively from (Cp*)Fe(MeCN)3 
in acetonitrile solvent (equation 2).6  This reaction was not catalytic, however, due to 
strong η6-binding of the pyridine product to the iron reagent. 
 
 
These examples demonstrate the overwhelming reactivity of alkynes as compared 
to nitriles in iron-mediated [2+2+2] cycloaddition.  Guerchais was able to overcome the 
barrier to nitrile incorporation by utilizing a complex with precoordinated acetonitrile 
ligands.  Additionally, the reaction was carried out in acetonitrile solvent.  In this case, 
both factors seem to increase the local concentration of nitrile around the iron center, 
leading to exclusive pyridine formation. 
We theorized that, if a nitrile could be held in close proximity to the iron center, 
catalytic pyridine production may be possible.  Using a stoichiometric iron reagent with 




which employs a large nitrile:alkyne ratio could improve the selectivity for pyridine 
products.  Such an approach would, however, negate the atom-economy provided by 
[2+2+2] cycloaddition by leaving unreacted nitrile.  Such disadvantages would make 
reactions requiring elaborate nitriles highly unattractive.  A third and more elegant 
method would be to utilize substrates where the unreactive nitrile is tethered to the more 
reactive alkyne.  Such a substrate should facilitate nitrile incorporation regardless of the 
metallacyclic intermediate (Figure 11).  Thus we set out to develop an iron-catalyzed 
cycloaddition of alkynenitriles and alkynes. 
 
Discussion 
To begin developing this system, a wise approach would be to start with the iron 
complexes that have previously catalyzed pyridine synthesis.  The half-sandwich 
complex synthesized by Zenneck and co-workers required the addition of iron vapor to a 
solution of phosphinine and cyclooctadiene (cod).  Guerchais’ (Cp*)Fe(MeCN)3 (3) 
complex was available in four synthetic steps and was low yielding.  Neither complex 
offers practical access to an iron catalyst platform on which to begin screening. 
In contrast to these problematic catalysts, Okomoto’s triyne cyclotrimerization 
system utilizes readily accessible catalyst systems (equation 3).3  This method only 
requires catalytic amounts of an iron salt, a ligand, and zinc dust.  Presumably the iron 
salt coordinates to the ligand in situ, then undergoes a two-electron reduction by zinc 
(equation 4).  The authors followed their initial report with a description of the various 
ligands that are effective for this reaction (Figure 12).3  If modified, this simple and 
practical approach could be applied toward the cyclization of alkynenitriles and alkynes. 





Figure 11.  Alkynenitriles will aid nitrile incorporation no matter which 
catalytic cycle is operative. 
 
 
Figure 12.  Ligands which effectively catalyzed the cycloaddition of 





MesBisimine ligand (L4), and 40 mol% Zn dust in DMA at 80 °C.  Despite the 
exhaustive optimization of this system, yields never exceeded 47% (GC yield) (Table 2).  
The ligands from Okamoto’s report were then reassessed in greater depth.  While iPrPDAI 
(L7) was ineffective, the very similar MesPDAI (L8) provided significantly improved 




of the ligand, iPr,OBnPDAI (L10) was determined to be optimum the ligand for this 
reaction.  The final optimized conditions utilized 10 mol% Fe(OAc)2, 13 mol% 
iPr,OBnPDAI, 20 mol% Zn dust in DMF at 85 °C. 
 
 
The scope and limitations of this reaction were assessed (Table 3).  Substitution of the 
alkynenitrile-alkyne tolerated both alkyl and aryl substituents (entries 1-3).  Despite a 
propensity to cyclotrimerize into benzene products, the challenging terminal alkyne-
containing substrate, 1d, provided 3d in 30% yield (entry 4).  Remarkably the bulky TMS 
substituent of 1e was cyclized in 57% yield, demonstrating a high tolerance for steric 
bulk at this position (entry 5).  Decreasing the bulk of the free alkyne made no significant 
difference to the yield (entry 6).  Diphenyl acetylene (2c) was effectively cyclized if two-
equivalents were employed (entry 7).  Changing the backbone of the alkynenitrile 
demonstrated varied results.  Heteroatom tethers afforded moderate yields of pyridine 
product (entries 9-11) while the alkyl tether of 1f was well tolerated, with a 65% yield 
(entry 8).  The aromatic backbone of 1k can afford an interesting tricyclic pyridine in 
good yield (entry 13).  Finally, increasing the tether length tested the boundaries of this 
reaction (entry 12).  The creation of a 6-6-bicyclic pyridine 3l could be done in moderate 




Table 2.  Ligand Screening 
 




 The regioselectivity of unsymmetrical alkynes was also studied (Table 4).  
Alkyl/aryl-substituted alkynes demonstrated a moderate selectivity to place the alkyl 
substituent next to the pyridine nitrogen atom (entries 1-4, 6).  This trend was 
exaggerated to a ratio of 4:1 when using an electron-withdrawing substituent (2f) on the 
aryl group or when using a pyridyl-substituted alkyne (2g).  The latter likely invokes a 
chelation effect to provide its regioselectivity.  Interestingly, the larger n-butyl substituent 
reversed the regioselectivity in entry 5.  This system was unable to differentiate linear 
alkyl from methyl substituents (entry 7), however, tert-butyl afforded complete 
regioselectivity to place the bulkier substituent adjacent to the pyridine nitrogen atom 
(entry 8).  The regioisomer identity of 3n was confirmed by x-ray crystallography (Figure 
13). 
To identify the structure of the precatalyst, unsuccessful attempts were made to 
synthesize (iPr,OBnPDAI)Fe(OAc)2.  Instead the similar (OBn,iPr PDAI)FeBr2 proved to be 
more readily accessible.  This complex could effectively catalyze the reaction along with 
the in situ zinc reductant (equation 6).  The 58% isolated yield of this reaction compares 
well with the 54% GC yield of the reaction run with uncoordinated FeBr2.  Crystals of 
(iPr,OBnPDAI)FeBr2 were grown, however, x-ray crystallographic analysis demonstrated  
 






Figure 13.  Ortep of 3n. 
 
 
significant disorder in the benzyloxy substituents.  This analysis did, however confirm the 
tridentate coordination mode of the complex.  Subsequently the analogous methoxy-
substituted complex (iPr,OMnPDAI)FeBr2 was synthesized and characterized by x-ray 








The first general and practical method to synthesize pyridines via iron-catalyzed 
[2+2+2] cycloaddition has been successfully developed.  By tethering the unreactive 
nitrile to the more reactive alkyne, the obstacle of poor nitrile reactivity was overcome.  
Furthermore the key to this reaction was the utilization of the dimethoxy-substituted 
bis(aldimino)pyridine ligand (iPr,OBnPDAI)FeBr2.  The oxidative identity of the active 
catalyst as well as the likely catalytic pathway will be addressed in Chapter 5.  Studies to 
improve and expand the applications of this catalyst system have since been undertaken 
and are disclosed in the subsequent chapters of this thesis. 
 
Experimental 
General experimental.  All reactions were conducted under an atmosphere of N2 
using standard Schlenk techniques or in a N2, filled glove box, unless otherwise noted.  
Toluene was dried over neutral alumina under N2 using a Grubbs-type solvent 
purification system.  Dimethyl formamide was purchased from Sigma Aldrich in a sure-
seal bottle.  THF was freshly distilled from Na/benzophenone.  Iron acetate (99.995% 
purity) was purchased from Sigma Aldrich.  Alkynenitriles 1a, 1b,7 1i,8 and 1j,9 were 
prepared by known literature procedures.  1H and 13C Nuclear Magnetic Resonance 
spectra of pure compounds were acquired at 400 and 100 MHz, respectively, unless 
otherwise noted.  All spectra are referenced to residual proteated CHCl3 via a singlet at 
7.27 ppm for 1H and to the center line of a triplet at 77.26 ppm for 13C.  The abbreviations 
s, d, dd, dt, dq, t, q, and quint stand for singlet, doublet, doublet of doublets, doublet of 
triplets, doublet of quartets, triplet, quartet, and quintet, respectively.  All 13C NMR 
spectra are proton decoupled.  Gas Chromatography was performed using the following 




temperature: 300 ºC held for 12 minutes; detector temperature: 250 ºC. S2  
Ligand syntheses.  Ligands L1-L610 and L7-L1011 were synthesized by the 
reported methods. Ligands L11 and L12 were synthesized as follows:  
Step 1 (general procedure).  Adapted from the literature procedure.12  To a 
stirring mixture of 2,6-substituted aniline and NaHCO3 (3 equiv) in methanol, a solution 
of iodinemonochloride (1.1 equiv) in CH2Cl2 was added dropwise over 1 hour. The 
reaction was stirred at room temperature for 24 hours. Solids were filtered from the 
mixture and rinsed with diethyl ether. The filtrate was reduced in vacuo to a dark red oil 
to which a 300 mL solution of saturated sodium thiosulfate was added. The solution was 
stirred for 10 minutes then extracted with 3 x 200 mL portions of diethyl ether. The 
organic extracts were dried with Na2SO4 and reduced in vacuo. 
Synthesis of 4-iodo-2,6-dimethylaniline.  4-iodo-2,6-dimethylaniline was 
prepared using the Step 1 general procedure with 2,6-dimethylaniline (10.0 g, 83 mmol), 
iodinemonochloride (14.7 g, 91 mmol), and sodium bicarbonate (20.8 g, 248 mmol). The 
reaction was stirred at room temperature with 115 mL of methanol and 90 mL of 
dichloromethane to yield 4-iodo-2,6-dimethylaniline (19.2g, 93%) as a dark red oil. 
Spectral data match the reported values.13 
Synthesis of 4-iodo-2,6-diisopropylaniline.  4-iodo-2,6-diisopropylaniline was 
prepared using the Step 1 general procedure with 2,6 diisopropylaniline (10.0 g, 56 
mmol), iodinemonochloride (10.1 g, 62 mmol), and sodium bicarbonate (14.2 g, 169 
mmol). The reaction was stirred at room temperature with 80 mL of methanol and 60 mL 
of dichloromethane to yield 4-iodo-2,6-diisopropylaniline (16.8 g, 93%) as a dark red oil. 




Step 2 (general procedure).  Adapted from the literature procedure.14  In a 
nitrogen glove box, a 20 mL scintillation vial was filled with CuI (7 mol%) 3,4,7,8-
tetramethyl-1,10-phenanthroline (Me4Phen, 14 mol%), Cs2CO3 (2.0 equiv), and 4-iodo-
2,6-dialkyl aniline (1.0 equiv). The vial was sealed with a rubber septum, removed from 
the glove box, then evacuated and backfilled with Argon three times. Toluene was added 
and the mixture was stirred at 80 °C for 20 minutes. Benzyl alcohol (2.0 equiv) was 
added and the rubber septum was quickly replaced with a vial cap. The reaction was 
stirred for 24 hours at 80 °C then cooled to room temperature, filtered through a silica gel 
plug, and flushed with 150 mL of ethyl acetate. The resulting solution was reduced in 
vacuo and purified using silica gel flash chromatography with 10% ethyl acetate in 
hexanes.   
Synthesis of 4-(benzyloxy)-2,6-dimethylaniline.  4-(benzyloxy)-2,6-
dimethylaniline was prepared using the Step 2 general procedure with CuI (57.8 mg, 0.30 
mmol), Me4Phen (143.5 mg, 0.61 mmol), cesium carbonate (1.56 g, 8.1 mmol), 4-iodo-
2,6-dimethylaniline (1.0 g, 4.0 mmol), and benzyl alcohol (875.3 mg, 8.1 mmol). The 
reaction was run for 24 hours at 80 °C in 1.9 mL of toluene to yield 4-(benzyloxy)-2,6-
dimethylaniline (362.9 mg, 40%) as a blue solid. Mp: 71-73 °C. 1H NMR (300 MHz, 
CDCl3): δ (ppm) 7.48-7.33 (m, 5H), 6.68 (s, 2H), 5.01 (s, 2H), 3.35 (s, 2H), 2.20 (s, 6H). 
13C NMR (75 MHz, CDCl3): δ (ppm) 151.5, 137.9, 136.9, 128.7, 127.9, 127.7, 123.4, 
115.2, 70.9, 18.2. IR (cm-1) 3450, 3375, 3032, 2969, 2908, 2735, 1602, 1489, 1380, 
1328, 1298, 1242, 1150, 1054, 856, 738, 698.  HRMS (ESI) calcd for C15H17NO [M+H]+ 
228.1388, found 228.1385. 




diisopropylaniline was prepared using the Step 2 general procedure with CuI (57.8 mg, 
0.30 mmol), Me4Phen (143.5 mg, 0.61 mmol), cesium carbonate (1.56 g, 8.1 mmol), 4-
iodo-2,6-diisopropylaniline (1.0 g, 4.0 mmol), and benzyl alcohol (875.3 mg, 8.1 mmol).  
The reaction was run for 24 hours at 80 °C in 1.9 mL of toluene to yield 4-(benzyloxy)-
2,6-diisopropylaniline (948.9 mg, 84%) as a dark red oil.  1H NMR (400 MHz, CDCl3): δ 
(ppm) 7.48-7.27 (m, 5H), 6.74 (s, 2H), 3.48 (s, 2H), 3.01- 2.94 (m, 2H), 1.28 (d, J = 6.8, 
12H).  13C NMR (75 MHz, CDCl3): δ (ppm) 152.4, 138.0, 134.5, 134.4, 128.7, 128.01, 
127.96, 110.1, 71.0, 28.4, 22.7.  IR (cm-1) 3382, 2960, 1599, 1463, 1347, 1218, 1175, 
1100, 1027, 737, 696.  HRMS (ESI) calcd for C19H26NO [M+H]+ 284.2014, found 
284.2013. 
Step 3 (general procedure).  Adapted from the literature procedure.12  4-
benzyloxy-2,6-dialkyl aniline (2.0 equiv) and 2,6-pyridinedicarboxaldehyde (1.0 equiv) 
and a catalytic amount of glacial acetic acid were stirred in 100% ethanol overnight at 
room temperature. The mixture was cooled to 0 °C, filtered, and rinsed with cold 100% 
ethanol.   
Synthesis of (N,N'E,N,N'E)-N,N'-(pyridine-2,6-
diylbis(methanylylidene))bis(4-(benzyloxy)-2,6-dimethylaniline) (L11).  Coumpound 
L11 was prepared using the Step 3 general procedure with 4-(benzyloxy)-2,6-
dimethylaniline (194.6 mg, 0.86 mmol), 2,6-pyridinedicarboxaldehyde (57.8 mg, 0.43 
mmol), and 5 drops of glacial acetic acid.  The reaction was run at room temperature in 
10 mL of 100% ethanol yielding L11 (108.0 mg, 45.6%) as a yellow solid.  Mp: 174-177 
°C.  1H NMR (500 MHz, CDCl3): δ (ppm) 8.40 (s, 2H), 8.38 (d, J = 8.0 2H), 7.97 (t, J = 




MHz, CDCl3): δ (ppm).  IR (cm-1) 3087, 2970, 2948, 1602, 1584, 1480, 1455, 1379, 
1332, 1312, 1198, 1052, 738, 698. HRMS (ESI) calcd for C37H35N3O2 [M+H]+ 
576.2627, found 576.2633. 
Synthesis of (N,N'E,N,N'E)-N,N'-(pyridine-2,6-
diylbis(methanylylidene))bis(4-(benzyloxy)-2,6-diisopropylaniline) (L12).  
Coumpound L12 was prepared using the Step 3 general procedure with 4-(benzyloxy)-
2,6-diisopropylaniline (2.35 g, 8.3 mmol), 2,6-pyridinedicarboxaldehyde (599.5 mg, 4.1 
mmol), and 10 drops of glacial acetic acid.  The reaction was run at room temperature in 
10 mL of 100% ethanol to yield L12 (2.48 g, 85%) as a yellow solid.  M.P. 170-173 °C. 
1H NMR (300 MHz, CDCl3): δ (ppm) 8.40-8.38 (m, 4H), 7.99 (t, J = 8.0, 1H), 7.51-7.28 
(m, 10H), 6.83 (s, 4H), 5.08 (s, 4H), 3.07-2.98 (m, 4H), 1.18 (d, J = 7.2, 24H).  13C NMR 
(75 MHz, CDCl3): δ (ppm) 163.4, 156.3, 154.8, 142.4, 139.1, 137.6, 137.5, 128.1, 128.2, 
128.0,122.8, 109.9, 70.5, 28.4, 23.7.  IR (cm-1) 3391, 2961, 2869, 1637, 1600, 1458, 
1326, 1190, 1026, 736. HRMS (ESI) calcd for C45H51N3O2 [M+H]+ 688.3879, found 
688.3882. 
Synthesis of dimethyl-2-(cyanomethyl)malonate.  To a stirring suspension of 
NaH (1.8 g, 75.7 mmol) in 150 ml THF was added dimethylmalonate (10 g, 75.7 mmol) 
under N2 counter-flow.  The resulting solution was stirred at room temperature for 1 h, 
after which time bromoacetonitrile (5.0 g, 42.1 mmol) was added.  The mixture was 
stirred at room temperature for 24 h, at which time the solution was quenched with 100 
mL of a saturated NH4Cl solution. The layers were separated and the aqueous layer was 
extracted with Et2O (3 x 100 mL).  The combined organics were washed with brine (100 




yellow oil was purified by flash column chromatography (20% EtOAc/hexanes) to yield 
dimethyl-2-(cyanomethyl)malonate (4.1 g, 57%) as a pale yellow oil.  1H NMR (400 
MHz, CDCl3) δ (ppm) 3.78 (s, 6H), 3.73 (t, J= 8.8 Hz, 1H), 2.89 (d, J= 7.2 Hz, 2H).  13C 
NMR (100 MHz, CDCl3) δ (ppm) 167, 116.8, 53.5, 47.8, 17.1. 
Synthesis of dimethyl 2-(cyanomethyl)-2-(prop-2-yn-1-yl)malonate (1d). 
Dimethyl-2-(prop-2-yn-1-yl)malonate was prepared by known literature procedure.15  To 
a stirring suspension of NaH (0.21 g, 8.82 mmol) in 50 mL THF was added dimethyl-2-
(prop-2-yn-1-yl)malonate (1.0g, 5.88 mmol) under N2 counter-flow.  The resulting 
solution was stirred at room temperature for 1 h, after which time bromoacetonitrile (1.0 
g, 8.82 mmol) was added.  A reflux condenser was attached and the mixture was stirred 
at reflux for 8-12 h, at which time GC analysis showed no starting material. The solution 
was cooled to room temperature and quenched with 100 mL of a saturated NH4Cl 
solution. The layers were separated and the aqueous layer was extracted with Et2O (3 x 
100 mL). The combined organics were washed with brine (100 mL), dried over 
anhydrous MgSO4, and concentrated in vacuo. The resulting crude yellow oil was 
purified by flash column chromatography (10% EtOAc/hexanes then 12% 
EtOAc/hexanes) to yield 1d (0.6 g, 49%) as pale yellow oil.  1H (400 MHz, CDCl3): 3.83 
(s, 6H), 3.17 (s, 2H), 3.03 (d, J= 2.8Hz, 2H), 2.13 (t, J= 2.8Hz, 1H).  13C (100 MHz, 
CDCl3) δ (ppm) 168.3, 116.4, 81.0, 71.8, 53.9, 24.2, 22.1, 3.7.  IR (cm-1) 3288, 2960, 
2253, 1743, 1483, 1327, 1217, 971, 892.  HRMS calculated for C10H11NO4Na 232.0586, 
found 232.0592. 
Synthesis of dimethyl-2-(cyanomethyl)-2-(3-phenylprop-2-yn-1-yl)malonate 




solution of 1d (3.0 g, 14.5 mmol) in Et3N (17 mL).  To the mixture was added a solution 
of phenyl iodide (1.6 g, 8.1 mmol). The resulting mixture was stirred at 50 °C for 6 h.  
The reaction was quenched by the addition of water and extracted with Et2O.  The 
organic layer was washed with saturated aqueous NH4Cl, and the water layer was 
extracted with Et2O.  The combined organic layer was washed with brine, dried over 
Na2SO4, and concentrated.  The residue was purified on a silica gel column 
chromatography (10% EtOAc/Hexanes), which furnished 1c (1.2 g, 52% yield) as a dark 
brownish yellow oil.  1H (400 MHz, CDCl3): δ (ppm) 7.34 (m, 5H), 3.85 (s, 6H), 3.25 (s, 
2H) 3.22 (s, 2H).  13C NMR (100 MHz, CDCl3) δ (ppm) 168.1, 132.0, 128.7, 128.5, 
122.6, 116.2, 85.2, 82.3, 55.5, 54.0, 24.7, 22.3.  IR (cm-1) 2957, 2253, 1743, 1438, 1295, 
1215, 1030.  HRMS (ESI) calculated for C16H15NO4Na (M+Na)+ 308.0899, observed 
308.0895. 
Synthesis of dimethyl 2-(cyanomethyl)-2-(3-(trimethylsilyl)prop-2-yn-1-
yl)malonate (1e).  To a stirring suspension of NaH (0.12 g, 4.82 mmol) in 30 mL THF 
was added dimethyl-2-(cyanomethyl)malonate (0.55 mg, 3.21 mmol) under N2.  The 
resulting solution was stirred at room temperature for 1 h, after which time (3-
bromoprop-1-yn-1-yl)trimethylsilane (0.50 g, 4.82 mmol) was added.  A reflux condenser 
was attached and the mixture was stirred at reflux for 12 h, at which time GC analysis 
showed no starting material.  The solution was cooled to room temperature and quenched 
with 70 mL of a saturated NH4Cl solution.  The layers were separated and the aqueous 
layer was extracted with Et2O (3 x 70 mL).  The combined organics were washed with 
brine (100 mL), dried over anhydrous magnesium sulfate, and concentrated in vacuo.  




EtOAc/hexanes) to yield 1e (0.79 g, 87%) as a colorless solid.  Mp: 34-36 °C.  1H NMR 
(400 MHz, CDCl3): δ(ppm) 3.82 (s, 6H), 3.14 (s, 2H), 3.03 (s, 2H), 0.15 (s, 9H).  13C 
NMR (100 MHz, CDCl3) δ(ppm) 167.9, 116.2, 99.1, 90.5, 55.4, 53.9, 25.4, 22.1, 0.1.  IR 
(cm-1): 2960, 2902, 2253, 2181, 1746, 1437, 1322, 1294, 1028, 847.  HRMS calculated 
for C13H19NO4NaSi 304.0981, found 304.0977. 
Synthesis of 2-(pent-2-yn-1-yloxy)acetonitrile (1f).  To a stirring suspension of 
NaH (0.7 g, 30.9 mmol) in 25 ml THF was added pent-2-yn-1-ol (2.0 g, 23.8 mmol) 
under N2 counter-flow in two portions.  The resulting solution was stirred at room 
temperature for 1 h, after which time bromoacetonitrile (3.7 g, 30.9 mmol) was added.  
The reaction mixture was stirred at room temperature for 8-12 h, at which time GC 
analysis showed no starting material.  The solution was cooled and quenched with 100 
mL of a saturated NH4Cl solution.  The layers were separated and aqueous layer was 
extracted with Et2O (3 x 100 mL).  The combined organics were washed with brine (100 
mL), dried over anhydrous Na2SO4, and concentrated in vacuo.  The resulting crude 
yellow oil was purified by flash column chromatography (10% EtOAc/hexanes) to yield 
1f (1.2 g, 42%) as a pale yellow oil.  1H NMR (400 MHz, CDCl3): δ (ppm) 4.34 (s, 2H), 
4.28 (t, J= 4.4 Hz, 2H), 2.25 (m, 2H), 1.15 (t, J= 7.6 Hz, 3H).  13C NMR (100 MHz, 
CDCl3) δ (ppm) 115.9, 91.3, 72.8, 58.9, 54.0, 13.7, 12.5.  IR (cm- 1) 2980, 2919, 2292, 
1452, 1320, 1140, 1092, 902.  HRMS (ESI) calcd for C21H24NO5 [M+H]+ 124.0762, 
found 124.0776. 
Synthesis of 2-((3-phenylprop-2-yn-1-yl)oxy)acetonitrile (1g).  To a stirring 
suspension of NaH (0.3 g, 9.1 mmol) in 50 ml THF was added 3-phenylprop-2-yn-1-ol 




temperature for 1 h, after which time bromoacetonitrile (1.1 g, 9.1 mmol) was added.  
The mixture was stirred at room temperature for 12 h, at which time GC analysis showed 
no starting material.  The solution was cooled and quenched with 100 mL of a saturated 
NH4Cl solution.  The layers were separated and aqueous layer was extracted with Et2O (3 
x 100 mL).  The combined organics were washed with brine (100 mL), dried over 
anhydrous Na2SO4, and concentrated in vacuo.  The resulting crude yellow oil was 
purified by flash column chromatography (20% EtOAc/hexanes) to yield 1g (1.2 g, 92%) 
as pale yellow oil.  1H NMR (400 MHz, CDCl3): δ (ppm) 7.49 (m, 2H), 7.36 (m, 3H), 
4.55 (s, 2H), 4.43 (s, 2H).  13C NMR (100 MHz, CDCl3) δ (ppm) 132.0, 129.2, 128.6, 
121.9, 115.9, 88.8, 82.3, 59.1, 54.3.  IR cm-1 3060, 2908, 2857, 2242, 1964, 1598, 1490, 
1350, 1249, 1093, 902, 759, 692.  HRMS (ESI) calcd for C11H10NO [M+H]+ 172.0762, 
found 172.0728. 
Synthesis of N-(cyanomethyl)-4-methyl-N-(3-phenylprop-2-yn-
1yl)benzenesulfonamide (1h).  To a stirring suspension of NaH (0.05 g, 1.9 mmol) in 20 
ml THF was added 4-methyl-N-(3-phenylprop-2-yn-1-yl)benzenesulfonamide16 (0.5 g, 
1.7 mmol) under N2.  The resulting solution was stirred at room temperature for 1 h, after 
which time bromoacetonitrile (0.2 g, 1.9 mmol) was added.  A reflux condenser was 
attached and the mixture was stirred at reflux for 12 h, at which time GC analysis showed 
no starting material.  The solution was cooled to room temperature and quenched with 
100 mL of a saturated NH4Cl solution.  The layers were separated and the aqueous layer 
was extracted with Et2O (3 x 100 mL).  The combined organics were washed with brine 
(100 mL), dried over anhydrous MgSO4, and concentrated in vacuo. The resulting crude 




1h (0.34 g, 60%) as a colorless solid.  Mp: 97-99 °C.  1H (400 MHz, CDCl3): δ (ppm) 
7.78 (d, J= 8Hz, 2H), 4.28 (t, J= 4.4 Hz, 2H), 2.25 (m, 2H), 1.15 (t, J= 7.6 Hz, 3H).  13C 
(100 MHz, CDCl3) δ (ppm) 145.2, 134.3, 131.9, 130.3, 129.2, 128.5, 128.1, 121.8, 113.8, 
87.6, 80.1, 38.8, 35.4, 21.8.  IR (cm-1) 2958, 2253, 1744, 1438, 1215, 1072, 759.  HRMS 
(ESI) calculated for C18H16N2O2NaS (M+Na) 347.0830, observed: 347.0835. 
Synthesis of dimethyl-2-(but-2-yn-1-yl)-2-(2-cyanoethyl)malonate (1k).  To a 
stirring suspension of NaH (0.24 g, 10.1 mmol) in 100 ml THF was added 
dimethylmalonate (2.00 g, 15.14 mmol) under N2.  The resulting solution was stirred at 
room temperature for 1 h, after which time bromopropionitrile (1.35 g, 10.1 mmol) was 
added.  A reflux condenser was attached and the mixture was stirred at reflux for 12 h, at 
which time the solution was cooled to room temperature and quenched with 100 mL of a 
saturated NH4Cl solution.  The layers were separated and the aqueous layer was extracted 
with Et2O (3 x 100 mL).  The combined organics were washed with brine (100 mL), 
dried over anhydrous MgSO4, and concentrated in vacuo.  The resulting crude yellow oil 
was purified by flash column chromatography (40% EtOAc/hexanes) to yield dimethyl-2-
(2-cyanoethyl)malonate (1.2 g, 64%) as a pale yellow oil.  Spectral data were compared 
with known literature values.17 
To a stirring suspension of NaH (0.16 g, 6.5 mmol) in 50 ml THF was added 
dimethyl-2-(2-cyanoethyl)malonate (1g, 5.4 mmol) under N2.  The resulting solution was 
stirred at room temperature for 1 h, after which time 1-bromo-2-butyne (0.86 g, 6.5 
mmol) was added.  A reflux condenser was attached and the mixture was stirred at reflux 
for 12 h, at which time the solution was cooled to room temperature and quenched with 




was extracted with Et2O (3 x 50 mL).  The combined organics were washed with brine 
(50 mL), dried over anhydrous Na2SO4, and concentrated in vacuo.  The resulting crude 
yellow oil was purified by flash column chromatography (40% EtOAc/hexanes) to yield 
1k (0.6 g, 50%) as a colorless solid.  Mp: 62-63 °C.  1H (400 MHz, CDCl3): δ (ppm) 3.78 
(s, 6H), 2.79 (q, J= 2.4, 2.8 Hz, 2H), 2.44 (m, 4H), 1.77 (t, J= 2.4, 2.8 Hz, 3H).  13C NMR 
(100 MHz, CDCl3) δ (ppm) 170.0, 119.2, 80.3, 72.4, 56.2, 53.3, 28.9, 24.2, 13.2, 3.7.  IR 
(cm-1) 2957, 2249, 1736, 1441, 1340, 1209.  HRMS C12H15NO4Na calculated: 260.0899, 
observed 260.0898. 
Synthesis of tert-butyl(4-phenylbut-3-yn-1-yl)tosylcarbamate (2i).  Under N2, 
diisopropylazodicarboxylate (1.7 ml, 8.92 mmol, 1.1 equiv) was added to a solution of N-
(tert-butyoxycarbonyl)-p-toluenesulfonamide (2.2 g, 8.1 mmol, 1 equiv), 
triphenylphosphine (8.9 g, 1.3 mmol, 1.1 equiv) and 4-phenylbut-3-yn-1-ol18 (1.3 g, 8.92 
mmol, 1.1 equiv) in a dropwise fashion at 0 °C.  The reaction mixture was then stirred at 
room temperature for 15 h.  The solvent was removed under reduced pressure.  Hexanes 
(100 mL) were added to the resultant yellow mixture and the white precipitate was 
filtered.  The solid was preabsorbed on silica gel and purified by flash column 
chromatography (20% EtOAc and Hexanes) affording the product 2i as a white solid (3.1 
g, 96%).  Mp: 98-99 °C.  1H (400 MHz, CDCl3) δ (ppm) 7.84 (d, J= 6.8 Hz, 2H), 7.38 (m, 
2H), 7.28 (m, 5H), 4.10 (t, J= 7.2 Hz, 2H), 2.89 (t, J= 8 Hz, 2H), 2.43 (s, 3H), 1.35 (s, 
9H).  13C (100 MHz, CDCl3) δ ppm 151.1, 144.4, 137.6, 131.9, 129.5, 128.4, 128.2, 
128.1, 123.7, 86.3, 84.7, 82.8, 45.6, 28.1, 21.8, 21.1.  IR (in cm-1): 3058, 2980, 2932, 
1739, 1598, 1357, 1287, 1162, 970, 846, 693.  HRMS (ESI) calculated for m/z 




General Procedure for Cycloaddition.  In a nitrogen-filled glove box, a solution 
of alkynenitrile (>1.0 M in DMF) was added to a vial containing 10 mol% Fe(OAc)2 and 
13 mol% L12.  Additional DMF was added to make the final concentration of 
cyanoalkyne 0.4 M (accounting for alkyne volume).  The mixture was stirred for 10 
minutes, then 1 equiv of alkyne and 20 mol% of zinc dust were added.  The vial was 
capped and removed from the glove box then stirred at 85 °C for the indicated period of 
time.  The crude mixture was purified via silica gel flash chromatography. 
Synthesis of dimethyl-2,3-dibutyl-4-methyl-5H-cyclopenta[b]pyridine-
6,6(7H)-dicarboxylate (3a).  Compound 3a was prepared using the general procedure 
with 1a (51.3 mg, 0.23 mmol), 2a (32.8 mg, 0.23 mmol), Fe(OAc)2 (4.0 mg, 2.3 x 10-2 
mmol), L12 (20 mg, 3.1 x 10-2 mmol), and zinc (3.0 mg, 4.6 x 10-2 mmol) in 533 mL of 
N,N-dimethylformamide.  The reaction was stirred at 85 °C for 2 hours and the resulting 
brown mixture was purified with silica gel flash chromatography using 10% ethyl acetate 
in hexanes to yield 3a (58.2 mg, 70%) as a viscous, yellow oil.  1H NMR (400 MHz, 
CDCl3): δ (ppm) 3.75 (s, 6H), 3.70 (s, 2H), 3.64 (s, 2H), 2.72 (t, J = 8 Hz, 2H), 2.56, (t, J 
= 8 Hz, 2H), 2.19 (s, 3H), 1.62 (m, 2H), 1.42 (m, 2H), 0.93 (m, 6H).  13C NMR (100 
MHz, CDCl3): δ (ppm) 172.4, 159.8, 156.6, 141.6, 123.3, 130.3, 57.7, 53.2, 42.2, 38.1, 
35.6, 33.0, 32.5, 28.4, 23.4, 23.3, 15.9, 14.2, 14.1.  IR (cm-1) 3476, 2963, 2019, 1736, 
1582, 1438, 1380, 1241, 1071, 963, 863, 818, 737.  HRMS (ESI) calcd for C21H32NO4 
[M+H]+ 362.2331, found 362.2338. 
Synthesis of dimethyl-2,3-dibutyl-4-ethyl-5H-cyclopenta[b]pyridine-6,6(7H)-
dicarboxylate (3b).  Compound 3b was prepared using the general procedure with 1a 




L12 (29.9 mg, 4.5 x 10-2 mmol), and zinc (4.5 mg, 6.9 x 10-2 mmol) in 800 mL of 
dimethylformamide.  The reaction was stirred at 85 °C for 4 hours and the resulting 
brown mixture was purified with silica gel flash chromatography using 10% ethyl acetate 
in hexanes to yield 3b (102.9 mg, 86%) as a viscous, yellow oil.  1H NMR (400 MHz, 
CDCl3): δ (ppm) 3.75 (s, 6H), 3.63 (s, 2H), 3.51 (s, 2H), 2.76 (q, J = 7.6, 7.6, 7.6 Hz, 
2H), 2.62 (q, J = 7.2, 7.2, 7.2 Hz, 2H), 2.20 (s, 3H), 1.24 (t, J = 7.6, 7.6 Hz, 3H), 1.10 (t, J 
= 7.6, 7.6 Hz, 3H).  13C NMR (100 MHz, CDCl3): δ (ppm) 172.3, 160.4, 157.1, 147.4, 
131.4, 129.7, 58.1, 53.2, 42.0, 37.5, 42.0, 37.5, 35.5, 33.7, 33.0, 27.9, 23.5, 23.4, 23.3, 
14.2, 14.04, 13.98.  IR (cm-1) 3476, 2958, 1744, 1580, 1437, 1408, 1378, 1253, 1104, 
1070, 964, 905, 865, 736.  HRMS (ESI) calcd for C22H34NO4 [M+H]+ 376.2488, found 
376.2497. 
Synthesis of dimethyl-2,3-dibutyl-4-phenyl-5H-cyclopenta[b]pyridine-
6,6(7H)-dicarboxylate (3c). Compound 3c was prepared using the general procedure 
with 1c (98.4 mg, 0.35 mmol), 2a (47.7 mg, 0.35 mmol), Fe(OAc)2 (6.0 mg, 3.5 x 10-2 
mmol), L12 (29.9 mg, 4.5 x 10-2 mmol), and zinc (4.5 mg, 6.9 x 10-2 mmol) in 800 mL 
of N,N-dimethylformamide.  The reaction was stirred at 85 °C for 4 h and the resulting 
brown mixture was purified with silica gel flash chromatography using 10% ethyl acetate 
in hexanes to yield 3c (136.6 mg, 75%) as a viscous, yellow oil.  1H NMR (400 MHz, 
CDCl3): δ (ppm) 7.42 (t, J = 8Hz, 2H), 7.36 (d, J = 7.2, 1H), 7.17 (d, J = 8 Hz, 2H), 3.71 
(s, 6H), 3.22 (s, 2H), 2.78 (t, J = 10 Hz, 2H), 2.41 (t, J = 8 Hz, 2H), 1.70 (q, J = 7.2 Hz, 8 
Hz, 2H), 1.46 (sext, J = 7.2 Hz, 7.2 Hz, 2H), 1.28 (q, J = 6.8 Hz, 8 Hz, 2H), 1.15 (q, J = 
7.2 Hz, 7.2 Hz, 7.2 Hz, 2H), 0.96 (t, J = 7.2, 3H), 0.71 (t, J = 7.2 Hz, 3H).  13C NMR (100 




127.7, 57.9, 42.3, 38.4, 35.4, 33.2, 32.9, 28.6, 23.3, 22.9, 14.2, 13.7.  IR (cm-1) 2956, 
2869, 1783, 1576, 1490, 1437, 1273, 1198, 1073, 964, 739.  HRMS (ESI) calcd for 
C26H34NO4 [M+H]+ 424.2488, found 424.2484. 
Synthesis of dimethyl 2,3-dibutyl-5H-cyclopenta[b]pyridine-6,6(7H)-
dicarboxylate (3d).  Compound 3d was prepared using the general procedure with 1d 
(32.8 mg, 0.23 mmol), 2a (32.8 mg, 0.23 mmol), Fe(OAc)2 (4.0 mg, 2.3 x 10-2 mmol), 
L12 (20 mg, 3.1 x 10-2 mmol), and zinc (3.0 mg, 4.6 x 10-2 mmol) in 533 mL of N,N-
dimethylformamide.  The reaction was stirred at 85 °C for 26 h and the resulting brown 
mixture was purified with silica gel flash chromatography using 10% ethyl acetate in 
hexanes to yield 3d (24.0 mg, 30%) as a viscous, yellow oil.  1H NMR (400 MHz, 
CDCl3): δ (ppm) 7.23 (s, 1H), 3.76 (s, 6H), 3.65 (s, 2H), 3.54, (s, 2H), 2.76 (t, J = 8 Hz, 
2H), 2.56 (t, J =8 Hz, 2H), 1.63 (m, 4H), 1.53 (m, 4H), 1.42 (m, 4H), 0.95 (td, J = 7.2 Hz, 
1.2 Hz, 6H).  13C NMR (100 MHz, CDCl3): δ (ppm) 172.2, 159.7, 157.7, 133.8, 133.2, 
130.6, 58.4, 53.3, 41.9, 38.5, 35.0, 33.4, 32.6, 32.2, 30.6, 23.3, 22.9, 14.24, 14.17.  IR 
(cm-1) 3286, 2958, 2868, 1737, 1603, 1572, 1437, 1379, 1249, 1072, 969, 853, 654.  
HRMS (ESI) calcd for C26H34NO4 [M+H]+ 348.2175, found 348.2176. 
Synthesis of dimethyl 2,3-dibutyl-4-(trimethylsilyl)-5H-
cyclopenta[b]pyridine-6,6(7H)-dicarboxylate (3e).  Compound 3e was prepared using 
the general procedure with 1e (64.7 mg, 0.23 mmol), 2a (32.8 mg, 0.23 mmol), Fe(OAc)2 
(4.0 mg, 2.3 x 10-2 mmol), L12 (20 mg, 3.1 x 10-2 mmol), and zinc (3.0 mg, 4.6 x 10-2 
mmol) in 533 mL of N,N-dimethylformamide.  The reaction was stirred at 85 °C for 26 h 
and the resulting brown mixture was purified with silica gel flash chromatography using 




NMR (400 MHz, CDCl3): δ (ppm) 3.75 (s, 6H), 3.60 (s, 4H), 2.72 (t, J = 8 Hz, 2H), 2.66 
(t, J = 7.6 Hz, 2H, 1.64 (m, 4H), 1.42 (m, 4H), 0.96 (m, 6H), 0.39 (s, 9H).  13C NMR (100 
MHz, CDCl3): δ (ppm) 172.3, 159.3, 156.5, 144.4, 138.8, 136.0, 58.3, 53.2, 41.3, 41.0, 
35.4, 35.3, 33.0, 32.2, 29.9, 23.4, 23.3, 14.2, 14.1, 2.4.  IR (cm-1) 3476, 2957, 2870, 
2179, 1739, 1556, 1436, 1376, 1253, 1200, 1167, 1072, 1049, 965, 877, 843, 762, 695, 
633.  HRMS (ESI) calcd for C23H38NO4 [M+H]+ 420.2570, found 420.2579. 
Synthesis of dimethyl 2,3-diethyl-4-methyl-5H-cyclopenta[b]pyridine-
6,6(7H)- dicarboxylate (3f).  Compound 3f was prepared using the general procedure 
with 1a (100.0 mg, 0.45 mmol), 2b (36.8 mg, 0.45 mmol), Fe(OAc)2 (7.8 mg, 4.5 x 10-2 
mmol), L12 (38.8 mg, 5.8 x 10-2 mmol), and zinc (5.9 mg, 9.0 x 10-2 mmol) in 1.0 mL 
of N,N-dimethylformamide.  The reaction was stirred at 85 °C for 6 h and the resulting 
brown mixture was purified with silica gel flash chromatography using 10% ethyl acetate 
in hexanes to yield 3f (97.0 mg, 71%) as a viscous, yellow oil.  1H NMR (300 MHz, 
CDCl3): δ (ppm) 3.77 (s, 6H), 3.65 (s, 2H), 3.52 (s, 2H), 2.78 (q, J = 7.8 Hz, 7.5, Hz, 7.5 
Hz, 2H), 2.64 (q, J = 7.5 Hz, 7.5 Hz, 7.5 Hz, 2H), 2.21 (s, 3H), 1.29-1.23 (m, 3H), 1.11 (t, 
J = 7.5 Hz, 7.5 Hz, 3H).  13C NMR (100 MHz, CDCl3): δ (ppm) 172.3, 160.6. 156.7, 
141.6, 133.4, 130.5, 57.7, 53.2, 42.2, 38.1, 28.7, 21.6, 15.6, 14.9, 14.5.  IR (cm-1) 2965, 
1737, 1584, 1437, 1377, 1259, 1071, 961, 928, 864, 820, 733.  HRMS (ESI) calcd for 
C17H24NO4 [M+H]+ 306.1705, found 306.1707. 
Synthesis of dimethyl-4-methyl-2,3-diphenyl-5H-cyclopenta[b]pyridine-
6,6(7H)- dicarboxylate (3g).  Compound 3g was prepared using the general procedure 
with 1a (100.0 mg, 0.45 mmol), 2c (159.7 mg, 0.90 mmol), Fe(OAc)2 (7.8 mg, 4.5 x 10-




of N,N-dimethylformamide.  The reaction was stirred at 85 °C for 6 h and the resulting 
brown mixture was purified with silica gel flash chromatography using 10% ethyl acetate 
in hexanes to yield 3g (88.0 mg, 54%) as a viscous, yellow oil.  1H NMR (300 MHz, 
CDCl3): δ (ppm) 7.27-7.02 (m, 10H), 3.82 (s, 8H), 3.65 (s, 2H), 2.09 (s, 3H).  13C NMR 
(100 MHz, CDCl3): δ (ppm).  IR (cm-1) 3057, 2854, 1737, 1601, 1554, 1495, 1432, 
1400, 1266, 1201, 1121, 1073, 908, 862, 819, 797, 771, 736, 701, 574.  HRMS (ESI) 
calcd for C25H24NO4 [M+H]+ 402.1705, found 402.1700. 
Synthesis of 2,3-dibutyl-4-ethyl-5,7-dihydrofuro[3,4-b]pyridine (3h). 
Compound 3h was prepared using the general procedure with 1f (28.3 mg, 0.23 mmol), 
2a (32.8 mg, 0.23 mmol), Fe(OAc)2 (4.0 mg, 2.3 x 10-2 mmol), L12 (20 mg, 3.1 x 10-2 
mmol), and zinc (3.0 mg, 4.6 x 10-2 mmol) in 533 mL of N,Ndimethylformamide.  The 
reaction was stirred at 85 °C for 26 h and the resulting brown mixture was purified with 
silica gel flash chromatography using 10% ethyl acetate in hexanes to yield 3h (24.7 mg, 
41%) as a yellow, viscous oil.  1H NMR (300 MHz, CDCl3): δ (ppm) 5.13 (s, 2H), 5.02 
(s, 2H), 2.77, (t, J = 8.4 Hz, 8.1 Hz, 2H), 2.64-2.50 (m, 4H), 1.71-1.6 (m, 2H), 1.50-1.41 
(m, 6H), 1.15 (t, J = 7.8 Hz, 7.8 Hz, 3H), 1.00-0.929 (m, 6H).  13C NMR (100 MHz, 
CDCl3): δ (ppm) 160.9, 156.9, 145.2, 131.6, 128.7, 73.4, 71.9, 35.4, 33.7, 32.8, 27.6, 
23.7, 23.4, 23.2, 14.1, 14.02, 13.97.  IR (cm-1) 2959, 1768, 1583, 1462, 1406, 1376, 
1304, 1186, 1104, 1049, 903, 795, 742.  HRMS (ESI) calcd for C17H28NO [M+H]+ 
262.2171, found 262.2173. 
Synthesis of 2,3-dibutyl-4-phenyl-5,7-dihydrofuro[3,4-b]pyridine (3i). 
Compound 3i was prepared using the general procedure with 1g (39.4 mg, 0.23 mmol), 




mmol), and zinc (3.0 mg, 4.6 x 10-2 mmol) in 533 mL of N,Ndimethylformamide.  The 
reaction was stirred at 85 °C for 4 h and the resulting brown mixture was purified with 
silica gel flash chromatography using 10% ethyl acetate in hexanes to yield 3i (37.8 mg, 
45%) as a colorless solid.  Mp 49-50 °C.  1H NMR (400 MHz, CDCl3): δ (ppm) 7.41 (m, 
3H), 7.19 (m, 2H), 5.1 (s, 2H), 4.8 (s, 2H), 2.85 (t, J = 8.0 Hz, 8.0 Hz, 2H), 2.49 (t, J = 
8.0 Hz, 8.4 Hz, 2H), 1.74 (m, 2H), 1.45 (sext, J = 7.2 Hz, 7.2 Hz, 7.2 Hz, 2H), 1.34 (m, 
2H), 1.18 (sext, J = 7.2, 7.2 Hz, 7.2 Hz, 2H), 0.98 (t, J = 7.6 Hz, 7.6 Hz, 3H), 0.74 (t, J = 
7.2 Hz, 7.2 Hz, 3H).  13C NMR (100 MHz, CDCl3): δ (ppm) 161.3, 156.9, 144.5, 137.9, 
131.9, 129.0, 128.8, 128.1, 128.0, 73.8, 72.6, 35.5, 33.4, 32.9, 28.4, 23.3, 23.0, 14.2, 13.7.  
IR (cm-1) 3058, 2957, 1952, 1780, 1581, 1497, 1463, 1399, 1289, 1257, 1181, 1101, 
1042, 999, 900, 849, 748, 704, 647.  HRMS (ESI) calcd for C21H28NO [M+H]+ 
310.2171, found 310.2171. 
Synthesis of 2,3-dibutyl-4-phenyl-6-tosyl-6,7-dihydro-5H-pyrrolo[3,4-
b]pyridine (3j).  Compound 3j was prepared using the general procedure with 1h (74.6 
mg, 0.23 mmol), 2a (32.8 mg, 0.23 mmol), Fe(OAc)2 (4.0 mg, 2.3 x 10-2 mmol), L12 
(20 mg, 3.1 x 10-2 mmol), and zinc (3.0 mg, 4.6 x 10-2 mmol) in 533 mL of 
N,Ndimethylformamide.  The reaction was stirred at 85 °C for 4 h and the resulting 
brown mixture was purified with silica gel flash chromatography using 10% ethyl acetate 
in hexanes to yield 3j (43.5 mg, 41%) as a colorless solid.  MP 158-160 °C.  1H NMR 
(400 MHz, CDCl3): δ (ppm) 7.71 (d, J= 8Hz, 2H), 7.43 (q, J= 6.0, 7.2, 81.0 Hz, 4H), 7.29 
(d, J= 8.4 Hz, 2H), 7.10 (dd, J= 18.4, 0.8 Hz, 2H), 4.63 (s, 2H), 4.28 (s, 2H), 2.78 (t, J= 
7.6, 8.4 Hz, 2H), 2.41 (t, J= 10.4, 5.6 Hz, 5H), 1.68 (q, J= 6.8, 8.4, 7.6 Hz, 2H), 1.43 




3H), 0.71 (t, J= 7.2, 7.6 Hz, 3H).  13C NMR (100 MHz, CDCl3): δ (ppm) 161.8, 153.3, 
145.7, 143.9, 137.2, 134.0, 132.7, 130.0, 129.0, 128.3, 127.9, 127.8, 126.7, 54.5, 52.4, 
35.4, 33.2, 32.7, 28.5, 23.2, 23.0, 21.7, 14.2, 13.7.  IR (cm-1) 3064, 2957, 2926, 2860, 
1725, 1494, 1212, 1097, 1061, 966, 740.  HRMS (ESI) calcd for C28H35N2O2 [M+H]+ 
463.2419, found 463.2426. 
Synthesis of 2,3-dibutyl-4-phenyl-6,7-dihydro-5H-cyclopenta[b]pyridine (3k). 
Compound 3k was prepared using the general procedure with 1i (38.9 mg, 0.23 mmol), 
2a (32.8 mg, 0.23 mmol), Fe(OAc)2 (4.0 mg, 2.3 x 10-2 mmol), L12 (20 mg, 3.1 x 10-2 
mmol), and zinc (3.0 mg, 4.6 x 10-2 mmol) in 533 mL of N,Ndimethylformamide.  The 
reaction was stirred at 85 °C for 4 h and the resulting brown mixture was purified with 
silica gel flash chromatography using 10% ethyl acetate in hexanes to yield 3k (54.3 mg, 
65%) as a yellow, viscous oil.  1H NMR (300 MHz, CDCl3): δ (ppm) 7.46-7.39 (m, 3H), 
7.19 (dd, J = 1.5 Hz, 6.6 Hz, 1.2 Hz, 2H), 5.09 (s, 2H), 4.84 (s, 2H), 2.85 (t, J = 7.8 Hz, 
8.1 Hz, 2H), 2.49 (t, J = 7.5 Hz, 8.4 Hz, 2H), 1.79 (m, 2H), 1.48 (sext, 7.5 Hz, 7.2 Hz, 7.8 
Hz, 8.7 Hz, 6.0 Hz, 2H), 1.38-1.12 (m, 6H), 0.98 (t, J = 7.2 Hz, 7.8 Hz, 3H), 0.74 (t, J = 
7.2 Hz, 7.5 Hz, 3H).  13C NMR (100 MHz, CDCl3): δ (ppm) 161.6, 159.1, 146.7, 139.0, 
133.2, 130.3, 128.5, 128.32, 128.25, 127.3, 35.5, 34.7, 33.3, 33.1, 30.4, 28.6, 23.3, 23.0, 
22.9, 14.2, 13.6.  IR (cm-1) 3057, 3029, 2959, 1950, 1725, 1573, 1496, 1462, 1393, 1338, 
1243, 1178, 1104, 1073, 1028, 964, 916, 846, 739, 703, 619.  HRMS (ESI) calcd for 
C22H30N [M+H]+ 308.2378, found 308.2384. 
2,3-diethyl-4-phenyl-9H-indeno[2,1-b]pyridine (3l).  Compound 3l was 
prepared using the general procedure with 1j (50.0 mg, 0.23 mmol), 2b (18.9 mg, 0.23 




(3.0 mg, 4.6 x 10-2 mmol) in 552 mL of N,Ndimethylformamide.  The reaction was 
stirred at 85 °C for 2 h.  To the resulting brown mixture, 5 mL of dichloromethane, 5 mL 
of acetone and 10 mL of 6M HCl was added.  The solution was stirred for 2 h.  The 
aqueous layer was extracted with 3 x 25 mL portions of dichloromethane and the organic 
layer was collected and concentrated in vacuo.  The resulting greenish-yellow oil was 
dissolved in minimal dichloromethane and loaded onto a silica plug.  The silica plug was 
then washed with 100 mL of ethyl acetate and the resulting filtrate was discarded.  A 100 
mL solution of 1% acetic acid in ethyl acetate was passed through the plug which was 
also discarded.  A 100 mL of 1% NEt3 solution in ethyl acetate was run through the plug, 
collected, concentrated in vacuo, and further purified by column with silica gel flash 
chromatography using 10% ethyl acetate in hexanes to yield 3l (44.2 mg, 64%) as a 
yellow solid.  Mp: 118-122 °C.  1H NMR (500 MHz, CDCl3): δ (ppm) 7.56-7.50 (m, 4H), 
7.31 (d, J = 2.0 Hz, 2H), 7.19 (t, J = 7.5 Hz, 8.0 Hz, 1H), 6.15 (d, J = 8.0 Hz, 1H), 3.99 (s, 
2H).  13C NMR (75 MHz, CDCl3): δ (ppm) 161.4, 159.9, 144.5, 141.8, 140.2, 138.4, 
132.9, 131.1, 129.2, 128.6, 128.1, 126.7, 125.1, 122.7, 38.7, 28.8, 22.2, 15.8, 15.0.  
HRMS (ESI) calcd for C22H22N [M+H]+ 300.1752, found 300.1746. 
Synthesis of dimethyl 2,3-dibutyl-4-methyl-7,8-dihydroquinoline-6,6(5H)-
dicarboxylate (3m).  Compound 3m was prepared using the general procedure with 1k 
(54.6 mg, 0.23 mmol), 2a (32.8 mg, 0.23 mmol), Fe(OAc)2 (4.0 mg, 2.3 x 10-2 mmol), 
L12 (20 mg, 3.1 x 10-2 mmol), and zinc (3.0 mg, 4.6 x 10-2 mmol) in 533 mL of N,N-
dimethylformamide.  The reaction was stirred at 85 °C for 24 h and the resulting brown 
mixture was purified with silica gel flash chromatography using 10% ethyl acetate in 




CDCl3): δ (ppm) 3.74 (s, 6H), 3.12 (s, 2H), 2.86 (t, J= 6.5, 6.5 Hz, 2H), 2.70 (t, J= 8.5, 
8.0 Hz, 2H), 2.59 (t, J= 8 Hz, 2H), 2.37 (t, J= 7.0, 6.0 Hz, 2H), 2.19 (s, 3H), 1.62 (m, 2H), 
1.44 (m, 6H), 0.96 (m,6H).  13C NMR (100 MHz, CDCl3): δ (ppm) 171.8, 157.4, 150.4, 
131.6, 127.7, 124.8, 53.7, 52.8, 35.5, 32.6, 32.3, 32.0, 29.5, 28.5, 27.7, 23.3, 23.1, 14.6, 
14.0, 13.8.  IR (cm-1) 2957, 2870, 1738, 1665, 1571, 1438, 1332, 1242, 1169, 1084, 
1027, 976, 858, 792, 737, 700.  HRMS (ESI) calcd for C22H34NO4 [M+H]+ 376.2488, 
found 376.2486. 
Synthesis of Dimethyl-2,4-dimethyl-3-phenyl-5H-cyclopenta[b]pyridine-
6,6(7H)- dicarboxylate (3n) and dimethyl-3,4-dimethyl-2-phenyl-5H-
cyclopenta[b]pyridine-6,6(7H)- dicarboxylate (3n’).  Compounds 3n and 3n’ were 
prepared using the general procedure with 1a (100 mg, 0.45 mmol) and 2e (52 mg, 0.45 
mmol), 10 mol% Fe(OAc)2 (7.80 mg, 4.5x10-2 mmol), 13 mol% of L12 (39.7 mg, 
5.9x10-2 mmol), and zinc (5.9 mg, 9.0 x 10-2 mmol) in N,N-dimethylformamide.  After 
6 h the crude reaction mixture was purified via flash column chromatography using 100 
ml hexanes then 20% ethyl acetate in hexanes to afford 3m and 3m’ in a 1.2:1.0::3n:3n’ 
as yellowish oils (105.3 mg, 69% yield).  3n:  1H NMR (400 MHz, CDCl3) δ ppm 7.41 
(d, J = 8.4Hz, 2H), 7.34 (m, 1H), 7.41 (m, 2H), 3.78 (s, 6H), 3.71 (s, 2H), 3.55 (s, 2H), 
2.21 (s, 3H), 1.97 (s, 3H).  13C NMR (100 MHz, CDCl3) δ (ppm) 172.2, 158.2, 155.5, 
141.7, 139.1, 135.5, 130.1, 129.3, 128.8, 127.4, 127.4, 57.8, 53.3, 42.2, 37.8, 23.7, 17.1.  
IR (cm-1) 3472, 2954, 1737, 1575, 1437, 1273, 1071, 868, 705.  nOe correlation of the 
methyl group and the phenyl ring and between the methyl and the methylene on the 5-
membered ring.  HRMS (ESI) calcd for C20H22NO4 [M+H]+ 340.1549, found 340.1552.  




3.78 (s, 6H), 3.72 (s, 2H), 3.6 (s, 2H), 2.25 (s, 3H), 2.17 (s, 3H).  13C NMR (100 MHz, 
CDCl3) δ (ppm) 172.2, 158.4, 157.1, 142.8, 141.5, 131.3, 129.3, 128.3, 127.9, 127.7, 
57.9, 53.3, 42.2, 37.9, 16.5, 16.4.  IR (cm-1) 3055, 2955, 1736, 1575, 1436, 1269, 1073, 
738, 703.  nOe corelation between the 2 methyl groups and the methyl group with the 
methylene on the 5-membered ring.  HRMS (ESI) calcd for C20H22NO4 [M+H]+ 
340.1549, found 340.1553. 
Synthesis of dimethyl-3-(4-methoxyphenyl)-2,4-dimethyl-5H-cyclopenta[b] 
pyridine-6,6(7H)-dicarboxylate (3o) and dimethyl-2-(4-methoxyphenyl)-3,4-
dimethyl-5Hcyclopenta[b]pyridine-6,6(7H)-dicarboxylate (3o’).  Compounds 3o and 
3o’ were prepared using the general procedure with 1a (100 mg, 0.45 mmol) and 2f (65 
mg, 0.45 mmol), 10 mol% Fe(OAc)2 (7.80 mg, 4.5x10-2 mmoles), 13 mol% of L12 (39.7 
mg, 5.9x10-2 mmol), and zinc (5.9 mg, 9.0 x 10-2 mmol) in N,N-dimethylformamide.  
After 6 h the crude reaction mixture was purified via flash column chromatography using 
100 ml hexanes then 20% ethyl acetate in hexanes and finally 30% ethyl acetate and 
hexanes to afford 3o and 3o’ in a 3:2::3o:3o’ as oils (65.2 mg, 39% yield).  3o:  1H NMR 
(400 MHz, CDCl3) δ ppm 7.02 (d, J= 8.8Hz, 2H), 6.96 (d, J= 8.4Hz 2H), 7.41 (m, 2H), 
3.86 (s, 3H), 3.79 (s, 6H), 3.72 (s, 2H), 3.55 (s, 2H), 2.23 (s, 3H), 1.94 (s, 3H).  13C NMR 
(100 MHz, CDCl3) δ (ppm) 172.3, 158.9, 158.0, 156.0, 142.3, 135.1, 131.2, 130.5, 130.2, 
114.3, 57.9, 55.5, 53.3, 42.2, 37.9, 23.8, 17.2.  IR (cm-1): 3053, 2956, 2842, 1736, 1515, 
1269, 1246, 1071, 838, 737.  nOe corelation between the methyl group and phenyl ring.  
HRMS (ESI) calcd for C19H21N2O4 [M+H]+ 370.1654, found 370.1660.  3o’:  1H NMR 
(400 MHz, CDCl3) δ ppm 7.37 (d, J= 8.8Hz, 2H), 6.95 (d, t, J= 8.8Hz, 2H), 3.84 (s, 3H), 




CDCl3) δ (ppm) 172.3, 159.3, 158.1, 157.1, 142.8, 134.2, 130.9, 130.6, 127.9, 113.8, 
58.0, 55.5, 53.3, 42.2, 38.0, 16.6, 16.5.  IR (cm-1): 2955, 2840, 1736, 1608, 1437, 1247, 
1107, 1071, 839, 765.  nOe correation between the two methyl groups and the methylene 
on the 5-membered ring.  HRMS (ESI) calcd for C21H24NO5 [M+H]+ 370.1654, found 
370.1660 
Synthesis of dimethyl-2,4-dimethyl-3-(4-(trifluoromethyl)phenyl)-
5Hcyclopenta[b]pyridine-6,6(7H)-dicarboxylate (3p) and dimethyl-3,4-dimethyl-2-
(4-(trifluoromethyl)phenyl)-5H-cyclopenta[b]pyridine-6,6(7H)-dicarboxylate (3p’). 
Compounds 3p and 3p’ were prepared using the general procedure with 1a (100 mg, 0.45 
mmol) and 2g (65 mg, 0.45 mmol), 10 mol% Fe(OAc)2 (7.80 mg, 4.5x10-2 mmol), 13 
mol% of L12 (39.7 mg, 5.9x10-2 mmol), and zinc (5.9 mg, 9.0 x 10-2 mmol) in DMF.  
After 4 h the crude reaction mixture was purified via flash column chromatography using 
100 ml hexanes then 20% ethyl acetate in hexanes, and finally 30% ethyl acetate in 
hexanes to afford 3p and 3p’ in a 4:1::3p:3p’ as yellowish oils (63.7 mg, 39%).  3p:  1H 
NMR (400 MHz, CDCl3) δ ppm 7.02 (d, J= 8.8Hz, 2H), 6.96 (d, J= 8.4Hz 2H), 7.41 (m, 
2H), 3.86 (s, 3H), 3.79 (s, 6H), 3.72 (s, 2H), 3.55 (s, 2H), 2.23 (s, 3H), 1.94 (s, 3H).  13C 
NMR (100 MHz, CDCl3) δ (ppm) 172.2, 158.9, 158.0, 156.0, 142.3, 135.1, 131.2, 130.5, 
130.2, 114.3, 57.9, 55.5, 53.3, 42.2, 37.9, 23.8, 17.2.  IR (cm-1): 2956, 2927, 2856, 1737, 
1615, 1438, 1325, 1167, 1126, 1067, 848.  nOe correaltion between the methyl and the 
methylene, and also the methyl group with the phenyl ring.  HRMS (ESI) calcd for 
C21H21NO4F3 [M+H]+ 408.1423, found 408.1425.  3p’:  1H NMR (400 MHz, CDCl3) δ 
ppm 7.69 (d, J= 8Hz, 2H), 7.25 (d, J= 8Hz, 2H), 3.78 (s, 6H), 3.71 (s, 2H), 3.55 (s, 2H), 




143.1, 141.5, 134.0, 130.3, 130.0, 126.0, 125.9, 57.8, 53.4, 42.3, 37.8, 23.8, 17.1.  nOe 
correlation between the methyl group and the phenyl and also between the 2 methyl 
groups.  IR (CH2Cl2, cm-1): HRMS (ESI) calcd for C19H21N2O4 [M+H]+ 370.16, found 
370.1660  
Synthesis of dimethyl-2,4-dimethyl-3-(pyridin-2-yl)-5H-
cyclopenta[b]pyridine-6,6(7H)-dicarboxylate (3q) and dimethyl-3,4-dimethyl-2-
(pyridin-2-yl)-5H-cyclopenta[b]pyridine-6,6(7H)-dicarboxylate (3q’).  Compounds 3q 
and 3q’ were prepared using the general procedure with 1a (50 mg, 0.22 mmol) and 2g 
(39.4 mg, 0.22 mmol) with 10 mol% Fe(OAc)2 (3.89 mg, 2.2x10-2 mmol), 13 mol% of 
L12 (19.83 mg, 2.9x10-2 mmol), and zinc (3.0 mg, 4.6 x 10-2 mmol) in DMF.  After 5 h 
the crude reaction mixture was purified via flash column chromatography using using 
50% EtOAc in hexanes then 2% dichloromethane in methanol, and finally 5% 
dichloromethane in methanol to afford 3q and 3q’ in a 7:3::3q:3q’ as yellowish oils (42.7 
mg, 56%).  3q:  1H NMR (400 MHz, CDCl3) δ ppm 8.80 (s, 1H), 7.70 (dt, J= 8Hz. 1.2Hz, 
1H), 7.28 (m, 1H), 7.21 (d, J= 7.6 Hz, 1H), 3.77 (s, 6H), 3.70 (s, 2H), 3.54 (s, 2H), 2.22 
(s, 3H), 1.95 (s, 3H).  13C NMR (100 MHz, CDCl3) δ (ppm) 172.1, 159.2, 158.3, 155.4, 
150.1, 141.7, 136.8, 134.2, 130.3, 124.9, 122.4, 58.0, 53.3, 42.2, 37.7, 23.3, 16.7.  IR 
(cm-1): 2954, 2924, 2851, 1736, 1588, 1434, 1274, 1071, 964, 823.  nOe corelation 
between the methyl group and the pyridyl ring and also with the methylene protons on 
the 5-membered ring.  HRMS (ESI) calcd for C19H21N2O4 [M+H]+ 341.1517, found 
341.1511.  3q’:  1H NMR (400 MHz, CDCl3) δ (ppm) 8.70 (s, 1H), 7.79 (t, J= 7.6Hz, 
1H), 7.60 (d, J= 7.6Hz, 1H), 7.28 (m, 1H), 3.78 (s, 6H), 3.73 (s, 2H), 3.61 (s, 2H), 2.26 




149.0, 143.4, 136.7, 132.4, 129.0, 124.6, 122.6, 58.1, 53.4, 42.2, 38.0, 16.5, 15.9.  IR 
(cm-1): 2954, 2924, 2853, 1736, 1585, 1436, 1276, 1072, 964.  HRMS (ESI) calcd for 
C19H21N2O4 [M+H]+ 341.1501, found 341.1505. 
Synthesis of dimethyl-2-butyl-4-methyl-3-phenyl-5H-cyclopenta[b]pyridine-
6,6(7H)-dicarboxylate (3r) and dimethyl-3-butyl-4-methyl-2-phenyl-5H-
cyclopenta[b]pyridine-6,6(7H)-dicarboxylate (3r’).  Compounds 3r and 3r’ were 
prepared using the general procedure with 1a (50 mg, 0.22 mmol) and 2i (26.2 mg, 0.22 
mmol), 10 mol% Fe(OAc)2 (3.89 mg, 2.2x10-2 mmol), 13 mol% of L12 (19.83 mg, 
2.9x10-2 mmol) catalyst, and zinc (3.0 mg, 4.6 x 10-2 mmol) in DMF.  After 16 h the 
crude reaction mixture was purified via flash column chromatography using 100 ml 
hexanes and then 20% EtOAc in hexanes to afford 3r and 3r’ in a 3:2::3r:3r’ as oils 
(45.2 mg, 53%).  3r:  1H NMR (400 MHz, CDCl3) δ ppm 7.36 (m, 5H), 3.76 (s, 6H), 3.71 
(s, 2H), 3.60 (s, 2H), 2.53 (t, J= 8.4Hz, 2H), 2.29 (s, 3H), 1.35 (s, 2H), 1.21 (sext, J= 7.2 
Hz, 2H), 0.77 (t, J=7.2 Hz, 3H).  13C NMR (100 MHz, CDCl3) δ (ppm) 172.3, 159.0, 
156.8, 142.3, 141.8, 132.9, 131.8, 128.9, 128.2, 127.6, 57.8, 53.3, 42.2, 38.1, 32.5, 29.0, 
23.0, 16.0, 13.8.  IR (cm-1): 2956, 2860, 1737, 1574, 1437, 1273, 1071, 736, 705.  
HRMS (ESI) calcd for C23H27NO4 [M+H]+ 382.2018, found 382.2022  3r’:  1H NMR 
(400 MHz, CDCl3) δ (ppm) 7.39 (m, 3H), 7.60 (td, J1= 6.8 Hz, J2= 1.6 Hz, J3= 1.2 Hz, 
2H) 3.80 (s, 6H), 3.74 (s, 2H), 3.56 (s, 2H), 2.45 (t, J1= 8.4Hz, J2= 7.6 Hz, 2H), 1.91 (s, 
3H), 1.76 (sext, J1= 7.6 Hz, J2= 7.2 Hz, J3= 7.2 Hz, 2H), 0.73 (t, J1= 7.6 Hz, J2= 7.2 Hz, 
3H).  13C NMR (100 MHz, CDCl3) δ (ppm) 172.2, 159.7, 158.4, 141.9, 139.0, 135.0, 
129.9., 129.0, 128.6, 127.4, 57.7, 53.3, 42.4, 38.0, 36.1, 32.6, 22.9, 17.2, 14.0.  IR (cm-1): 




C23H28NO4 [M+H]+ 382.2018, found 382.2032. 
Synthesis of dimethyl 2-(2-(N-(tert-butoxycarbonyl)-4-
methylphenylsulfonamido)ethyl-4-methyl-3-phenyl-5H-cyclopenta[b]pyridine-
6,6(7H)-dicarboxylate (3s), and dimethyl 3-(2-(N-(tert-butoxycarbonyl)-4-
methylphenylsulfonamido)ethyl)-4-methyl-2-phenyl-5Hcyclopenta[b]pyridine-
6,6(7H)-dicarboxylate (3s’).  Compounds 3s and 3s’ were prepared using the general 
procedure with 1a (50 mg, 0.22 mmol), 2i (26.2 mg, 0.22 mmol), 10 mol% Fe(OAc)2 
(3.89 mg, 2.2x10-2 mmol), 13 mol% of L12 (19.83 mg, 2.9x10-2 mmol) catalyst, and 
zinc (3.0 mg, 4.6 x 10-2 mmol) in DMF.  After 16 h the crude reaction mixture was 
purified via flash column chromatography using 100 ml hexanes, then 20% EtOAc in 
hexanes and finally 40% EtOAc in hexanes to afford 3s and 3s’ in a 3:2::3s:3s’ as 
yellowish oils (61.8 mg, 44%).  3s:  1H NMR (400 MHz, CDCl3) δ (ppm) 7.52 (d, J= 8.4 
Hz, 2H), 7.44 (m, 4H), 7.39 (m, 1H), 7.21 (d, J= 8.14 Hz, 2H), 3.80 (s, 6H), 3.74 (s, 2H), 
3.61 (s, 2H), 3.03 (t, J= 8.4, 8.0 Hz, 2H), 2.42 (d, J= 8.4 Hz, 6H), 1.29 (s, 9H).  13C NMR 
(100 MHz, CDCl3) δ (ppm) 172.2, 160.0, 158.0, 151.0, 144.3, 143.6, 141.3, 137.5, 132.1, 
129.4, 129.1, 128.6, 128.2, 128.1, 127.9, 84.6, 57.8, 53.4, 46.1, 42.3, 38.1, 30.1, 28.1, 
21.8, 16.3.  nOe correlation between the methyl group and the phenyl ring and also the 
methyl group and the methylene protons on the 5-membered ring.  IR (cm-1): 2956, 
1734, 1575, 1437, 1400, 1278, 1159, 1090, 969, 736.  HRMS (ESI) calcd for 
C33H38N2O8SNa [M+Na]+ 645.2247, found 645.2264.  3s’:  1H NMR (400 MHz, CDCl3) 
δ (ppm) 7.61(d, J=8.4 Hz, 2H), 7.45 (t, J=7.2 Hz, 2H), 7.39 (d, J=7.2 Hz, 2H), 7.20 (d, 
J=7.6, 2H), 7.13 (d, J=7.6 Hz, 2H), 4.12 (t, J=7.6 Hz, 2H), 3.80 (s, 6H), 3.72 (s, 2H), 3.57 




MHz, CDCl3) δ (ppm) 172.3, 158.7, 155.6, 151.0, 144.0, 141.7, 138.5, 137.7, 135.6, 
130.4, 129.6, 129.2, 128.9, 128.1, 127.5, 84.0, 57.8, 53.3, 46.8, 42.2, 37.9, 35.8, 28.0, 
21.8, 17.2.  nOe corelation between the methylene on the side chain with the phenyl and 
also the methyl group.  IR (cm-1): 2956, 1734, 1596, 1439, 1400, 1277, 1159, 1088, 970, 
735.  HRMS (ESI) calcd for C33H38N2O8SNa [M+Na]+ 645.2247, found 645.2254. 
Synthesis of dimethyl-3-butyl-2,4-dimethyl-5H-cyclopenta[b]pyridine-
6,6(7H)-dicarboxylate (3t) and dimethyl-2-butyl-3,4-dimethyl-5H-
cyclopenta[b]pyridine-6,6(7H)-dicarboxylate (3t’).  Compounds 3t and 3t’ were 
prepared using the general procedure with 1a (50 mg, 0.22 mmol) and 2j (28.9 mg, 0.22 
mmol), 10 mol% Fe(OAc)2 (3.89 mg, 2.2x10-2 mmol) and 13 mol% of L12 (19.83 mg, 
2.9x10-2 mmol), and zinc (3.0 mg, 4.6 x 10-2 mmol) in 0.53 ml DMF.  After 16 h the 
crude reaction mixture was purified via flash column chromatography using 100 mL 
hexanes, then 20% EtOAc in hexanes and finally 30% EtOAc in hexanes to afford 3t and 
3t’ in a 1:1::3t:3t’ as oils (44.3 mg, 62%).  3t:  1H NMR (400 MHz, CDCl3) δ (ppm) 3.76 
(s, 3H), 3.63 (s, 2H), 3.51 (s, 2H), 2.57 (t, J= 8Hz, 2H), 2.50 (s, 3H), 2.20 (s, 3H), 1.42 
9m, 4H), 0.96 (t, J= 6.8 Hz, 3H).  13C NMR (100 MHz, CDCl3) δ (ppm) 172.3, 156.4, 
155.7, 141.4, 133.0, 130.6, 57.9, 53.3, 42.2, 38.1, 31.6, 28.9, 23.3, 22.8, 15.8, 14.1.  IR 
(cm-1) 2956, 2869, 1737, 1586, 1437, 1274, 1070, 961, 736.  nOe correlation between 
the methyl group and the butyl group and also the methyl group with the methylene 
protons on the 5-membered ring.  HRMS (ESI) calcd for C18H26NO4 [M+H]+ 320.1862, 
found 320.1867.  3t’:  1H NMR (400 MHz, CDCl3) δ (ppm) 3.76 (s, 6H), 3.65 (s, 2H), 
3.52 (s, 2H), 2.76 (t, J= 8.4 , 8.0Hz, 2H), 2.17 (d, J= 3.6 Hz, 6H), 1.60 (m, 2H), 1.43 




172.3, 159.8, 156.5, 142.0, 130.1, 127.6, 57.9, 53.3, 42.2, 38.0, 36.5, 32.0, 23.2, 16.5, 
14.5, 14.2.  IR (cm-1) 2956, 1737, 1583, 1436, 1378, 1273, 1199, 1163, 1103, 1071, 962, 
863, 735.  nOe correation between the methylene of the butyl group and the methyl 
group.  HRMS (ESI) calcd for C18H25NO4 [M+H]+ 320.1862, found 320.1866. 
Synthesis of dimethyl-2-(tert-butyl)-3,4-dimethyl-5H-cyclopenta[b]pyridine-
6,6(7H)-dicarboxylate (3u).  Compound 3u was prepared using the general procedure 
with 1a (50 mg, 0.22 mmol) and 2j (28.9 mg, 0.22 mmol), 10 mol% Fe(OAc)2 (3.89 mg, 
2.2x10-2mmoles), 13 mol% of L12 (19.83 mg, 2.9x10-2mmoles), and zinc (3.0 mg, 4.6 x 
10-2 mmol) in 0.53 ml DMF.  After 16h the crude reaction mixture was purified via flash 
column chromatography using 100 ml hexanes, then 20% EtOAc in hexanes and finally 
30% EtOAc in hexanes to afford 3u as a single product as an oil (44.3 mg, 26%).  3u:  1H 
NMR (400 MHz, CDCl3) δ (ppm) 3.78 (s, 6H), 3.66 (s, 2H), 3.53 (s, 2H), 2.35 (s, 2H), 
2.16 (s, 3H), 1.43 (s, 12H).  13C NMR (100 MHz, CDCl3) δ (ppm) 172.5, 165.0, 155.2, 
142.9, 129.7, 128.7, 128.0, 57.7, 53.2, 42.4, 38.8, 38.1, 30.6, 24.4, 23.7, 22.7, 17.1, 16.7.  
nOe correlation between the 2 methyl groups and one methyl group with the t-butyl 
group.  IR (cm-1): 2956, 2900, 1731, 1638, 1438, 1273, 1199, 1071, 961, 737, 701.  
HRMS (ESI) calcd for C18H26NO4 [M+H]+ 320.1862, found 320.1861. 
Synthesis of (L12)FeBr2.  The FeBr2 and L12 complex was prepared by a 
previously reported method19 using FeBr2 (20 mg, 9.2 x10-2 mmol) L12 (61.8 mg, 9.2 
x10-2 mmol) in THF in the glove box.  The reaction mixture was stirred for 3 h and then 
filtered over celite.  Removal of THF in vacuo afforded the complex as a dark green 
solid.  1H NMR (300 MHz, CD2Cl2) (All peaks appeared broad) δ (ppm) 59.5 (2H), 14.02 




Crystals were grown by slow diffusion of diethyl ether from dichloromethane.  Based on 
the preliminary crystal structure analysis, we found that the iron is coordinated to the 3 
nitrogens of L12.  The crystal system is triclinic A= 8.8401 Å, B= 9.9680 Å, C= 27.2923 
Å, α= 90.91°, β= 94.59°, γ= 113.99°.  Unit cell volume = 2194.98 Å³, Space group = Pī.  
Disorder in the p-substituted benzyloxy region was also observed. 
Compound 3a was prepared using 1a (51.3 mg, 0.23 mmol), 2a (32.8 mg, 0.23 
mmol), (L12)FeBr2 complex (20.3 mg, 2.3x 10-2 mmol), and zinc (30 mg, 4.6x10-2 
mmol) in 533 mL of N,N-dimethyl formamide.  The reaction was stirred at 85 °C for 2 h 
and the resulting brown mixture was purified with silica gel flash chromatography using 
10% EtOAc in hexanes to yield 3a (48 mg, 58%) as a viscous, yellow oil 
(characterization reported above). 
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THE IRON-CATALYZED CYCLOADDITION OF DIYNES AND CYANAMIDES 
 
 
Reproduced in part with permission from J. Org. Chem. 2012, 77, 7555-7563. 




The first general iron-catalyzed method for pyridine synthesis was recently 
developed in the Louie Lab.1  In this initial report, the strong tendency for iron to 
cyclotrimerize alkynes was overcome using alkynenitrile substrates along with a unique 
bis(aldimino)pyridine ligand (L1) (equation 1).2  Shortly after this report, Wan and co-
workers published an iron-catalyzed synthesis of pyridines from diynes and nitriles 
(equation 2).3  Unfortunately, relatively high catalyst loadings were required in both 
systems.  In addition, these systems either gave pyridines in moderate yields (former) or 
required 10 to 20 molar equivalents of nitrile (latter).4  Although these reports are an 
important step forward, an efficacious iron-catalyzed route to pyridines that utilizes low 







Attempts to react unactivated nitriles with diynes using the Louie system afforded 
only traces of pyridine products.  Reactions with electron-deficient nitriles were also 
unsuccessful.5  Recent work with cyanamides suggested that they could be suitable 
partners in Fe-catalyzed cycloaddition chemistry, as they appeared to be more reactive in 
Ni-catalyzed cycloadditions.6  Thus, 2-aminopyridines could potentially be prepared by 
our iron bisiminopyridine catalyst without requiring a large excess of cyanamide or 
having to tether the cyanamide to an alkyne. 
Variations on the 2-aminopyridine core have been studied extensively due to their 
potential as medicinally useful compounds.7  2-Aminopyridines are also a central 
structural motif in α-carboline natural products8 as well as in a variety chromophores,9 
pharmacophores,10 OLED’s,11 and inorganic ligands.12  These broadly applicable 
compounds are commonly synthesized by Buchwald-Hartwig-type aminations,13 
nucleophilic aromatic substitutions,14 and multicomponent condensations.15  Such 
methods are useful for the creation of simple 2-aminopyridines, but more complex 
substitution patterns require additional synthetic manipulations.  For more complex 
aminopyridines, Co, Ni, Rh, and Ti, catalysts and a photocatalytic system have all been 
used to mediate [2+2+2] cycloadditions.16  However, in most of these studies (i.e., Rh 
and Ti), only a single example of a [2+2+2] cycloaddition with a cyanamide was 
demonstrated.  In an effort to improve the conditions and expand the scope of these 




formation of 2-aminopyridines from diynes and cyanamides.6  Although this system was 
high yielding and regioselective, the low-cost and environmentally-benign nature of iron 
compares favorably to nickel.  Additionally, highly reactive cyanamides present an 
opportunity to improve on iron-catalyzed pyridine formation.  This chapter outlines the 
successful development of an iron catalyst for the cycloaddition of diynes and 
cyanamides to afford 2-aminopyridines. 
 
Results and Discussion 
The first attempt to make 2-aminopyridine 3a from diyne 1a and 2 equivalents of 
cyanamide 2a using the original catalyst system (10 mol% Fe(OAc)2, 13 mol% Zn and 13 
mol% L1 in DMF) afforded 2-aminopyridine 3a in 69% isolated yield at 85 °C (equation 
3).  Furthermore, the use of a simpler ligand (L2) led to an increase in isolated yield 
(85%).17  Further optimization led to conditions employing 5 mol% catalyst loading of 
inexpensive FeCl2, 10 mol% Zn and 10 mol% L2 in benzene over 4 h at room 
temperature.  Evaluation of other ligands (N-heterocyclic carbenes, phosphines, and 
pyridyl diimines provided no product.18 
 
 
Unfortunately, the mild conditions that worked for the model substrates (i.e., 1a 




to 70 °C led to good reactivity of the substrates, diyne dimerization accounted for as 
much as half of substrate conversion.  An excess of cyanamide (10 equiv) led to no 
reactivity suggesting that cyanamide binding outcompetes alkyne binding at high 
concentrations.  Gratifyingly, slow addition of diyne over the course of 3 h solved this 
problem and provided a general method for coupling a variety of diynes.  Slow addition 
of the diyne also allowed us to decrease the cyanamide:diyne ratio to 1.2:1 with no 
deleterious effects on the yield. 
Control studies were performed to establish the necessity of iron in this catalytic 
system.  Importantly, removing any part of the catalytic system renders the reaction 
ineffective.  Additionally, (L2)FeBr2 (Figure 15) was independently synthesized and used 
directly as an all-in-one catalyst precursor to provide a 97% NMR yield (equation 4).  
That is, the combination of (L2)FeBr2 and Zn dust provided a catalytically competent 
system.  The comparable activity of (L2)FeBr2 indicates that the active catalyst is bound 
to a single ligand.  The use of a 1:2 ratio of FeCl2:L2 is only necessary to increase the 
rate of complexation of the iron salt to the ligand.  No reaction occurred in the absence of 
zinc dust.19 
 
A broad range of diynes and cyanamides were successfully converted to their 





Figure 15.  Ortep of (L2)FeBr2. 
 
 









malonate backbone diyne 1b both afforded products (3a and 3b) in excellent yield 
(entries 1-2).  The challenging terminal diyne 1c provided 3c in good yield (entry 3).  
However, other difficult substrates such as phenyl and TMS-substituted diynes (1d and 
1e respectively, entries 4-5) were unreactive.  The lack of Thorpe-Ingold effect in 
substrates 1f and 1g did not affect cycloaddition, as products 3f and 3g were both 
obtained in 84% yield (entries 6-7).  Notably, entries 1 and 6 demonstrate that heteroatom 
tethers, which were problematic in the previous iron systems,1,3 are well tolerated by this 
system.  Diyne 1h successfully provided the 6,6-bicyclic pyridine (3h) in good yield 
(entry 8).  High yields of 2-aminopyridine were obtained with methyl-phenyl (2d) and 
dimethyl (2b)-substituted cyanamide substrates (entries 9 and 11).  Cycloaddition of 
diethyl cyanamide 2c afforded a lower yield of product, suggesting a poor tolerance 
toward sterically bulky cyanamides (entry 10).  Cyclic cyanamides N-cyanopiperidine 
(2e) and N-cyanomorpholine (2f) reacted readily (entries 12-13).  In contrast to the 
apparent negative effect of cyanamide sterics in entry 10, the large dibenzazepinyl 
cyanamide provided 3n in good yield (entry 14).  This result compares well with the 19% 
yield afforded by cobalt.16  Attempts to react (dimethylamino)acetonitrile with diyne 1b 
were unsuccessful, which may indicate that the inherent electronic structure of 
cyanamides, not a chelation effect, is the source of their high reactivity in this system.20  
To demonstrate the synthetic utility of this methodology, entry 1 was repeated on a 1 
mmol scale, leading to a comparable yield of 94% (equation 5). 
For future synthetic application, an understanding of the regioselectivity of 






optimized conditions and the results are summarized in Table 6.  In each of these cases, 
good yields of 2-aminopyridine products were obtained.  What is surprising, however, is 
that each of the reactions shows a strong preference to place the larger substituent 
proximal to the pyridine nitrogen.  For example, the cycloaddition of H, Me-substituted 
diyne 1i, and cyanamide 2b provided an 85:15 ratio of 3o and 3o’ in 72% combined yield 
(entry 1).  A similar product ratio was obtained in the cycloaddition of a bulkier diyne 
(1j, entry 2) as well as aryl/alkyl diyne (1k, entry 3).  These regioselectivity trends nicely  
 Table 6.  Unsymmetrical diynes 
 
aYields reported as a combination of both regioisomers. 





complement the nickel-catalyzed systems where the larger substituent is placed at the 3-
position of the 2-aminopyridine ring.6  Additionally, this Fe-catalyzed method is milder  
than the cobalt-catalyzed system, which is primarily limited to terminal alkynes.16  
Notably, the regioselectivity is the reverse of that observed in the previous Fe-catalyzed 
system involving diynes and nitriles, wherein the larger alkyne substituent was placed 
ortho- to the nitrile substituent.3  To verify that this trend is a result of the catalyst and not 
the type of nitrile, diyne 1k was reacted with dimethyl cyanamide 2b under the catalyst 
developed by Wan and co-workers (equation 6). 
 
  The FeI2/dppp system provided the product in a 63% combined yield but with 
3q’ as the major regioisomer in a 10:90 (3q, 3q’) ratio.  This represents opposite 
regioselectivity compared to the Louie system.  The regioisomers of these reactions were 
identified through the use of 2-D NOESY, HMBC, and HMQC NMR experiments.  An 
x-ray quality crystal of 3q’ was grown, verifying the regioselectivity trends established 
by NMR (Figure 16). 
The fully intermolecular [2+2+2] cycloaddition of alkynes and nitriles to form 
pyridines is a challenging reaction.  To date, intermolecular reactions with cyanamides 





Figure 16.  Ortep of 3q’. 
 
using unsymmetrical internal alkynes.21  Furthermore, no reports of [2+2+2] 
cycloadditions involving aryl acetylenes and cyanamides exist, to our knowledge.  
Terminal aryl acetylenes are particularly challenging substrates since these tend to 
undergo rapid oligomerization to provide unwanted side products.22  Despite this 
potential pitfall, as well as the possibility of forming multiple regioisomers, the reaction 
of two equivalents of alkyne 4a and one equivalent of cyanamide 2b afforded 5a as a 
single regioisomer in 90% yield (equation 7). 
 
This mild and efficient route to 2-amino-4,6-aryl pyridines may provide an 
alternative to multistep syntheses of biologically active compounds.23  Furthermore, this 
reaction overcomes the greatest obstacle present in [2+2+2] cycloaddition.  That is, the 
regioselective three-component cyclization of unsymmetrical alkynes with a nitrile.  This 




to regioselectively produce monocyclic 2-aminopyridines from simple alkynes and 
cyanamides.  This project holds the promise to provide simple and efficient access to a 
variety of substituted pyridines that would otherwise require multiple synthetic 
manipulations.  Additionally, the products of these reactions can be used as building 
block chemicals.  Recent work has demonstrated that aryl amines are a useful synthetic 
handle.  The amine can be easily converted to an ammonium salt, which can then allow 
for cross-coupling reactions.24  
The contrast in regioselectivity between our FeCl2/L2 system and the FeI2/dppp 
system is a rare example of ligand-dependent regioselectivity in metal-catalyzed [2+2+2] 
pyridine formation.25  The regioselectivity observed in the Louie Fe system mirrors that 
observed in Co-catalyzed protocols.  As such, this preliminarily suggests that the L2/Fe-
catalyzed cycloaddition of cyanamides may follow a similar mechanism to that of the 
well-established mechanism for Co-catalyzed pyridine formation.26   Following in situ 
ligand coordination and reduction by zinc, a reduced Fe catalyst binds the diyne and 
facilitates oxidative coupling of the two alkyne units to form a ferracyclopentadiene 
(Figure 17).  Insertion of cyanamide and reductive elimination subsequently afford the  
pyridine product.  Interestingly, the FeI2/dppp catalyst system, which follows the 
regioselectivity patterns of nickel, has been proposed to undergo a mechanism involving 
initial oxidative coupling between an alkyne and a nitrile instead.3  This is in agreement 
with the proposed mechanism for nickel-catalyzed pyridine formation.27  The 
regioselectivity results of this study, combined with what is known about cobalt and 
nickel systems, may indicate that iron is capable of following either mechanistic pathway 






Figure 17.  Mechanistic hypothesis. 
 
Conclusions 
The iron-catalyzed [2+2+2] cycloaddition of alkynes and cyanamides is a high-
yielding, atom-efficient and regioselective method to obtain 2-aminopyridines.  Iron 
catalyzed pyridine synthesis is no longer limited by alkynenitrile substrates or large 
excesses of nitrile.  The ability to use cheap and inexpensive FeCl2 in only 5 mol% adds 
further to the overall efficiency of this system.  Differences in regioselectivity trends 
between the Louie and Wan iron catalyst systems raise interesting mechanistic questions.  
Studies into the mechanism of the Louie system have begun and are discussed in Chapter 
5.  The surprisingly effective 3-component cyclization that is catalyzed by this method 
opens the door to an exciting new avenue of study.  This reaction will be optimized and 
developed into a practical route to access monocyclic 2-aminopyridines. Finally the 
Louie iron catalyst system has now been demonstrated as a versatile cyclotrimerization 
tool.  More reactions should be explored using this catalyst system.  One such reaction is 





All reactions were conducted under an atmosphere of N2 using standard Schlenk 
techniques or in a N2-filled glove box unless otherwise noted.  Benzene was dried over 
neutral alumina under N2 using a Grubbs type solvent purification system.  Iron Chloride 
(99.95% purity) was purchased from Alfa Aesar.  Diynes 1a,28 1b-c,29 1d,30 1e,31 1f,32 
1g,33 1h,34 1i,35 and 1j-k36 were prepared from known literature procedures.  Liquid 
cyanamides were degassed using three sequential freeze-pump-thaw cycles.  Slow 
addition of diyne was performed using a syringe pump and a disposable 1 mL syringe 
with a 6 inch, stainless steel, 24 gauge needle.  The needle was dried overnight at 160 °C 
and was fitted to the syringe while hot.  The syringe/needle joint was then wrapped 
tightly with Teflon tape. 
1H and 13C Nuclear Magnetic Resonance spectra of pure compounds were 
acquired at 400 and 100 MHz, unless otherwise noted.  All spectra are referenced to a 
singlet at 7.27 ppm for 1H and to the center line of a triplet at 77.23 ppm for 13C.  The 
abbreviations s, d, dd, dt, dq, td, t, q, and quint stand for singlet, doublet, doublet of 
doublets, doublet of triplets, doublet of quartets, triplet of doublets, triplet, quartet, and 
quintet, respectively.  All 13C NMR spectra were proton-decoupled.  The infra-red spectra 
were recorded on a Bruker Tensor 27 FT-IR spectrometer.  Gas Chromatography was 
performed on an Agilent 6890 gas chomatograph with a 30 meter HP-5 column using the 
following conditions: initial oven temperature: 100 ºC; temperature ramp rate 10 ºC/min.; 
final temperature: 300 ºC held for 12 minutes;  detector temperature:  250 ºC. 
General Procedure for the Cycloaddition.  In a nitrogen-filled glove box, 5 




10 to 15 minutes, at which time 1.2 equivalents of cyanamide and 10 mol% Zn dust were 
added. The vial was then capped with a Teflon-lined septum screw cap and removed 
from the glove box.  The vial was stirred in a 70 °C oil bath, and a solution of diyne in 
benzene was slowly added to the vial over 3 hours (unless otherwise noted) via syringe 
pump.  The final concentration of the diyne after addition was 0.4 M. 
Purification Procedure A.  For 2-aminopyridines with an Rf > 0.3 (20% ethyl 
acetate in hexanes) L2 (Rf = 0.51, 20% ethyl acetate in hexanes) may co-elute with and 
contaminate the final product.  This method was devised to avoid this issue.  Once the 
reaction was complete, as determined by GC, the crude mixture was stirred in aqueous 
HCl for 10 minutes to protonate the 2-aminopyridine product.  The aqueous layer was 
collected and the organic layer was further extracted with 4 x 15 mL portions of aqueous 
HCl.  The aqueous extracts were collected, then a saturated aqueous NaHCO3 solution 
was carefully added until the pH >7, causing the product to precipitate.  The aqueous 
layer was then extracted with 3 x 25 mL portions of diethyl ether.  The organic extracts 
were collected, dried over Na2SO4, filtered, and the solvent was removed in vacuo.  The 
crude product was then purified via silica gel flash chromatography. 
Purification Procedure B.  For 2-aminopyridines with Rf < 0.3 (20% ethyl 
acetate in hexanes). Once the reaction was complete, as determined by GC, the crude 
mixture was purified via flash silica gel chromatography.  The product often contained 
unreacted cyanamide at this point, so the product was stirred in aqueous HCl for 10 
minutes.  The aqueous layer was collected and the organic layer was further extracted 
with 4 x 15 mL portions of aqueous HCl.  The aqueous extracts were collected, then a 




product to precipitate.  The aqueous layer was then extracted with 3 x 25 mL portions of 
diethyl ether.  The organic extracts were collected, dried over Na2SO4, filtered, and the 
solvent was removed in vacuo. 
Synthesis of 4,7-dimethyl-6-(pyrrolidin-1-yl)-2-tosyl-2,3-dihydro-1H-
pyrrolo[3,4-c]pyridine (3a).  Compound 3a was prepared using the general procedure 
with 2a (42 mg, 4.4 x 10-1 mmol), FeCl2 (2.3 mg, 1.8 x 10-2 mmol), L2 (13.4 mg, 3.6 x 
10-2 mmol), and zinc (2.4 mg, 3.6 x 10-2 mmol) in 418 μL of benzene.  Diyne 1a (100 
mg, 3.6 x 10-1 mmol), dissolved in 490 μL benzene was added over 3 h at 70 °C.  The 
reaction was stirred an additional 1 h for a total reaction time of 4 h.  After the reaction 
was complete (reaction monitored by GC), the product was isolated as described in 
Purification Procedure B, with silica gel flash chromatography using 10% ethyl acetate in 
hexanes followed by an acid/base extraction with 3M HCl to yield 3a (126 mg, 93%) as a 
white solid.  Rf = 0.19 (20% ethyl acetate in hexanes).  1H and 13C NMR spectral data 
were compared with known literature values.6 
Synthesis of dimethyl 1,4-dimethyl-3-(pyrrolidin-1-yl)-5H-
cyclopenta[c]pyridine-6,6-(7H)-dicarboxylate (3b).  Compound 3b was prepared using 
the general procedure with 2a (49 mg, 5.1 x 10-1 mmol), FeCl2 (2.7 mg, 2.1 x 10-2 mmol), 
L2 (16 mg, 4.2 x 10-2 mmol), and zinc (2.8 mg, 4.2 x 10-2 mmol) in 560 μL of benzene.  
Diyne 3b (100 mg, 4.2 x 10-1 mmol), dissolved in 498 μL benzene, was added over 3 h at 
70 °C.  The reaction mixture was stirred for an additional 3 h for a total reaction time of 6 
h.  After the reaction was complete (reaction monitored by GC), the product was isolated 
as described in Purification Procedure B, with silica gel flash chromatography using 20% 




(127 mg, 90%) as a yellowish solid.  Rf = 0.27 (20% ethyl acetate in hexanes).  1H and 
13C NMR spectral data were compared with known literature values.6 
Synthesis of dimethyl 3-(pyrrolidin-1-yl)-5H-cyclopenta[c]pyridine-6,6-(7H)-
dicarboxylate (3c).  Compound 3c was prepared using the general procedure with 2a (55 
mg, 5.7 x 10-1 mmol), FeCl2 (3.0 mg, 2.4 x 10-2 mmol), L2 (18 mg, 4.8 x 10-2 mmol), and 
zinc (3.1 mg, 4.8 x 10-2 mmol) in 194 μL of benzene.  Diyne 1c (99 mg, 4.8 x 10-1 
mmol), dissolved in 1 mL benzene, was added over 3 h at 70 °C.  The reaction was 
stirred at 70 °C for an additional 15 h for a total reaction time of 18 h.  After the reaction 
was complete (reaction monitored by GC), the product was isolated as described in 
Purification Procedure B, with silica gel flash chromatography using 2% methanol in 
dichloromethane followed by an acid/base extraction with 1M HCl to yield 3c (94 mg, 
65%) as a white solid.  Rf = 0.01 (20% ethyl acetate in hexanes).  1H and 13C NMR 
spectral data were compared with known literature values.6 
Synthesis of 4,7-diethyl-6-(pyrrolidin-1-yl)-1,3-dihydrofuro[3,4-c]pyridine 
(3f).  Compound 3f was prepared using the general procedure with 2a (36 mg, 3.8 x 10-1 
mmol), FeCl2 (2.0 mg, 1.6 x 10-2 mmol), L2 (12 mg, 3.2 x 10-2 mmol), and zinc (2.1 mg, 
3.2 x 10-2 mmol) in 0.292 μL of benzene.  Diyne 1f (47 mg, 3.2 x 10-1 mmol), dissolved 
in 497 μL benzene, was added over 5 h at 70 °C.  The reaction was stirred an additional 1 
h for a total reaction time of 6 h.  After the reaction was complete (reaction monitored by 
GC), the product was isolated as described in Purification Procedure A, with an acid/base 
extraction using 1M HCl then silica gel flash chromatography using 5% ethyl acetate in 
hexanes (500 mL), then 10% ethyl acetate in hexanes (500 mL) to yield 3f (65 mg, 84%) 




(ppm) 1.14 (t, J = 7.7 Hz, 3H), 1.23 (t, J = 7.5 Hz, 3H), 1.93 (quint, J = 3.3 Hz, 4H), 
2.51-2.60 (m, 4H), 3.52 (quint, J = 3.2 Hz, 4H), 5.05 (s, 4H).  13C (75 MHz, CDCl3) δ 
(ppm) 158.0, 150.3, 149.8, 122.9, 116.2, 72.8, 72.4, 50.3, 29.2, 25.8, 23.0, 13.8, 12.5.  IR 
(cm-1): 2966, 2932, 2869, 1761, 1600, 1428, 1381, 1343, 1311, 1228, 1143, 1053, 906, 
783.  HRMS (ESI, TOF) calcd for C15H23N2O [M+H]+ 247.1810, found 247.1814. 
Synthesis of 1,4-dimethyl-3-(pyrrolidin-1-yl)-6,7-dihydro-5H-
cyclopenta[c]pyridine (3g).  Compound 3g was prepared using the general procedure 
with 2a (55 mg, 5.7 x 10-1 mmol), FeCl2 (3.0 mg, 2.4 x 10-2 mmol), L2 (18 mg, 4.8 x 10-2 
mmol), and zinc (3.1 mg, 4.8 x 10-2 mmol) in 429 μL of benzene.  Diyne 1g (57 mg, 4.8 x 
10-1 mmol), dissolved in 765 μL benzene, was added over 5 h at 70 °C.  The reaction was 
stirred an additional 2 h for a total reaction time of 7 h.  After the reaction was complete 
(reaction monitored by GC), the product was isolated as described in Purification 
Procedure A, with an acid/base extraction using 1M HCl then silica gel flash 
chromatography using 5% ethyl acetate in hexanes (500 mL), then 10% ethyl acetate in 
hexanes (500 ml) to yield 3g (86 mg, 84%) as a yellow oil.  Rf = 0.49 (20% ethyl acetate 
in hexanes).  1H (300 MHz, CDCl3): δ (ppm) 1.89-1.92 (m, 4H), 2.06, (quint, J = 7.4 Hz, 
2H), 2.17 (s, 4H), 2.33 (s, 3H), 2.80 (t, J = 7.5 Hz, 4H), 3.44 (t, J = 6.5 Hz, 4H).  13C (75 
MHz, CDCl3) δ (ppm) 154.5, 147.4, 129.1, 129.0, 114.3, 50.4, 32.3, 30.6, 25.6, 24.8, 
22.0, 16.0.  IR (cm-1): 2953, 2868, 1595, 1425, 1347, 1204, 1137, 1063, 938, 858, 756.  
HRMS (ESI, TOF) calcd for C14H21N2 [M+H]+ 217.1705, found 217.1709. 
Synthesis of tetraethyl-1,4-dimethyl-3-(pyrrolidin-1-yl)isoquinoline-
6,6,7,7(5H,8H)-tetracarboxylate (3h).  Compound 3h was prepared using the general 




mg, 1.5 x 10-2 mmol), and zinc (1.0 mg, 1.5 x 10-2 mmol) in 100 µL of benzene.  Diyne 
1h (67 mg, 1.6 x 10-1 mmol) dissolved in 300 μL benzene was added over 3 h at 70 °C.  
The reaction mixture was stirred an additional 3 h for a total reaction time of 6 h.  After 
the reaction was complete (reaction monitored by GC), the crude product was isolated 
with only silica gel flash chromatography (no acid/base extraction) using 10% ethyl 
acetate in hexanes (200 mL), then 15% ethyl acetate in hexanes (400 mL) to yield 3h (65 
mg, 80%) as a yellow oil.  Rf = 0.19 (20% ethyl acetate in hexanes).  1H (400 MHz, 
CDCl3): δ (ppm) 1.23 (td, J1 = 3.2, J2 = 3.2, J3 = 3.2 Hz, 12H), 1.86-1.92 (m, 4H), 2.12 
(s, 3H), 2.34 (s, 3H), 3.30 (s, 2H), 3.36 (m, 6H), 4.13-4.25 (m, 8H).  13C (100 MHz, 
CDCl3) δ (ppm) 170.2, 170.1, 157.9, 150.2, 141.7, 118.2, 115.8, 62.2, 62.0, 61.9, 57.4, 
57.1, 50.4, 33.1, 31.8, 25.5, 22.3, 14.8, 13.9.  IR (cm-1): 2981, 2937, 2871, 2361, 1735, 
1571, 1429, 1367, 1326, 1270, 1241, 1202, 1096, 1052, 942, 864, 784, 703, 650, 614, 
580.  HRMS (ESI, TOF) calculated for C28H27N2O4 455.1971, found 455.1969. 
Synthesis of dimethyl 3-(dimethylamino)-1,4-dimethyl-5H-
cyclopenta[c]pyridine-6,6(7H)-dicarboxylate (3i). Compound 3i was prepared using 
the general procedure B with 2b (20 mg, 2.8 x 10-1 mmol), FeCl2 (1.5 mg, 1.2 x 10-2 
mmol), L2 (8.8 mg, 2.4 x 10-2 mmol), and zinc (1.6 mg, 2.4 x 10-2 mmol) in 103 μL of 
benzene.  Diyne 1b (56 mg, 2.4 x 10-1 mmol) dissolved in 489 μL benzene was added 
over 3 h at 70 °C.  The reaction mixture was stirred an additional 2 h for a total reaction 
time of 5 h.  After the reaction was complete (reaction monitored by GC), the product 
was isolated as described in Purification Procedure B, with silica gel flash 
chromatography using 5% ethyl acetate in hexanes (500 mL), then 10% ethyl acetate in 




extraction with 1M HCl to yield 3i (71 mg, 97%) as a yellow oil.  Rf = 0.27.  1H and 13C 
NMR spectral data were compared with known literature values.6 
Synthesis of dimethyl-3-(diethylamino)-1,4-dimethyl-5H-
cyclopenta[c]pyridine-6,6(7H)-dicarboxylate (3j).  Compound 3j was prepared using 
the general procedure with 2c (22 mg, 2.8 x 10-1 mmol), FeCl2 (1.5 mg, 1.2 x 10-2 mmol), 
L2 (8.8 mg, 2.4 x 10-2 mmol), and zinc (1.6 mg, 2.4 x 10-2 mmol) in 103 μL of benzene.  
Diyne 1b (56 mg, 2.4 x 10-1 mmol) dissolved in 489 μL benzene was added over 3 h at 
70 °C.  The reaction mixture was stirred an additional 2 h for a total reaction time of 5 h.  
After the reaction was complete (reaction monitored by GC), the product was isolated as 
described in Purification Procedure B, with silica gel flash chromatography using 10% 
ethyl acetate in hexanes, followed by an acid/base extraction with 1M HCl to yield 3j (28 
mg, 35%) as a yellow oil.  Rf = 0.27 (20% ethyl acetate in hexanes).  1H and 13C NMR 
spectral data were compared with known literature values.6 
Synthesis of dimethyl 1,4-dimethyl-3-(methyl(phenyl)amino)-5H-
cyclopenta[c]pyridine-6,6(7H)-dicarboxylate (3k).  Compound 3k was prepared using 
the general procedure with 2d (22 mg, 1.8 x 10-1 mmol), FeCl2 (1.0 mg, 7.5 x 10-2 mmol), 
L2 (5.5 mg, 1.5 x 10-2 mmol), and zinc (1.0 mg, 1.5 x 10-2 mmol) in 65 μL of benzene.  
Diyne 1b (35 mg, 1.5 x 10-1 mmol) dissolved in 310 μL benzene was added over 3 h at 
70 °C.  The reaction mixture was stirred an additional 2 h for a total reaction time of 5 h.  
After the reaction was complete (reaction monitored by GC), the product was isolated as 
described in Purification Procedure B, with silica gel flash chromatography using 5% 
ethyl acetate in hexanes (250 mL), then 10% ethyl acetate in hexanes (250 mL), 20% 




yield 3k (39 mg, 70%) as a yellowish oil.  Rf = 0.16 (20% ethyl acetate in hexanes).  1H 
and 13C NMR spectral data were compared with known literature values.6 
Synthesis of dimethyl-1,4-dimethyl-3-(piperidin-1-yl)-5H-cyclopenta[c]-
pyridine-6,6-(7H)-dicarboxylate (3l).  Compound 3l was prepared using the general 
procedure B with 2e (31 mg, 2.8 x 10-1 mmol), FeCl2 (1.5 mg, 1.2 x 10-2 mmol), L2 (8.8 
mg, 2.4 x 10-2 mmol), and zinc (1.6 mg, 2.4 x 10-2 mmol) in 121 μL of benzene.  Diyne 
1b (56 mg, 2.4 x 10-1 mmol) dissolved in 471 μL benzene was added over 3 h at 70 °C.  
The reaction mixture was stirred an additional 2 h for a total reaction time of 5 h.  After 
the reaction was complete (reaction monitored by GC), the product was isolated as 
described in Purification Procedure B, with silica gel flash chromatography using 5% 
ethyl acetate in hexanes (250 mL), then 10% ethyl acetate in hexanes (250 mL), and 20% 
ethyl acetate and hexanes (250 mL), followed by an acid/base extraction with 1M HCl to 
yield 3l (78 mg, 97%) as a yellowish oil.  Rf = 0.27 (20% ethyl acetate in hexanes). 1H 
(400 MHz, CDCl3): δ (ppm) 1.58 (q, J = 7.2 Hz, 2H) 1.68 (quint, J = 6 Hz, 4H), 2.14 (s, 
3H), 2.33 (s, 3H), 3.0 (t, J = 4.8 Hz, 4H), 3.48 (s, 2H), 3.50 (s, 2H), 3.77 (s, 6H).  13C 
(100 MHz, CDCl3) δ (ppm) 172.3, 161.8, 150.2, 148.3, 127.6, 118.3, 59.7, 53.3, 51.7, 
40.1, 38.9, 26.6, 24.9, 21.9, 14.5.  IR (cm-1):  2930, 2851, 1738, 1586, 1432, 1371, 1266, 
1199, 1163, 1114, 1062, 1028, 963, 858, 610.  HRMS (ESI, TOF) calcd for C19H27N2O4 
[M+H]+ 347.1971, found 347.1980. 
Synthesis of dimethyl-1,4-dimethyl-3-morpholino-5H-cyclopenta[c]pyridine-
6,6-(7H)-dicarboxylate (3m).  Compound 3m was prepared using the general procedure 
B with 2f (48 mg, 4.7 x 10-1 mmol), FeCl2 (2.7 mg, 2.1 x 10-2 mmol), L2 (16 mg, 4.2 x 




2.1 x 10-1 mmol) dissolved in 400 μL benzene was added over 3 h at 70 °C.  The reaction 
mixture was stirred an additional 2 h for a total reaction time of 5 h.  After the reaction 
was complete (reaction monitored by GC), the product was isolated as described in 
Purification Procedure A, with an acid/base extraction using 1M HCl, then silica gel flash 
chromatography using 20% ethyl acetate in hexanes (200 mL), then 30% ethyl acetate in 
hexanes (400 mL) to yield  3m (49 mg, 67%) as a yellowish oil.  Rf = 0.38 (20% ethyl 
acetate in hexanes).  1H and 13C NMR spectral data were compared with known literature 
values.6 
Synthesis of dimethyl-3-(5H-dibenzo[b,f]azepin-5-yl)-1,4-dimethyl-5H-
cyclopenta[c]pyridine-6,6(7H)-dicarboxylate (3n).  Compound 3n was prepared using 
the general procedure with 2g (83 mg, 4.7 x 10-1 mmol), FeCl2 (2.68 mg, 2.1 x 10-2 
mmol), L2 (15.6 mg, 4.2 x 10-2 mmol), and zinc (2.8 mg, 4.2 x 10-2 mmol) in 121 μL of 
benzene.  Diyne 1b (50 mg, 2.1 x 10-1 mmol), dissolved in 471 μL benzene, was added 
over 3 h at 70 °C.  The reaction mixture was stirred an additional 19 h for a total reaction 
time of 22 h.  After the reaction was complete (reaction monitored by GC), the product 
was isolated as described in Purification Procedure B, with silica gel flash 
chromatography using 10% ethyl acetate in hexanes followed by an acid/base extraction 
with 1M HCl to yield  3n (133 mg, 69%) as a red oil.  Rf = 0.29 (20% ethyl acetate in 
hexanes).  1H (400 MHz, CDCl3): δ (ppm) 1.78 (s, 3H), 2.44 (s, 3H), 3.44 (s, 2H), 3.54 (s, 
2H), 3.75 (s, 6H), 6.85 (s, 2H), 7.07 (dt, J = 7.2 Hz, 0.8 Hz, 2H), 7.16 (dd, J = 8 Hz, 1.6 
Hz, 2H), 7.22 (dd, J = 8 Hz, 1.6 Hz, 2H), 7.71 (dd, J = 8 Hz, 0.8 Hz, 2H).  13C (100 MHz, 
CDCl3) δ (ppm) 172.2, 156.1, 151.7, 148.4, 148.1, 135.1, 132.4, 129.6, 128.8, 127.3, 




1737, 1589, 1482, 1432, 1340, 1266, 1200, 1163, 1113, 1060, 950, 922, 865, 794, 767, 




Compounds 3o and 3o’ were prepared using the 
general procedure with 2b (13 mg, 1.9 x 10-1 mmol), 
FeCl2 (1.0 mg, 7.9 x 10-2 mmol), L2 (5.8 mg, 1.6 x 10-2 mmol), and zinc (1.0 mg, 1.6 x 
10-2 mmol) in 93 μL of benzene.  Diyne 1i (41 mg, 1.6 x 10-1 mmol), dissolved in 303 μL 
benzene, was added over 3 h at 70 °C.  The reaction was stirred an additional 5 h for a 
total reaction time of 8 h.  After the reaction was complete (reaction monitored by GC), 
the product was isolated as described in Purification Procedure B, with silica gel flash 
chromatography using 20% ethyl acetate in hexanes, followed by an acid/base extraction 
with 3M HCl to yield 3o and 3o’ (38 mg, 72%, 85:15) as a white solid.  Rf = 0.11 (20% 
ethyl acetate in hexanes).  3o: 1H (400 MHz, CDCl3): δ (ppm) 2.26 (s, 3H), 2.42 (s, 3H), 
3.02 (s, 6H), 4.45 (s, 2H), 4.51 (s, 2H), 6.12 (s, 1H), 7.32 (d, J = 8, 2H), 7.77 (d, J = 8, 
2H).  13C (100 MHz, CDCl3) δ (ppm) 159.4, 150.6, 147.2, 143.9, 134.0, 130.0, 118.2, 
96.4, 53.9, 51.9, 38.4, 22.3, 21.7.  MP 176 °C.  2-D NOESY (500 MHz, CDCl3): Hb (6.12 
ppm) correlates to Ha (4.51 ppm).  Hc (2.56 ppm) shows no correlation to Ha.  IR (cm-1): 
2918, 2849, 1614, 1579, 1503, 1408, 1342, 1309, 1159, 1099, 815, 669, 579, 543.  
HRMS (ESI, TOF) calcd for C17H22N3O2S [M+H]+ 332.1433, found 332.1433.   
Synthesis of 4-(tert-butyl)-N,N,7-trimethyl-2-tosyl-2,3-dihydro-1H-




general procedure with 2b (13 mg, 1.9 x 10-1 mmol), 
FeCl2 (1.0 mg, 7.9 x 10-2 mmol), L2 (5.8 mg, 1.6 x 10-
2 mmol), and zinc (1.0 mg, 1.6 x 10-2 mmol) in 59 μL 
of benzene.  Diyne 1j (50 mg, 1.6 x 10-1 mmol), 
dissolved in 336 μL benzene, was added over 3 h at 70 °C.  The reaction was stirred an 
additional 3 h for a total reaction time of 6 h.  After the reaction was complete (reaction 
monitored by GC), the product was isolated as described in Purification Procedure B, 
with silica gel flash chromatography using 10% ethyl acetate in hexanes, followed by an 
acid/base extraction with 3M HCl to yield 3p and 3p’ (49 mg, 80%, 88:12) as a white 
solid.  Rf = 0.27 (20% ethyl acetate in hexanes).  3p: 1H (500 MHz, CDCl3): δ (ppm) 1.29 
(s, 9H), 2.10 (s, 3H), 2.42 (s, 3H), 2.79 (s, 6H), 4.24 (s, 2H), 2.74 (s, 2H), 7.34 (d, J = 8 
Hz, 2H), 7.80 (d, J = 8 Hz, 2H).  13C (125 MHz, CDCl3) δ (ppm) 160.2, 157.6, 148.0, 
143.9, 134.0, 123.1, 127.8, 121.0, 114.6, 53.6, 52.3, 42.3, 38.6, 29.5, 21.7, 14.9.  MP 101 
°C.  2-D NOESY (800 MHz, CDCl3):  Ha (2.84 ppm) correlates to Hb (2.09 ppm).  Hc 
(1.28 ppm) does not correlate to Ha.  HMBC (800 MHz, CDCl3): C1 (161.1 ppm) couples 
with Ha (2.84 ppm) and Hb (2.09 ppm).    IR (cm-1): 3633, 2954, 2866, 2792, 2361, 1726, 
1599, 1566, 1478, 1453, 1416, 1392, 1351, 1315, 1251, 1204, 1165, 1099, 1066, 955, 
930, 816, 772, 737, 711, 665, 607, 570, 548, 513.  HRMS (ESI, TOF) calcd for 
C21H30N3O2S [M+H]+ 388.2059, found 388.2069. 
Synthesis of N,N,7-trimethyl-4-phenyl-2-
tosyl-2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-6-
amine (3q).  Compounds 3q and 3q’ were prepared 




mmol), L2 (5.8 mg, 1.6 x 10-2 mmol), and zinc (1.0 mg, 1.6 x 10-2 mmol) in 93 μL of 
benzene.  Diyne 1k (53 mg, 1.6 x 10-1 mmol), dissolved in 302 μL benzene, was added 
over 3 h at 70 °C.  The reaction was stirred an additional 3 h for a total reaction time of 6 
h.  After the reaction was complete (reaction monitored by GC), the product was isolated 
as described in Purification Procedure B, with silica gel flash chromatography using 10% 
ethyl acetate in hexanes followed by an acid/base extraction with 3M HCl to yield 3q and 
3q’ (43 mg, 67%, 86:14) as a white solid.  Rf = 0.14 (20% ethyl acetate in hexanes).  3q: 
1H (400 MHz, CDCl3): δ (ppm) 2.18 (s, 3H), 2.42 (s, 3H), 2.87 (s, 6H), 4.53 (s, 2H), 4.82 
(s, 2H), 7.28-7.47 (m, 5H), 7.76 (dd, J = 6.5, 7.5 Hz, 4H).   13C (125 MHz, CDCl3) δ 
(ppm) 161.9, 148.2, 147.1, 144.0, 139.4, 134.0, 130.1, 128.8, 128.7, 127.9, 127.8, 122.5, 
116.9, 53.7, 52.9, 42.2, 21.7, 15.3.  HMBC (800 MHz, CDCl3): C1 (165.2 ppm) couples 
with Ha(2.86 ppm) and Hb (2.17 ppm).  MP 176 °C.  IR (cm-1): 2924, 2854, 2361, 1733, 
1595, 1491, 1458, 1400, 1349, 1161, 1098, 1065, 913, 816, 753, 703, 673, 614, 581, 548.  
HRMS (ESI, TOF) calcd for C23H26N3O2S [M+H]+ 408.1746, found 408.1752.  A crystal 
of 3q’ suitable for x-ray analysis was grown by slow evaporation from an ether solution 
(see supporting information). 
Synthesis of N,N-dimethyl-4,6-di-p-tolylpyridin-2-amine 
(5a).  Compound 5a was prepared using the general procedure with 
2b (22 mg, 3.2 x 10-1 mmol), FeCl2 (2.0 mg, 1.6 x 10-2 mmol), L2 
(11.7 mg, 3.2 x 10-2 mmol), and zinc (2.1 mg, 3.2 x 10-2 mmol) in 
108 μL of benzene.  4-ethynyltoluene (73 mg, 6.3 x 10-1 mmol), 
dissolved in 287 μL benzene was added over 3 h at 50 °C.  The reaction was stirred an 




monitored by GC), the product was isolated as described in Purification Procedure A, 
with an acid/base extraction using 1M HCl then silica gel flash chromatography using 5% 
ethyl acetate in hexanes (500 mL to yield  5a (86 mg, 90%) as a white solid.  Rf = 0.57 
(20% ethyl acetate in hexanes).  1H-NMR (500 MHz, CD2Cl2) δ (ppm) 2.41 (d, J = 4.0 
Hz, 6H), 3.20 (s, 6H), 6.67 (s, 1H), 7.24 (s, 1H), 7.26 (d, J = 8.0 Hz, 2H), 7.30 (d, J = 7.5 
Hz, 2H), 7.56 (d, J = 8.5 Hz, 2H), 8.0 (d, J = 7.0 Hz, 2H) .  13C (125 MHz, CDCl3) δ 
(ppm) 159.9, 155.8, 150.7, 138.51, 138.48, 137.8, 137.7, 129.7, 129.3, 127.2, 127.0, 
107.1, 102.2, 38.3, 21.5, 21.4.  2-D NOESY (800 MHz, CDCl3): Ha (3.24 ppm) correlates 
with Hb (6.66 ppm).  HMBC (800 MHz, CDCl3): C1 (159.6 ppm) couples with Ha (3.24 
ppm) and Hb (6.66 ppm). C2 (137.6 ppm) couples with Hb (6.66 ppm) and Hc (7.30 ppm). 
MP 99 °C.  IR (cm-1): 3026, 2920, 1599, 1543, 1511, 1416, 1401, 1250, 1181, 1114, 986, 
836, 807, 602, 559.  HRMS (ESI, TOF) calcd for C21H23N2 [M+H]+ 303.1861, found 
303.1864. 
Ligand Synthesis.  L1,1 L2,37 and L430 were synthesized according to the 
literature methods. 
Synthesis of 4-(methoxy)-2,6-dimethylaniline 4-(methoxy)-2,6-
dimethylaniline was prepared using a similar literature procedure.31  In a 
nitrogen-filled glove box, a 20 mL scintillation vial was filled with CuI (353.8 
mg, 1.86 mmol) 3,4,7,8-tetramethyl-1,10-phenanthroline (877.4 mg, 3.71 mmol), Cs2CO3 
(21.5g, 111.4 mmol), and 4-iodo-2,6-dimethyl aniline1 (9.17 g, 37.1 mmol).  The vial was 
sealed with a rubber septum, removed from the glove box, then evacuated and backfilled 
with Argon three times.  Toluene (14 mL) was added and the mixture was stirred at 80 °C 




quickly replaced with a vial cap.  The reaction was stirred for 24 h at 80 °C then cooled to 
room temperature, filtered through a silica gel plug, and flushed with 150 mL of ethyl 
acetate.  The resulting solution was reduced in vacuo and purified via silica gel flash 
chromatography with 10% ethyl acetate in hexanes to yield 4-(methoxy)-2,6-
dimethylaniline (3.90 g, 51%) as a blue solid.  Rf = 0.12 (20% ethyl acetate in hexanes).  
1H NMR (300 MHz, CDCl3): δ (ppm) 2.20 (s, 6H), 3.23 (s, 2H), 3.75 (s, 3H), 6.58 (s, 
2H).  13C NMR (125 MHz, CDCl3): δ (ppm) 152.23, 134.61, 123.4, 114.1, 55.9, 18.2. MP 
38 °C.  IR (cm-1): 3449, 3371, 1923, 2835, 1604, 1490, 1378, 1328, 1300, 1243, 1192, 
1150, 1064, 949, 854, 728, 599.  HRMS (ESI, TOF) calcd for C9H14NO [M+H]+ 
152.1075, found 152.1083. 
Synthesis of 4-(methoxy)-2,6-diisopropylaniline 4-(methoxy)-
2,6-diisopropylaniline was prepared using a similar literature procedure.38 
In a nitrogen-filled glove box, a 20 mL scintillation vial was filled with 
CuI (91.9 mg, 0.48 mmol) 3,4,7,8-tetramethyl-1,10-phenanthroline (228 mg, 0.95 mmol), 
Cs2CO3 (5.58 g, 28.9 mmol), and 4-iodo-2,6-diisopropyl aniline1 (2.93 g, 9.65 mmol).  
The vial was sealed with a rubber septum, removed from the glove box, then evacuated 
and backfilled with Argon three times.  Toluene (5 mL) was added and the mixture was 
stirred at 80 °C for 20 minutes.  Methanol (869 mg, 28.9 mmol) was added and the 
rubber septum was quickly replaced with a vial cap.  The reaction was stirred for 24 h at 
80 °C then cooled to room temperature, filtered through a silica gel plug, and flushed 
with 150 mL of ethyl acetate.  The resulting solution was reduced in vacuo and purified 
via silica gel flash chromatography with 10% ethyl acetate in hexanes to yield 4-




acetate in hexanes).  1H NMR (300 MHz, CDCl3): δ (ppm) 1.32 (d, J = 6.5 Hz, 12H), 
3.01 (quint J = 7.5 Hz, 2H), 3.50 (s, 2H), 3.82 (s, 3H), 6.70 (s, 2H).  13C NMR (125 MHz, 
CDCl3): δ (ppm) 152.9, 134.4, 134.0, 108.8, 55.7, 28.3, 22.6.  IR (cm-1): 3459, 3382, 
2961, 2871, 2832, 2361, 1600, 1466, 1435, 1383, 1348, 1311, 1242, 1219, 1172, 1123, 
1103, 1042, 939, 865, 760, 669.  HRMS (ESI, TOF) calcd for C13H22NO [M+H]+ 
208.1701, found 208.1700. 
Synthesis of (N,N'E,N,N'E)-N,N'-(pyridine-
2,6-diylbis(methanylylidene))bis(4-methoxy-2,6-
dimethylaniline) (L3).  L3 was prepared from the 
similar literature procedure37 with 4-methoxy-2,6-
methyl aniline (1.54 g, 10.2 mmol) and 2,6-pyridinedicarboxaldehyde (673 mg, 4.98 
mmol) and 10 drops of glacial acetic acid in 15 mL 100% ethanol.  The reaction was 
stirred overnight at room temperature.  The mixture was then cooled to 0 °C, filtered and 
rinsed with cold 100% ethanol to yield L3 (1.9 g, 95%) as a yellow solid.  Rf = 0.37 (20% 
ethyl acetate in hexanes).  1H NMR (300 MHz, CDCl3): δ (ppm) 2.21, (s, 12H), 3.81 (s, 
6H), 6.67 (s, 4H), 7.97 (t, J = 7.8 Hz, 1H), 8.37-8.40 (m, 4H).  13C NMR (75 MHz, 
CDCl3): δ (ppm) 163.4, 156.4, 154.8, 143.9, 137.4, 128.8, 122.8, 113.7, 55.53, 19.0.  MP 
190 °C.  IR (cm-1): 3044, 2924, 2863, 2300, 1608, 1545, 1518, 1491, 1459, 1421, 1388, 
1263, 1226, 1157, 1034, 996, 948, 879, 818, 736, 638, 573, 516.  HRMS (ESI, TOF) 
calcd for C25H28N3O2 [M+H]+ 402.2182, found 402.2189. 
Synthesis of (N,N'E,N,N'E)-N,N'-(pyridine-
2,6-diylbis(methanylylidene))bis(4-(benzyloxy)-2,6-




similar literature procedure,37 with 4-methoxy-2,6-diisoproply aniline (807 mg, 3.89 
mmol) and 2,6-pyridinedicarboxaldehyde (263 mg, 1.95 mmol) and 5 drops of glacial 
acetic acid in 5 mL 100% ethanol.  The reaction was stirred overnight at room 
temperature.  The mixture was then cooled to 0 °C, filtered, and rinsed with cold 100% 
ethanol to yield L3 (891 mg, 89%) as a yellow solid.  Rf = 0.61 (20% ethyl acetate in 
hexanes).  1H NMR (500 MHz, CDCl3): δ (ppm) 1.20 (d, J = 6.7 Hz, 24H), 3.03 (quint, J 
= 6.9 Hz, 4H), 3.85 (s, 6H), 6.74 (s, 4H), 7.99 (t, J = 7.8 Hz, 1H), 8.36-8.40 (m, 4H).  13C 
NMR (125 MHz, CDCl3): δ (ppm) 163.4, 157.0, 154.7, 142.1, 139.1, 137.5, 122.8, 108.8, 
55.5, 28.4, 23.7.  MP 181 °C.  IR (cm-1): 3046, 2961, 2871, 2836, 1638, 1601, 1582, 
1462, 1383, 1327, 1289, 1238, 1198, 1169, 1125, 1107, 1076, 1039, 990, 942, 866, 763, 
739, 625, 526.  HRMS (ESI, TOF) calcd for C33H44N3O2 [M+H]+ 514.3434, found 
5143.3441. 
Synthesis of (L2)FeBr2.  Adapted from the literature 
procedure.18  In a nitrogen-filled glove box, L2 (109 mg, 5.1 x 
10-1 mmol), FeBr2 (111 mg, 5.1 x 10-1 mmol), and 3.0 mL of 
THF were combined in a vial and stirred at room temperature overnight.  Pentane was 
added to the mixture, creating a green precipitate.  This green solid was filtered and 
rinsed with pentane then dried in vacuo, yiedling a dark green solid (299.3 mg, >99%).  A 
crystal suitable for x-ray analysis was grown from slow diffusion of pentane into a 
solution of (L2)FeBr2 in THF.  Elemental Analysis calculated: C, 51.31 H, 4.65 N, 7.18 
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THE IRON-CATALYZED CONSTRUCTION OF 2-AMINOPYRIMIDINES FROM 
ALKYNENITRILES AND CYANAMIDES 
 
[Chem. Commun., 2013, 49, 7735-7737.] – 




The domain of [2+2+2] cycloaddition is poised to enter a new step in its 
evolution.  Cyclic compounds with multiple heteroatoms constitute a vast collection of 
molecules attracting considerable interest.  Such motifs are prevalent in pharmaceuticals, 
natural products, and other biologically active compounds, as well as in polymers and 
supramolecules.1  Despite such importance, the use of highly efficient [2+2+2] 
cycloadditions for the construction of these compounds has received little attention.  Such 
a reaction requires the incorporation of two heteroatom coupling partners to one 
hydrocarbon coupling partner.  However, the latter substrates are typically more reactive 
in cycloaddition and lead to products that exclude the less reactive heteroatom coupling 
partner.2   For example, the combination of alkynes and excess nitriles in the presence of 
a variety of [2+2+2] cycloaddition catalysts affords either pyridines or substituted 
benzenes, or a mixture thereof.3   Even when employing nitrile as a solvent, incorporation 
of multiple nitrogen atoms is typically not observed.4   Despite this significant obstacle, 




heteroatoms are possible.  The first example by Hoberg involved the cycloaddition of an 
alkyne and two isocyanates in the presence of stoichiometric Ni(0), producing a 
pyrimidine dione.5  The Louie lab revisited this reactivity and successfully developed the 
first catalytic [2+2+2] route to pyrimidine diones.6  This work was later followed up by 
Kondo and co-workers.7  A more recent example by Obora utilizes a niobium Lewis acid 
to afford pyrimidines from an alkyne and two nitriles (equation 1).8  While this method is 
regioselective, it requires an excess of NbCl5 that must be added in six portions over the 
course of the reaction.  Yields in this system are moderate and substrates are limited to 
aromatic nitriles.  The niobium reagent likely acts as a Lewis acid, invoking a 
nucleophilic attack of the nitrile nitrogen onto a Nb coordinated alkyne.  Such a scarcity 
of examples in this area led us to seek a new metal-catalyzed [2+2+2] cycloaddition 
method for the creation of cyclic compounds with two heteroatoms. 
 
Research by the Louie lab has demonstrated that cyanamides perform 
exceptionally well in nickel- and iron-catalyzed cycloadditions with diynes (equation 
2).9,10  Furthermore, utilizing alkynenitriles aids in the incorporation of nitrogen into 
cycloaddition products when using an iron catalyst.11  This chapter describes the 
development of a novel Fe-catalyzed cycloaddition reaction between alkynenitriles and 
cyanamides to provide 2-aminopyrimidines, a class of compounds with rich biological 








Results and Discussion 
This study was begun by applying alkynenitrile 1a and cyanamide 2a to various 
[2+2+2] transition metal catalysts under their previously developed conditions (Table 
7).14  Rhodium, cobalt, nickel, and ruthenium catalysts (entries 1-7) were ineffective 
while iridium (entry 8) only afforded a trace of 3a, as detected by GCMS.  Additionally, 
niobium, gold, silver, and copper reagents provided no products (entries 9-13).  FeI2/dppp 
was ineffective (entries 14 and 15).  However, the previously discussed Fe(OAc)2/p-
OMe,iPrPDAI system11 provided a trace of 2-aminopyrimidine (entries 16).  Curiously, our 
FeCl2/MesPDAI catalyst (entry 17) under the conditions used to produce 2-
aminopyridines10 afforded 2-aminopyimidine 3a in 16% NMR yield. 
Exhaustive optimization was carried out by myself and Minh Nguyen (Table 8).  
Expensive and highly toxic benzene was replaced with toluene at the outset of 
optimization.  Initially Fe(OAc)2 was identified as the optimum iron source (entry 3); 
however, subsequent optimization with Fe(OAc)2 was unproductive.  Attention was then 
turned to FeI2 (entry 4), which allowed for significant improvements.  Decreasing 
concentration (entry 5), increasing cyanamide loading to 3 equivalents, and ensuing 

















Figure 18.  Ligands. 
 
carbene, and bisimine ligands were ineffective, while PDI ligands could only afford 
traces of product.  Decreasing the temperature to 40 °C and increasing Zn dust loading to 
30 mol% allowed for catalyst loading to be reduced to 5 mol% (entry 16).  The need to 
increase Zn loading suggests that, at lower concentrations, the reduction of iron pre-
catalyst by Zn is perhaps more difficult, leading to the necessity for higher loading.  The 
final conditions utilize a 1:3 ratio of alkynenitrile with 5 mol% FeI2, 10 mol% iPrPDAI, 





The final optimized conditions were applied to various combinations of substrates 
(Table 9).  Model substrates 1a and 2a afforded 3a in 90% yield in 12 h (entry 1, Figure 
19); however, other substrates required extended reaction times.  Cyclic cyanamides were 
incorporated, providing 3b, 3c, and 3d in 40, 82, and 35% yields, respectively (entry 2-
4).  Me/Ph cyanamide 2e provided 3e in 40% yield over 3 days.   
Under the standard conditions 1b was unreactive, however, in the presence of 30 
mol% ZnI2, 3f was obtained in 27% yield.  While ZnI2 is known to aid in cobalt catalysis 
by stabilizing transient Co(I) species,15 its effect in iron-catalyzed reactions is still 
unclear.2,16  Applying ZnI2 to all reactions involving 1a resulted in increased reaction 
times and decreased yields.  This inconsistent activity of ZnI2 has been observed in a 
previous study.14i  Finally, the challenging terminal alkyne 1c failed to react under these 
conditions (entry 7).  Efforts to replace the cyanamide substrate with an unactivated 
nitrile, such as benzonitrile, were ineffective.  Also ineffective were 3-component 
cyclizations of 4-ethynyl toluene with either 2 equivalents of free nitrile (such as 
benzonitrile) or cyanamides (such as 2a).  Although yields are modest in many cases, this 
work demonstrates that bicyclic 2-aminopyrimidines with complex substitution patterns 
can be prepared through iron-catalyzed cycloaddition chemistry.  In some cases, 
however, yields are high, indicating that this system could be synthetically useful if 
optimization is done on a case-by-case basis. 
 
Conclusions 
????????????This work has led to the first catalytic [2+2+2] cycloaddition to produce aromatic 
diazaheterocycles.  What is especially remarkable is that iron, which has traditionally 











Figure 19.  Ortep of 3a. 
 
multiple nitriles into aromatic products.  Furthermore, traditionally more efficient 
catalysts were ineffective toward this strategy of 2-aminopyrimidine synthesis.  By 
testing the boundaries of these PDAI/iron catalyst systems, the reactivity of [2+2+2] 
cycloaddition has been expanded to include the synthesis of 2-aminopyrimidines.  
Despite exhaustive optimization for this reaction, yields remained generally low.  A 
mechanistic study of these iron systems could provide the insight necessary to improve 
and expand this methodology.  The preliminary mechanistic study will be discussed in 
the next chapter. 
 
Experimental 
All reactions were conducted under an atmosphere of N2 using standard Schlenk 
techniques or in a nitrogen-filled glove box unless otherwise noted.  Benzene and toluene 
were dried over neutral alumina under N2 using a Grubbs-type solvent purification 
system.  Iron Chloride (99.95% purity) was purchased from Alfa Aesar.  Iron(II) Bromide 
(98%), Iron(II) Iodide (anhydrous beads, ≥99.99%), and Iron(II) Acetate (≥99.99%) 
were purchased from Sigma Aldrich.  Alkynenitrile 1a was prepared from the literature 
procedure and was purified by column chromatrography and recrystallization as 
described below.17  Alkynenitrile 1c was prepared according to the literature procedure.11  




using three sequential freeze-pump-thaw cycles.  Cyanamide 2e was prepared from the 
literature procedure.9  Zinc dust was purchased from Sigma Aldrich and activated with 
HCl according to the literature procedure.18 
1H and 13C Nuclear Magnetic Resonance spectra of pure compounds were 
acquired at 300 and 75 MHz, unless otherwise noted.  All spectra are referenced to a 
singlet at 7.27 ppm for 1H and to the center line of a triplet at 77.23 ppm for 13C.  The 
abbreviations s, d, dd, dt, dq, td, t, q, quint, and sext stand for singlet, doublet, doublet of 
doublets, doublet of triplets, doublet of quartets, triplet of doublets, triplet, quartet, 
quintet, and sextet respectively.  All 13C NMR spectra were proton-decoupled.  The infra-
red spectra were recorded on a Bruker Tensor 27 FT-IR spectrometer.  Gas 
Chromatography was performed on an Agilent 6890 gas chomatograph with a 30 meter 
HP-5 column using the following conditions: initial oven temperature: 100 ºC; 
temperature ramp rate 10 ºC/min.; final temperature: 300 ºC held for 12 minutes;  
detector temperature:  250 ºC. 
General Procedure for the Cycloaddition.  In a 
nitrogen-filled glove box, 5 mol% FeI2 beads were added to the 
reaction vial.  The beads were thoroughly crushed into a fine 
powder to ensure complexation with ligand.  10 mol% iPrPDAI and toluene was added to 
a vial and the mixture was stirred for 1 hour.  At this time additional toluene, a toluene 
solution of alkynenitrile, 30 mol% Zn dust, and 3 equivalents of cyanamide were added.  
The vial was then capped, removed from the glove box and stirred in a 40 °C oil bath.  
After completion as monitored by GC, the crude mixture was purified by silica gel flash 




Synthesis of dimethyl 2-(dimethylamino)-4-methyl-5H-
cyclopenta[d]pyrimidine-6,6(7H)-dicarboxylate  (3a). Compound 3a was prepared 
using the general procedure with FeI2 (6.9 mg, 2.2 x 10-2 mmol) and iPrPDAI (16.6 mg, 
4.5 x 10-2 mmol), which were stirred in 1 mL of toluene for 1 hour.  2.5 mL of toluene, 
alkynenitrile 1a (100 mg, 4.5 x 10-1 mmol) dissolved in 1 mL of toluene, zinc dust (8.8 
mg, 1.3 x 10-1 mmol), and 2a (100 mg, 1.34 mmol) were added and the reaction was 
stirred at 40 °C for 12 h.  After the reaction was complete (monitored by GC), the product 
was isolated using silica gel flash chromatography with 25% ethyl acetate in hexanes to 
yield 3a (119 mg, 90%) as a white solid.  Rf =  0.38 (25% ethyl acetate in hexanes).  MP 
100.5-102 OC. 1H NMR (CDCl3, 300 MHz) δ 3.75 (s, 6H), 3.47 (s, 2H), 3.39 (s, 2H), 
3.15 (s, 6H), 2.25 (s, 3H). 13C NMR (CDCl3, 75 MHz) δ 172.1, 169.9, 163.1, 162.3, 
116.4, 57.4, 53.3, 42.1, 37.4, 36.2, 22.12.  IR (cm-1): 2950, 2852, 1729, 1602, 1440, 1281, 
1154, 871.  HRMS (ESI) m/z calcd for C14H20N3O4 [M + H]+ 294.1454, found 294.1455. 
Synthesis of dimethyl 4-methyl-2-(pyrrolidin-1-yl)-
5H-cyclopenta[d]pyrimidine-6,6(7H)-dicarboxylate (3b). 
Compound 3b was prepared using the general procedure with 
FeI2 (6.9 mg, 2.2 x 10-2 mmol) and iPrPDAI (16.6 mg, 4.5 x 10-2 mmol), which were 
stirred in 1 mL of toluene for 1 h.  2.5 mL of toluene, alkynenitrile 1a (100 mg, 4.5 x 10-1 
mmol) dissolved in 1 mL of toluene, zinc dust (8.8 mg, 1.3 x 10-1 mmol), and 2b (129 
mg, 1.34 mmol) were added and the reaction was stirred at 40 °C for 72 h.  After the 
reaction was complete (monitored by GC), the product was isolated using silica gel flash 
chromatography with 25% ethyl acetate in hexanes to yield 3b (57 mg, 40%) as a white 




MHz) δ 3.75 (s, 6H), 3.54 (t, J = 6.0, 4H), 3.49 (s, 2H), 3.40 (s, 2H), 2.26 (s, 3H), 1.94 (t, 
J = 6.0, 4H). 13C NMR (CDCl3, 75 MHz) δ 172.1, 169.9, 162.5, 161.3, 116.4, 57.4, 53.3, 
47.0, 42.1, 36.3, 25.7, 22.2.  IR (cm-1): 2954, 2869, 2360, 1737, 1600, 1515, 1271, 1198, 
1165, 883.  HRMS (ESI) m/z calcd for C16H22N3O4 [M + H]+ 320.1610, found 320.1610. 
Synthesis of dimethyl 4-methyl-2-(piperidin-1-yl)-
5H-cyclopenta[d]pyrimidine-6,6(7H)-dicarboxylate (3c). 
Compound 3c was prepared using the general procedure 
with FeI2 (6.9 mg, 2.2 x 10-2 mmol) and iPrPDAI (16.6 mg, 4.5 x 10-2 mmol), which were 
stirred in 1 mL of toluene for 1 h.  2.5 mL of toluene, alkynenitrile 1a (100 mg, 4.5 x 10-1 
mmol) dissolved in 1 mL of toluene, zinc dust (8.8 mg, 1.3 x 10-1 mmol), and 2c (148 
mg, 1.34 mmol) were added and the reaction was stirred at 40 °C for 48 h.  After the 
reaction was complete (monitored by GC), the product was isolated using silica gel flash 
chromatography with 25% ethyl acetate in hexanes to yield 3c (123 mg, 82%) as a clear 
oil.  Rf = 0.50  (25% ethyl acetate in hexanes).  1H NMR (CDCl3, 300 MHz) δ 3.75 (m, 
10H), 3.44 (s, 2H), 3.38 (s, 2H), 2.24 (s, 3H), 1.62 (m, 6H). 13C NMR (CDCl3, 75 MHz) 
δ 172.1, 170.0, 162.6, 162.4, 116.7, 57.4, 53.3, 45.2, 42.1, 36.2, 30.5, 26.03, 25.1, 22.24.   
IR (cm-1): 2932, 2852, 1737, 1600, 1566, 1462, 1443, 1361, 1291, 870.  HRMS (ESI) m/z 
calcd for C17H24N3O4 [M + H]+ 334.1767, found 334.1772. 
Synthesis of dimethyl 4-methyl-2-morpholino-
5H-cyclopenta[d]pyrimidine-6,6(7H)-dicarboxylate 
(3d). Compound 3d was prepared using the general 
procedure with FeI2 (6.9 mg, 2.2 x 10-2 mmol) and iPrPDAI (16.6 mg, 4.5 x 10-2 mmol) 




mg, 4.5 x 10-1 mmol) dissolved in 1 mL of toluene, zinc dust (8.8 mg, 1.3 x 10-1 mmol) 
and 2d (129 mg, 1.34 x 10-1 mmol), were added and the reaction was stirred at 40 °C for 
96 h.  After the reaction was complete (monitored by GC), the product was isolated using 
silica gel flash chromatography with 25% ethyl acetate in hexanes to yield 3d (57 mg, 
38%) as a white solid.  Rf = 0.19 (25% ethyl acetate in hexanes).  m.p. 104-106 OC. 1H 
NMR (CDCl3, 300 MHz) δ 3.76 (m, 12H), 3.47 (s, 2H), 3.41 (s, 2H), 2.26 (s, 3H). 13C 
NMR (CDCl3, 75 MHz) δ 175.1,, 172.0, 170.2, 162.6, 118.1, 67.1, 57.4, 53.4, 44.8, 42.0, 
36.2, 22.2. IR (cm-1): 2954, 1792, 1735, 1689, 1559, 1436, 1361, 1203.  HRMS (ESI) m/z 
calcd for C16H22N3O5 [M + H]+ 336.1559, found 336.1562. 
Synthesis of dimethyl 4-methyl-2-
(methyl(phenyl)amino)-5H-cyclopenta[d]pyrimidine-
6,6(7H)-dicarboxylate (3e). Compound 3e was prepared using 
the general procedure with FeI2 (6.9 mg, 2.2 x 10-2 mmol) and iPrPDAI (16.6 mg, 4.5 x 
10-2 mmol), which were stirred in 1 mL of toluene for 1 h.  2.5 mL of toluene, 
alkynenitrile 1a  (100 mg, 4.5 x 10-1 mmol) dissolved in 1 mL of toluene, zinc dust (8.8 
mg, 1.3 x 10-1 mmol), and 2e (178 mg, 1.34 mmol) were added and the reaction was 
stirred at 40 °C for 96 h.  After the reaction was complete (monitored by GC), the product 
was isolated using silica gel flash chromatography with 25% ethyl acetate in hexanes to 
yield 3e (64 mg, 40%) as a yellow oil.  Rf = 0.49  (25% ethyl acetate in hexanes).  1H 
NMR (CDCl3, 300 MHz) δ 7.30-7.38 (m, 3H),, 7.13-7.18 (m, 2H) 3.75 (s, 6H), 3.52 (s, 
3H), 3.48 (s, 2H), 3.42 (s, 2H), 2.25 (s, 3H). 13C NMR (CDCl3, 75 MHz) δ 172.0, 170.0, 
162.4, 146.2, 128.9, 126.3, 125.0, 118.7, 57.4, 53.4, 42.1, 39.0, 36.2, 22.2.  IR (cm-1): 




C19H22N3O4 [M + H]+ 356.1610, found 356.1613. 
Synthesis of N,N,4-trimethyl-6-tosyl-6,7-dihydro-5H-
pyrrolo[3,4-d]pyrimidin-2-amine (3f).  Compound 3f was prepared 
using the general procedure with FeI2 (5.9 mg, 1.9 x 10-2 mmol) and 
iPrPDAI (17.3 mg, 3.8 x 10-2 mmol), which were stirred in 1 mL of toluene for 1 h.  1.8 
mL of toluene, alkynenitrile 1b  (100 mg, 3.0 x 10-1 mmol) dissolved in 1 mL of toluene, 
zinc dust (5.9 mg, 9.0 x 10-2 mmol) and 2a (63.1 mg, 9.0 x 10-1 mmol) were added and 
the reaction was stirred at 40 °C for 96 h.  After the reaction was complete (monitored by 
GC), the product was isolated using silica gel flash chromatography with 10% ethyl 
acetate in hexanes to yield 3e (34 mg, 27%) as a white solid.  Rf = 0.12 (20% ethyl 
acetate in hexanes).  MP none, decomposed at 177 °C.  1H NMR (CDCl3, 300 MHz) δ 
7.76 (dd, J1 = 9.0, J2 = 3.0, 2H), 7.32 (dd, J1 = 9.0, J2 = 3.0, 2H), 4.46 (s, 2H), 4.40 (s, 
2H), 3.13 (s, 6H), 2.41 (s, 2.41), 2.22 (d, J = 3.0). 13C NMR (CDCl3, 75 MHz) δ 166.1, 
161.6, 133.8, 130.1, 127.8, 113.4, 54.0, 50.8, 37.4, 22.3, 21.8.  IR (cm-1): 2916.8, 2858.0, 
160.7, 1573.4, 1538.3, 1395.6, 1342.3, 1330.7, 1156.7, 1095.3, 1067.6, 820.3, 783.4.  
HRMS (ESI) m/z calcd for C16H20N4NaO2S [M + Na]+ 355.1205, found 355.1208. 
Substrate Synthesis dimethyl 2-(but-2-yn-1-yl)-2-
(cyanomethyl)malonate (1a)17.  Under nitrogen atmosphere, a 
round bottom and stir bar was charged with NaH (1.32g, 54.9 
mmol) and THF (40 mL) at 0oC.  A solution of dimethyl 2-(but-2-yn-1-yl)malonate 
(7.22g, 39.2 mmol) in 20 mL of THF was added slowly to the NaH solution at 0oC.  The 
reaction was stirred and warmed to room temperature over 30 min.  Then 




The reaction was stirred at room temperature for 1 h and refluxed for another 4 days at 
50oC.  The reaction was quenched with saturated NH4Cl, extracted with diethyl ether (3 x 
150 mL).  The solvent was removed from the extraction by reduced vacuum and purified 
by flask chromatography (2L 10%, 1L 25% EtOac/hexanes) to afford the product as a 
pale yellow oil (8.4g, 96%).  The product was further purified by recrystallization.  The 
yellow oil was dissolved in 10 mL of toluene which was layered with pentane.  This 
mixture was stored overnight at -40°C, which afforded a white solid.  MP 31.5-32.5 OC. 
1H NMR (CDCl3, 300 MHz) δ 3.79 (s, 6H), 3.11 (s, 2H), 2.94 (s, 2H), 1.2 (s, 3H).  
N-(but-2-yn-1-yl)-N-(cyanomethyl)-4-
methylbenzenesulfonamide (1b).   A 50 mL round-bottom flask was 
charged with 561.3 mg (2.14 mmol) of triphenyl phosphine, 456.0 mg 
(2.04 mmol) of N-(cyanomethyl)-4-methylbenzenesulfonamide,19 approximately 10 mL 
of anhydrous THF, and 150.0 mg (2.814 mmol) of 2-butyne-1-ol.  The reaction was 
cooled to 0 °C.  Next 432.7 mg (2.14 mmol) of Diisopropyl azodicarboxylate was added 
dropwise over 15 minutes.  The reaction was stirred for 48 h, concentrated, and isolated 
by flash column chromatography using 100 mL of each of 5%, 10%, 15%, 20%, 25%, 
and 30% of ethyl acetate in hexanes.  Evaporation of eluent yielded a clear yellow oil, 
which was further purified by recrystallization in layered pentane over toluene to obtain 
385 mg (72% yield) of the white solid title compound with melting point 60-61 °C.  Rf = 
.23 (20% ethyl acetate in hexanes).  1H NMR (500 MHz, CDCl3) δ = 7.74 (d, J = 8.5, 
2H), 7.36 (d, J = 8.5, 2H), 4.31 (s, 2H), 4.07 (s, 2H), 2.44 (s, 3H), 1.70 (m, 3H) ppm.  13C 
NMR (CDCl3, 75 MHz) δ = 145.0, 134.1, 130.1, 128.0, 113.8, 84.1, 70.3, 38.2, 35.0, 




2243.38, 1597.68, 1494.33, 1441.26, 1355.44, 1165.82, 1073.74, 909.05, 889.03, 816.30 
cm-1.  HRMS (EI) calcd. For C13H14N2O2S [M + Na]+ 285.0674; found 285.0679. 
Ligand Synthesis.  MePDAI, MesPDAI,20 p-OMe,MePDAI,10 EtPDAI, iPrPDAI, 20 and p-
OMe,iPrPDAI10 were synthesized according to the literature methods. 
Synthesis of tert-butyl (4-iodo-2,6-
diisopropylphenyl)carbamate.  A round-bottom flask was charged 
with 4-iodo-2,6-disiopropylaniline11 (1.55 g, 5.10 mmol), di-tert-
butyl dicarbonate (1.23 g, 5.61 mmol), and stir bar, and dissolved in ethanol (1.5mL). 
The reaction was stirred at 30 OC for 3 days. The resulting mixture was stirred with 1M 
HCl (~1 mL) and extracted with ether (3 x 25 mL). The organic fraction was removed in 
vacuo to yield tert-butyl (4-iodo-2,6-diisopropylphenyl)carbamate as orange solid (2g, 
97%).  MP 120-124 °C.  1H NMR (CDCl3, 300 MHz) δ 7.43 (s, 2H), 5.73, (s, 1H) 3.12 
(m, 2H), 1.52 (s, 9H), 1.18 (d, 12H).  13C (CDCl3, 75 MHz) δ 149.6, 133.1, 94.6, 85.4, 
80.3, 28.8, 28.5, 27.6, 23.6.  IR (cm-1): 3229, 3102, 2965, 2931, 2871, 1811, 1699, 1569, 
1366, 1119.  HRMS (ESI) m/z calcd for C17H26INO2Na [M + Na]+ 426.0906, found 
426.0914. 
Synthesis of 2,6-diisopropyl-4-(trifluoromethyl)aniline:  
2,6-diisopropyl-4-(trifluoromethyl)aniline was prepared using a 
similar literature procedure.21  In a glove box, a three-neck 250 mL 
round-bottom flask containing a stir bar was charged with tert-butyl (4-iodo-2,6-
diisopropylphenyl)carbamate (0.89 g, 2.20 mmol), copper iodide (2.48 g, 13.01 mmol), 
[1,1’-Bis(diphenylphosphino)ferrocene]dichloropalladium(II), complex with 




solution of methyl 2,2-difluoro-2-(fluorosulfonyl)acetate (2.5 g, 13.01 mmol) in DMF (5 
mL) was added.  The reaction was stirred at 100 OC with a reflux condenser outside the 
glove box for 2 days under N2.  The reaction was cooled to room temperature and diluted 
with CH2Cl2 (15 mL), filtered through a small plug of celite, affording a dark brown 
solution which was then washed with water (2 x 100 mL), 50% saturated aqueous NaCl 
(100 mL), and brine (100 mL).  The solution was dried over sodium sulfate, filtered 
through celite, concentrated in vacuo, purified by silica gel flash chromatography (10% 
EtOAc/hexanes) to afford deprotected 2,6-diisopropyl-4-(trifluoromethyl)aniline (0.38 
g, 50%) as an orange oil.  This product contained unknown impurities but was 
successfully carried through to the next step (p-CF3,iprPDAI).  1H NMR (CDCl3, 300 MHz) 




CF3,iPrPDAI):  p-CF3,iPrPDAI was prepared from 
the similar literature procedure20 with 2,6-
diisopropyl-4-(trifluoromethyl)aniline (0.19 g, 0.81 mmol) and 2,6-
pyridinedicarboxaldehyde (0.5 g, 0.369 mmol) and ~10 drops of glacial acetic acid in 3 
mL 100% ethanol.  The reaction was stirred for 3 days at room temperature.  The mixture 
was then cooled to 0 °C, filtered, and rinsed with cold 100% ethanol to yield p-
CF3,iPrPDAI (1.53 g, 70%) as a yellow solid.  MP 185-188 OC.  1H NMR (CDCl3, 300 
MHz) δ 8.41 (d, J = 9.0, 1H), 8.35 (s, 2H), 8.05 (t, J =9.0, 1H), 7.41 (s, 4H), 2.99 (q, J = 




126.6, 123.3, 120.3, 29.9, 28.4, 23.4.  IR (cm-1): 2962, 2917, 2869, 2849, 1704, 1646, 





terphenyl]-2'-amine)) (PhPDAI).  PhPDAI was prepared 
from the similar literature procedure20 with 2,4-diphenyl 
aniline (250 mg, 1.02 mmol)l, 2,6-pyridinedicarboxaldehyde (67.2 mg, 5.0 x 10-1 mmol) 
and ~5 drops of glacial acetic acid in 5 mL 100% ethanol.  The reaction was stirred 
overnight at room temperature.  The mixture was then cooled to 0 °C, filtered, and rinsed 
with cold 100% ethanol to yield PhPDAI (165 mg, 56%) as a yellow solid.  MP 249 °C.  
1H NMR (CDCl3, 500 MHz) δ 7.87 (s, 2H), 7.81 (d J = 9Hz, 2H), 7.58 (t, J = 9 Hz, 1H), 
7.38-7.35 (m, 12H), 7.29-7.15 (m, 14H).  13C NMR (CDCl3, 75 MHz) δ 165.0, 154.1, 
147.8, 139.9. 137.0, 133.4, 128.1, 125.2, 122.5.  IR (cm-1): 3056, 3027, 2886, 3261, 1598, 
1584, 1458, 1441, 1413, 1332, 1265, 1196, 1072, 1028, 992, 967, 917.  HRMS (ESI) m/z 
calcd for C33H38N3F6 [M + H]+ 590.2596, found 590.2592.  
Synthesis of (N,N'E,N,N'E)-N,N'-
(pyridine-2,6-diylbis(methanylylidene)) 
bis(2,4,6-tri-tert-butylaniline) (tBu3PDAI).  
tBu3PDAI was prepared from the similar 
literature procedure20 with 2,4,6-tri tert-butyl aniline (429 mg, 1.65 mmol), 2,6-
pyridinedicarboxaldehyde (109 mg, 8.0 x 10-1 mmol) and ~10 drops of glacial acetic acid 




mixture was then cooled to 0 °C, filtered, and rinsed with cold 100% ethanol to yield 
tBu3PDAI (339 mg, 59%) as a yellow solid.  MP 284-286 °C.  1H NMR (CDCl3, 300 
MHz) δ 8.41 (d, J = 1.5 Hz, 2H), 8.29 (s, 2H), 8.06 (t, J = 1.5 Hz, 1H), 7.38 (s, 4H), 1.37 
(s, 18H), 1.35 (s, 36H) .  13C NMR (CDCl3, 75 MHz) δ 163.1, 154.6, 149.6, 144.7, 138.1, 
137.7, 122.9, 122.0, 98.8, 36.1, 35.0, 31.2.  IR (cm-1): 2961, 2870, 2360, 1735, 1645, 
1567, 1455, 14427, 1392, 1269, 1213, 1118, 878, 812.  HRMS (ESI) m/z calcd for 
C33H38N3F6 [M + H]+ 644.4920, found 644.4918.  
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THE STUDY OF CATALYTIC INTERMEDIATES GENERATED IN IRON-
CATALYZED [2+2+2] PYRIDINE FORMATION 
 
Introduction 
The previously introduced iron-catalyzed [2+2+2] cycloaddition methods to 
produce pyridines, 2-aminopyridines, and 2-aminopyrimidines represent a significant 
advancement in the field of cycloaddition catalysis.  The traditionally poor catalytic 
activity of iron in this field was overcome by implementing factors that encourage the 
incorporation of nitriles into the cycloaddition product.  Nitrile incorporation was made 
possible by using alkynenitrile substrates (equation 1)1 or through the use of highly 
reactive cyanamides (equation 2).2  The combination of these two factors results in an 
entirely novel cycloaddition to afford 2-aminopyrimidines (equation 3).3  The key to 
developing these systems was the discovery that bis(aldimino)pyridine (PDAI) ligands 














 The generality of these iron-catalyzed cycloaddition systems, coupled with their 
unique reactivity trends, drive us to seek an understanding of the underlying mechanistic 
pathway.  Such an understanding will not only provide reasoning for observed trends, but 
may highlight new avenues of study.  The primary questions about these systems include: 
1) What is the oxidative identity of the active catalyst? 
 
2) What is the operative catalytic pathway; homocoupling or heterocoupling? 
 
3) Why are cyanamides more reactive than nitriles toward iron-catalyzed 
cycloaddition? 
  
Identifying the Oxidation State of the Active Catalyst 
??????????????Reactions with precatalyst complexes indicate that the active catalyst is bound to 
a single ligand.  The active catalyst has been assumed to be generated in situ when an 
?????Fe(II) salt coordinates to the ligand and undergoes a two-electron reduction by zinc 
Figure 21).  Another presumption has been that the resulting Zn(II) is a spectator playing 
??no part in the catalytic cycle.  To test these hypotheses it is necessary to obtain a well-





Figure 21.  Ligand coordination and reduction to provide active catalyst. 
 
 
workers have already studied several such complexes in depth. 
As discussed earlier, bis(imino)pyridine (PDI) ligands have demonstrated 
excellent activity in ethylene polymerization, hydrogenation, and hydrosilylation 
reactions.4  Curiously, the nearly identical bis(aldimino)pyridine (PDAI) ligands have 
exhibited rather low activity toward these reactions.  In an effort to understand these 
reactivity differences, Chirik synthesized a series of two-electron reduced (iPrPDAI)Fe(L) 
compounds and closely examined their electronic structures.5  This inquiry revealed that 
(iPrPDAI)Fe(L) and (PDI)Fe(L) complexes are nearly identical electronically.  As with 
PDI complexes, two-electron reduced (PDAI)Fe(L) complexes retain a formal Fe(II) 
oxidation state, with the additional electrons residing on the ligand (Figure 22).  The 
authors concluded that the difference in reactivity trends is perhaps due to the increased 
flexibility in the pincer arms of the aldimine ligands as compared to the ketimine 
derivatives. 
 The low-valent complex (iPrPDAI)Fe(η4-C4H6) (1) has been synthesized which, in 
a qualitative preliminary study, effected partial conversion (~50% GC yield) of 6 in the 
 reaction of alkynenitrile 4 and alkyne 5 (equation 4).  This result demonstrates that the 
  two-electron reduced 1 can catalyze the cycloaddition between 4 and 5.  When a similar 





Figure 22.  Two-electron reduction of (PDAI)FeII leads to a diradical 
dianionic ligand coordinated to FeII. 
 
 
products are detected (equation 5 and Chapter 2, Table 2).  Despite the fact that the 
iPrPDAI ligand has been proven to be effective for this type of cycloaddition (equation 4), 
it does not even produce traces of product in equation 5.  Based on the logic presented in 
Figure 21, the in situ reduced catalyst should be similar to 1 (without the butadiene 
ligand).  This may be an indication that the combination of Fe(II) salts, PDAI ligand, and 
Zn in the presence of unsaturated substrates does not generate exclusively (PDAI2-)Fe2+ 
species.  These alternative complexes will not only detract from the amount of active 
catalyst but may also hinder the desired reactivity.  Future tests of this hypothesis must 








The increased reactivity of (iPrPDAI)Fe(η4-C4H6) (1) may indicate that the in situ 
combination of Fe(OAc)2, PDAI ligand, and Zn does not completely convert into the 
active species.  Incomplete reduction could be caused by shielding of the iron center by 
the counter ions (halides, acetates, and so forth.).  Alternatively, if the reaction between 
Zn0 metal and Fe(II) is biphasic (a possibility if the zinc dust is not dissolving), the 
reduction of iron may be incomplete.  When the iron reacts with the Zn0 surface, it may 
leave a protective Zn(II) layer, preventing further reaction with the zinc particle. 
For the cycloaddition of diyne and cyanamide 9 and 10, a catalytic amount of 
(iPrPDAI)Fe(η4-C4H6) (1) led to full conversion into 11 in 24 hours (equation 6).  As 
before, this demonstrates that the active catalyst for this system is also a two-electron 
reduced complex.  Efforts to synthesize (MesPDAI)Fe(η4-C4H6) have been unsuccessful.  
The similar (MesPDAI)Fe(η4-C6H6) (27) has been made, although NMR indicates 
paramagnetic impurities.  Nevertheless, this compound demonstrates high catalytic 









The oxidative identity of the active catalyst in the reaction of alkynenitriles and 
cyanamides is not as easily determined.  Reactions with (iPrPDAI)Fe(η4-C4H6) (1) or 
(iPrPDAI)Fe(η4-C6H6) (2) provide only traces of product after 24 hours (equation 8).  
Adding Zn or ZnI2 to the reaction does not alter this result.  Curiously the combination of 
both Zn and ZnI2 with (iPrPDAI)Fe(η4-C6H6) (2) lead to a 50% (GC) yield (equation 9).  
Two potential scenarios exist which can rationalize this result.  First, both zinc and iron 
play a role in the catalytic cycle.  Second, the active catalyst is the result of further 
reduction of the iron complex.  The latter hypothesis is supported by the need for a larger 
amount (30 mol%) of Zn when generating the catalyst in situ.  The resulting anionic 








To test this second scenario, a technique used to make anionic 
tris(phosphino)borane/iron complexes (used as N2 fixation catalysts) was applied.6  
Reducing (iPrPDAI)Fe(Me2NCN)Br (13) (vide infra) with excess sodium amalgam in the 
presence of two equivalents of [12-crown-4] would theoretically generate 
(iPrPDAI)Fe(Me2NCN)- [12-crown-4]2•Na+ (14) (equation 10).  Importantly, we have 
verified that (iPrPDAI)Fe(Me2NCN)Br does not catalyze the cycloaddition of 
alkynenitriles and cyanamides.  Although it is not yet characterized, the reaction produces 
a brown product which crystalizes from THF.  Hopefully future group members will 
successfully grow x-ray-quality crystals of this potentially interesting complex.  Despite 
these efforts, a concrete understanding of the identity of the active catalyst remains 
elusive.  A 20 mol% catalyst loading of 14 only produced traces of 2-aminopyrimidine 








The above studies, combined with the information available from Chirik’s 
research, indicate that in two of the three catalytic systems, the active catalyst is a d6 
Fe(II) center bound to diradical dianionic PDAI ligand.  The third system (alkynenitriles 
+ cyanamides) may operate by a completely different catalytic pathway, perhaps 
involving zinc or utilizing an iron species of unknown electronic identity. 
 
Attempts to Isolate Metallacyclic Intermediates 
To determine the catalytic cycle employed in iron-catalyzed [2+2+2] pyridine 
formation (homocoupling or heterocoupling, Figure 23), attempts were made to isolate 
metallacyclic intermediates.  The regioselectivity of reactions between metallacycles and 
cyanamides should indicate which pathway is operative.  The cobalt-type homocoupling 
pathway tends to place the pyridine nitrogen adjacent to the larger alkyne substituent 
(when using unsymmetrical diynes, Chapter 3), while the nickel-type heterocoupling 





Figure 23.  Homocoupling and heterocoupling mechanistic pathways 
possible in iron-catalyzed cycloaddition of alkynes and nitriles. 
 
Louie iron catalysts utilize the metallacyclopentadiene intermediates similar to cobalt7, 
and not the azametallacyclopentadiene pathway employed by nickel.8 
Several attempts to isolate metallacycles from diynes or alkynenitriles were 
carried out.  Addition of these substrates to (PDAI2-)Fe2+ complexes led to mixtures 
which did not afford any isolable products (equations 12, 13).  Reduction of (PDAI)FeBr2 












When reactions with cyanamides are carried out (equations 2, 3), cyanamide is 
added last, initiating an immediate change from a green suspension to a dark green 
solution.  This may indicate that formation of a cyanamide complex initiates the catalytic 
cycle (Figure 24).  If cyanamide does coordinate to the iron prior to oxidative cyclization, 
an azaferracyclopentadiene is likely to follow, debunking the initial homocoupling 
hypothesis.  To test this hypothesis, attempts were made to isolate iron-cyanamide 
complexes.   
The first successfully isolated cyanamide complex was the trigonal bipyramidal 
(MesPDAI)Fe(Me2NCN)Br (16).  This compound is the result of coordination of 




quality crystals of compound 16 were grown and characterized by x-ray crystallography 
(Figure 25).  Due to low yields of 16, however, the analogous compound 13 was prepared 




In the absence of a reductant, compound 13 would not catalyze the cycloaddition 
of diynes and cyanamides (equation 18).  This result is consistent with the hypothesis that 
the active catalyst results from two-electron reduction.  However, in the presence of a 
zinc reductant, compound 13 affords 2-aminopyridine, effectively indicating that 






Figure 24.  Heterocoupling pathway is likely if cyanamide coordination 

















If (iPrPDAI)FeBr2 (17) is reduced in the same manner as before but in diethyl 
ether, the diazaferracyclopentadiene (iPrPDAI)Fe(Me2NCN)2 (18) is obtained (equation 
20, Figure 26A).  This unprecedented metallacycle is the result of oxidative cyclization  
of two cyanamides and exhibits a distorted square pyramidal geometry.  A related study 
by Chirik involved the oxidative cyclization of diynes or enynes with (iPrPDI)Fe(N2)2 
(Chapter 1).9  In this work, the resulting metallacycles were structurally and 
electronically characterized.  These ferracyclopentadiene products exhibited the same 
distorted square pyramidal geometry as (iPrPDAI)Fe(Me2NCN)2 (18).  Based on various 
bond length data, computational studies, and several spectroscopic analyses, the 
metallacycles were determined to be an Fe(III) species bound to a radical anionic ligand 
(Figure 27). 
Comparison of bond lengths between (iPrPDAI)Fe(Me2NCN)2 (18) and Chirik’s 
ferracyclopentadiene demonstrate remarkable similarities.  Most notably, the ligand 
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Figure 27.  (iPrPDAI)Fe(Me2NCN)2 (18) demonstrates similar geometry 
and bond distances to Chirik’s metallacycle 21. 
 
suggesting a partial double-bond characteristic.  This is indicative of a single-electron 
reduction of the ligand, with the additional electron residing primarily on the imines of 
the ligand.9  Based on this comparison we can conclude that (iPrPDAI)Fe(Me2NCN)2 (18) 
is also an Fe(III) species bound to a radical anionic ligand (Table 10).  To further 
supportthis conclusion, future studies will involve Mössbauer spectroscopy and SQUID 




Table 10.  Relevant bond length data of various (PDAI)Fe complexes 
 
 
(iPr,OMePDAI)Fe(Me2NCN)2 was also synthesized and an x-ray crystal structure was 
elucidated (Figure 26B).  Comparison of bond lengths between the two metallacycles 
demonstrates virtually no change (Table 10), suggesting that the methoxy substituent 
does not affect the electronic structure. 
The reduction of (iPrPDAI)FeBr2 in the presence of benzonitrile provides an 
interesting comparison between cyanamide and nitrile reactivity (equation 21).  Instead of  
forming a diazametallacycle, both nitriles coordinate in an end-on fashion 
(iPrPDAI)Fe(PhCN)2 (22) (Figure 28).  Although it has not oxidatively cyclized, it 






Figure 28.  Ortep of (iPrPDAI)Fe(PhCN)2 (22). 
 
Bond lengths on the ligand (imine elongation) are consistent with those of a one-electron 
reduced ligand coordinated to Fe(II) (Table 10).  The Fe-nitrile bond lengths present an 
interesting picture.  The axial Fe-N bond length is 1.8706 Å, while the equatorial nitrile is 
longer at 1.9435 Å.  This indicates that the second electron is mostly localized on the 
axial nitrile. 
In an attempt to isolate an azaferracyclopentadiene, compound 13 was stirred with 
alkyne 23 in the presence of two equivalents of a sodium amalgam reductant (Figure 29).   
The reaction quickly turns from green to brown.  From the dried crude mixture is a brown 
product which can be extracted with pentane.  When this brown solid is subjected to 
another equivalent of alkyne, an exothermic reaction occurs and a 2-aminopyridine 
product, 25, is detected by GCMS.  The 2,4,6-subsitution pattern of 25 is easily separated 
and differentiated from its other regioisomers by GCMS.  This GCMS match suggests 
that not only has the cycloaddition occurred, but with the same regioselectivity observed 
previously (chapter 3, equation 7).  The fact that this product was obtained by a 2-step 
alkyne addition to 13 suggests that an azametallacyclopentadiene, 24, was formed in the 





Figure 29.  Synthesis of 25 via azaferracyclopentadiene 24. 
 
25.  Remarkably, this reaction is so exothermic that addition of neat alkyne to a diethyl 
ether solution of 24 causes the ether to boil.  Computational studies of 
metallacyclopentadienes show that the transformation from metallacycle to metal-bound 
pyridine is significantly exothermic.10  The matching regioselectivity and the observable 
release of energy strongly suggest the presence of an azaferracyclopentadiene 
intermediate. 
Attempts to crystalize metallacycle 24 have been unsuccessful thus far.  However, 
an ether solution of this crude mixture has provided an x-ray-quality crystal of 
(iPrPDAI)Fe(Me2NCN) 26 (Figure 30).  Presumably, 26 is created when 13 undergoes a 
one-electron reduction but fails to coordinate and oxidatively cyclize an alkyne.  
Compound 26 is of significant interest to this study because we believe it is the active 





Figure 30.  Ortep of (iPrPDAI)Fe(Me2NCN) (26). 
 
cleanly produce 26 from 13 have proven unsuccessful (equation 22).  Chirik has 
synthesized a similar square planar complex 3 from 1 (equation 23).5  Analogously, 
useful quantities of 26 should be available from 1 (equation 24).  The reaction of 1 with 
dimethyl cyanamide produces a compound with the same brown color as 26.  The NMR 
of the product obtained from this reaction differs from that of 1 and exhibits broad peaks 
that fall in the range expected for 26.  However, to validate the identity of this product, it 
will be necessary to grow a crystal and compare the unit cell with that of the previously 
determined 26.  Once verified, useful amounts of compound 26 will allow for more 
comprehensive reactivity studies.  We hope that addition of an alkyne to 26 will cleanly 












Analysis of (iPrPDAI)Fe(Me2NCN) – Cyanamides vs Nitriles 
The x-ray crystal structure of 26 exhibits ligand bond lengths which are 




10).5  Particularly, the imine bond lengths (1.349 Å for both) are significantly elongated 
while the Cimine-Cipso bond lengths have contracted to 1.408 Å and 1.406 Å, respectively.  
Compound 3 was determined to be a d6 Fe(II) center coordinated to a dianionic diradical 
ligand (Figure 31).  Operating under the assumption that 26 is also a d6 Fe(II) center 
coordinated to a dianionic diradical ligand, we can qualitatively predict its electronic 
structure.  A square planar complex with C2v symmetry will adopt one of two possible 
crystal-field-splitting environments (Figure 32).  The relative energy of the dz2 orbital 
will depend on the ligand environment and could possibly be above or below the dxy 
orbital.  For a d6 metal, the HOMO will be either the dxy or dz2 orbital.  For 26, if dxy is 
the HOMO, this orbital will be unavailable to react because it is blocked by the ligands 
(Figure 32 B).  However, dz2 will be perpendicular to the ligand plane, making it 
available to react with outside LUMOs such as the π* orbital of an alkyne (Figure 32 A).  
In order for 26 to be the active catalyst, the dz2 orbital must be available to react. 
Of further interest is the cyanamide coordinated to the iron center in 26.  
Surprisingly, the dimethyl amino substituent of the cyanamide exhibits a planar geometry 
(Figure 33 A).  The planar amine can only result from significant resonance donation of 
the amine lone pair into the nitrile, creating a carbodiimide-like structure (Figure 33 B).   
This resonance structure is not available to regular nitriles (such as acetonitrile) and 
provides insight into the increased reactivity of cyanamides over nitriles.  The partial 
carbodiimide nature of the bound cyanamide may allow for an alternative nonlinear 
coordination mode.  Additionally, the partial negative charge on N1 may increase the 
overall electron density of the iron center. 









Figure 32.  Possible crystal field splittings for a d6 square planar complex 





Figure 33.  a) Cyanamide bond lengths and amine geometry of 
(iPrPDAI)Fe(Me2NCN) (26).  b) Resonance structures of 26 based 
on the planar geometry of the cyanamide amine. 
 
(iPrPDAI)Fe(Me2NCN)2 (18) , the (iPrPDAI)Fe(Me2NCN)2 (18) appears to have formed 
when a cyanamide coordinated to the open face of (iPrPDAI)Fe(Me2NCN) (26) (Figure 
34 A).  When oxidative cyclization occurs, the cyanamides do not change position in 
relation to the metal center.  We can envision the same transformation occurring between 
(iPrPDAI)Fe(Me2NCN) (26) and an alkyne.  This deviates from the traditionally accepted 
oxidative cyclization of two η2-bound coupling partners (Figure 34 B).  To substantiate 
this theory, further analysis of (iPrPDAI)Fe(Me2NCN) (26) will be necessary. 









Figure 35.  In-depth look at the formation of an azaferracyclopentadiene 




(iPrPDAI)Fe(Me2NCN) (26) and an alkyne.  Here alkyne coordination will lead to 
electron donation from the dz2 orbital of iron to the alkyne π* orbital (Figure 35 A).  
Filling the alkyne π* orbital will set in motion electron movement that breaks the alkyne 
triple bond, leading, momentarily, to a filled p-orbital at the C2-position of the alkyne.  
This filled p-orbital can then donate electrons to the π* orbital of the cyanamide, leading 
to cyclization.  While explained here in a step-wise fashion, a concerted movement of 
electrons is also reasonable.  In Figure 35 B, the same reaction occurs, but with the 
carbodiimide resonance structure of 26.  For the cases presented in Figure 35 A and B, 
the distance between C2 and C3 appears to be large enough that orbital overlap will be 
poor.  The distance from the iron center to C3 is 3.037 Å, while the average alkyne bond 
distance is only 1.20 Å (Figure 36).  The distance appears to be great enough that the 
alkyne π* orbitals will be unable to overlap with both the Fe dz2 orbital and the C3 π*  
orbital.  This poor overlap would suggest that cyclization occurs from the traditional η2-
bound coordination modes, however, one more possibility remains.  The angled 
coordination mode available from the carbodiimide resonance structure in Figure 35 C  
 
 
Figure 36.  The 1.2 Å length of an alkyne is likely not enough to bridge 





allows for increased overlap of the π* orbitals of C2 and C3.  Therefore the increased 
reactivity of cyanamides could be due to the existence of a carbodiimide-like resonance 
structure which can subsequently adopt a bent coordination mode. 
 
Conclusions 
By synthesizing and studying various bis(aldimino)pyridine iron complexes, we 
have begun to understand the mechanistic pathway in iron-catalyzed [2+2+2] 
cycloadditions of alkynes and cyanamides.  The active catalyst is likely a d6 Fe(II) bound 
to a two-electron reduced ligand.  This unique structure imparts a Lewis acidic property 
to the iron center while simultaneously providing the two electrons necessary for 
oxidative cyclization.  The Lewis acidic nature of the iron in this context likely attracts 
nitriles to coordinate in an end-on fashion, initiating a heterocoupling catalytic cycle.  
Square planar (iPrPDAI)Fe(Me2NCN) exhibits a coordinatively open dz2 HOMO, which 
can readily coordinate and donate electrons into a second coupling partner, leading to 
oxidative cyclization.  The cyclization with an end-bound cyanamide is possible due to 
the carbodiimide-like resonance structure of the coordinated cyanamide.  This resonance 
structure suggests it may be possible for the cyanamide to adopt a bent coordination 
mode, making the cyclization possible. 
The completion of this project will fall to Nathan Spahn and Shantel Leithead.  
The isolation and characterization of an azametallacyclopentadiene intermediate from 
(iPrPDAI)Fe(Me2NCN) is of paramount importance for demonstrating the above 
mentioned theories.  Additionally, further DFT calculations should be performed to 
substantiate the identity of the HOMO of (iPrPDAI)Fe(Me2NCN) and to compare the 




comparing the oxidative cyclization of η2- and η1- bound cyanamides will shed further 
light on the true nature of this important catalytic step. 
 
Experimental 
All reactions were conducted under an atmosphere of N2 using standard Schlenk 
techniques, or in a nitrogen-filled glove box, unless otherwise noted.  Toluene, diethyl 
ether, pentane, and THF were dried over neutral alumina under N2 using a Grubbs-type 
solvent purification system.  Iron Chloride (99.95% purity) was purchased from Alfa 
Aesar.  Compounds 1, 3,5 and 15, 172 were prepared from known literature procedures.  
Liquid cyanamides were distilled then degassed using three sequential freeze-pump-thaw 
cycles and stored under N2.  1H and 13C Nuclear Magnetic Resonance spectra of pure 
compounds were acquired at 400 and 100 MHz, unless otherwise noted.  The 
abbreviations s, d, dd, dt, dq, td, t, q, and quint stand for singlet, doublet, doublet of 
doublets, doublet of triplets, doublet of quartets, triplet of doublets, triplet, quartet, and 
quintet, respectively.  All 13C NMR spectra were proton-decoupled.  Gas 
Chromatography was performed on an Agilent 6890 gas chomatograph with a 30 meter 
HP-5 column using the following conditions: initial oven temperature: 100 ºC; 
temperature ramp rate 10 ºC/min.; final temperature: 300 ºC held for 12 minutes;  
detector temperature:  250 ºC. 
(iPrPDAI)Fe(Me2NCN)Br (13).  In a round-bottom 
flask, (iPrPDAI)FeBr2 (17) (1.02g, 1.52 mmol) and dimethyl 
cyanamide (116.9 mg, 1.68 mmol) were stirred in 50 mL of 
toluene for 30 minutes at room temperature.  Meanwhile a 




(14.0g, 69.8 mmol) in 5 mL of toluene was stirred for 30 minutes.  After 30 minutes the 
Na(Hg) mixture was added to 17 and dimethyl cyanamide, and the reaction was stirred 
for 30 minutes.  At this time the reaction was passed through a plug of celite and rinsed 
with 20 mL diethyl ether.  The solvent was removed and the resulting green solid was 
rinsed with 3 x 5 mol portions of pentane.  The pentane was discarded, yielding 651 mg 
of (iPrPDAI)FeBr2 (13) (65% yield).   
(iPrPDAI)Fe(Me2NCN)- [Na(12-C-4)]+ (14).  
In a 1.5 dram vial, sodium (7.8 mg, 0.33 mmol) and 
mercury (1.6g, 7.7 mmol) were stirred in 2 mL of 
toluene.  After 30 mintues the Na(Hg) mixture was 
added to a solution of (iPrPDAI)FeBr2 (17) (100 mg, 
0.15 mmol) and 12-C-4 (53.5 mg, 0.30 mmol) in 15 mL of toluene and stirred for 90 
minutes.  The resulting brown mixture was passed through a plug of celite and rinsed 
with 20 mL of THF.  The solvent was removed and the resulting green solid was rinsed 
with 3 x 2 mol portions of pentane then 3 x 2 mL portions of diethyl ether.  The 
remaining brown solid was dissolved in 5 mL of THF, passed through celite, and stored 
at -40°C.  Crystals had formed from this solution but were not of high enough quality for 
x-ray analysis.  The mother liquor was dried and the remaining reddish brown solid was 
stored under N2 at room temperature.  A % yield was not obtained. 
(MesPDAI)Fe(Me2NCN)Br (16).  In a 1.5 dram vial, 
(MesPDAI)FeBr2 (15) (50 mg, 0.086 mmol) and dimethyl 
cyanamide (6.3  mg, 0.090 mmol) were stirred in 2 mL of toluene 




with sodium (4.3 mg, 0.19 mmol) and mercury (874 mg, 4.4 mmol) in 1 mL of toluene 
was stirred for 30 minutes.  After 30 mintues the Na(Hg) mixture was added to 15 and 
dimethyl cyanamide and the reaction was stirred for 30 minutes.  At this time the reaction 
was passed through a plug of celite and rinsed with 5 mL diethyl ether.  The solvent was 
removed and the resulting green solid was rinsed with 2 x 1 mL portions of pentane 
which was discarded.  The remaining green solid was dissolved in 2 mL of diethyl ether, 
passed through pentane, and stored at -40°C.  Large green crystals formed which were of 
high enough quality for x-ray analysis.  A yield was not determined.  Elemental Analysis 
calculated: C, 58.45; H, 5.78; N, 12.17; found: C, 57.91; H, 5.82; N, 11.85.   
(iPrPDAI)Fe(Me2NCN)2 (18).  In a 20 mL 
scintillation vial, (iPrPDAI)FeBr2 (17) (500 mg, 
0.747 mmol) and dimethyl cyanamide (157 mg, 
2.24 mmol) were stirred in 15 mL of diethyl ether 
for 30 minutes at room temperature.  Meanwhile a separate vial with sodium (37.8 mg, 
1.64 mmol) and mercury (7.6 g, 38 mmol) in 5 mL of diethyl ether was stirred for 30 
minutes.  At this time the Na(Hg) mixture was added to 16 and dimethyl cyanamide, and 
the reaction was stirred for 30 minutes.  The brown mixture reaction was passed through 
a plug of celite and rinsed with 20 mL diethyl ether.  The solvent was removed and the 
resulting dark brown solid was stirred with 20 mL of pentane.  The pentane solution was 
passed through celite and stored at -40°C.  (iPrPDAI)Fe(Me2NCN)2 (18) crystalized with 
one molecule of pentane, yielding 67.7mg (14% yield).  These crystals were analyzed by 
x-ray crystallography.  Elemental Analysis calculated: C, 68.40; H, 7.91; N, 15.09; 




(OMe,iPrPDAI)FeBr2 (19).  In a round-bottom flask, 
OMe,iPrPDAI3 (101 mg, 0.20 mmol) and FeBr2 (43 mg, 0.20 mmol) 
were stirred in 2 mL of THF for 24 h.  Additional THF was added 
until the green product was dissolved, then the solution was passed 
through celite, removing a brown impurity.  Pentane was added until 
the product precipitated and the green/brown product was collected, 
yielding 63 mg (74% yield).   
(OMe,iPrPDAI)Fe(Me2NCN)2 (20).  In a 20 mL 
scintillation vial, (iPrPDAI)FeBr2 (17) (500 mg, 0.747 mmol) 
and dimethyl cyanamide (157 mg, 2.24 mmol) were stirred in 
15 mL of diethyl ether for 30 minutes at room temperature.  Meanwhile a separate vial 
with sodium (37.8 mg, 1.64 mmol) and mercury (7.6 g, 38 mmol) in 5 mL of diethyl 
ether was stirred for 30 minutes.  At this time the Na(Hg) mixture was added to 17 and 
dimethyl cyanamide, and the reaction was stirred for 30 minutes.  The brown mixture 
reaction was passed through a plug of celite and rinsed with 20 mL diethyl ether.  The 
solvent was removed and the resulting dark brown solid was stirred with 20 mL of 
pentane.  The pentane solution was passed through celite and stored at -40°C.  Crystals 
resulting from this solution were analyzed by x-ray crystallography. 
(iPrPDAI)Fe(PhCN)2 (22).  In a 25 mL round-bottom 
flask, (iPrPDAI)FeBr2 (17) (50 mg, 0.075 mmol) and 
benzonitrile (8.5 mg, 0.082 mmol) were stirred in 5 mL of 
toluene for 30 minutes at room temperature.  Meanwhile a 




of diethyl ether was stirred for 30 minutes.  At this time the Na(Hg) mixture was added to 
17 and benzonitrile and the reaction was stirred for 30 minutes.  The brown mixture 
reaction was passed through a plug of celite and rinsed with 10 mL diethyl ether.  The 
solvent was removed and the resulting dark brown solid was stirred with 10 mL of 
pentane for 2 minutes.  The pentane solution was passed through celite and stored at -
40°C.  Crystals resulting from this solution were analyzed by x-ray crystallography. 
Metallacycle (24) and (iPrPDAI)Fe(Me2NCN) (26).  
In a 25 mL round bottom flask, (iPrPDAI)Fe(Me2NCN)Br (13) 
(40 mg, 0.075 mmol) and 4-ethynyl toluene (8.5 mg, 0.067 
mmol) were stirred in 5 mL of toluene for 30 minutes at room 
temperature.  Meanwhile a separate vial with sodium (2.8 mg, 0.12 mmol) and mercury 
(559 mg, 2.8 mmol) in 2 mL of diethyl ether was stirred for 30 minutes.  At this time the 
Na(Hg) mixture was added to 13 and 4-ethynyl toluene, and the reaction was stirred for 
30 minutes.  The brown mixture reaction was passed through a plug of celite and rinsed 
with 20 mL diethyl ether.  The solvent was removed, and the resulting dark brown solid 
was stirred with 5 mL of pentane for 2 minutes.  The pentane solution was passed 
through celite and solvent was removed, yielding what is presumed to be (24).  1H NMR 
was too convoluted to provide any useful information.  After treatment with pentane, a 
brown solid remained.  This was stirred with 2 mL of diethyl ether for 2 minutes and the 
resulting brown solution was passed through celite and stored in the freezer.  A mixture 
of low-quality green crystals and a small amount of high-quality brown crystals were 





(MesPDAI)Fe(η6-C6-H6) (27).  Sodium (31 mg, 1.3 mmol) was 
stirred with mercury (6.2 g, 31 mmol) in 4 mL of diethyl ether for 30 
minutes.  The amalgam mixture was added to a suspension of 
(MesPDAI)FeBr2 (15) in 10 mL of benzene and the reaction was stirred 
for 16 hours.  The brown mixture was passed through celite and rinsed 
with 10 mL of pentane.  Solvent was removed, yielding 141 mg of (MesPDAI)Fe(η6-C6-
H6) (27) (55% yield).   
(MesPDAI)Fe(η6-C6-H6) (27) (4.6 mg, 0.0091 mmol) was dissolved in 109 μL of 
benzene and pyrrolidine-1-carbonitrile (21 mg, 0.22 mmol) was added in a 1.5 dram vial 
which was capped with a septum cap. A separate solution, containing N,N-di(but-2-yn-1-
yl)-4-methylbenzenesulfonamide in 323 μL of benzene, was added to a syringe.  The 
diyne solution was slowly added via syringe pump to the stirring mixture of 27 and 
cyanamide at 70 °C over 3 h.  After 6 h the product was purified as described in Chapter 
3, yielding 65 mg of 4,7-dimethyl-6-(pyrrolidin-1-yl)-2-tosyl-2,3-dihydro-1H-
pyrrolo[3,4-c]pyridine (96% yield). 
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